Section 73

EurekaMag PDF full texts Chapter 72,861


Mallick, I.H.; Winslet, M.C. 2004: Vascular complications of pancreatitis. Jop: Journal of the Pancreas 5(5): 328-337
Osius, E.A. 1960: Vascular complications of pregnancy. Illinois Medical Journal 117: 401-407
Daher, I.N.; Yeh, E.T.H. 2008: Vascular complications of selected cancer therapies. Nature Clinical Practice. Cardiovascular Medicine 5(12): 797-805
Alves, D.Dias.; Menezes, Hório.Sampaio.; Chacur, R.; Mafaldo, R.Cadore.; Chacur, Nívea.Maria.Bordin.da.Silva.; Gomes, L.Dias.; Nardi, Ríssa.; de Castro, G.Andressa.Marchesin.; Borges, V.Pletsch.Brendler.; Gomes, M.Guimarães.Dias. 2021: Vascular complications with injection implants: treatment with hyperbaric chamber. Case Reports in Plastic Surgery and Hand Surgery 8(1): 81-86
Robbs, J.V.; Naidoo, K.S. 1981: Vascular compression of the brachial plexus following stab injuries to the neck. South African Medical Journal 60(9): 345-346
Burrington, J.D. 1976: Vascular compression of the duodenum. Surgery 80(5): 655
Acosta, B.; Guachalla, G.; Martínez, C.; Felce, S.; Ledezma, G. 1991: Vascular compression of the duodenum. G.E.N 45(1): 61-64
Rietberg, M. 1966: Vascular compression of the duodenum. Nederlands Tijdschrift Voor Geneeskunde 110(45): 1981-1986
Del Valle Hernández, E.; Goyanes Martínez, A.; Muñiz González, J. 1984: Vascular compression of the duodenum. Revista Espanola de Las Enfermedades del Aparato Digestivo 65(1): 41-48
Morag, Y.; Altshuler, D.; Udager, K.; Yang, L.C. 2021: Vascular compromise in a torsed transposed ulnar nerve case in support of intravenous contrast administration. Clinical Imaging 70: 118-123
Ouellette, J.; Toussay, X.; Comin, C.H.; Costa, L.da.F.; Ho, M.; Lacalle-Aurioles, Mía.; Freitas-Andrade, M.; Liu, Q.Yan.; Leclerc, S.; Pan, Y.; Liu, Z.; Thibodeau, J-François.; Yin, M.; Carrier, M.; Morse, C.J.; Dyken, P.Van.; Bergin, C.J.; Baillet, S.; Kennedy, C.R.; Tremblay, M-Ève.; Benoit, Y.D.; Stanford, W.L.; Burger, D.; Stewart, D.J.; Lacoste, B. 2020: Vascular contributions to 16p11.2 deletion autism syndrome modeled in mice. Nature Neuroscience 23(9): 1090-1101
Gonzalez-Fernandez, E.; Liu, Y.; Auchus, A.P.; Fan, F.; Roman, R.J. 2021: Vascular contributions to cognitive impairment and dementia: the emerging role of 20-HETE. Clinical Science 135(15): 1929-1944
Adams, M.A.; Banting, J.D.; Maurice, D.H.; Morales, A.; Heaton, J.P. 1997: Vascular control mechanisms in penile erection: phylogeny and the inevitability of multiple and overlapping systems. International Journal of Impotence Research 9(2): 85-91
Morin-Poulard, Iël.; Sharma, A.; Louradour, I.; Vanzo, N.; Vincent, A.; Crozatier, Mèle. 2016: Vascular control of the Drosophila haematopoietic microenvironment by Slit/Robo signalling. Nature Communications 7: 11634
Van Steenkiste, C.; Trachet, B.; Casteleyn, C.; van Loo, D.; Van Hoorebeke, L.; Segers, P.; Geerts, A.; Van Vlierberghe, H.; Colle, I. 2010: Vascular corrosion casting: analyzing wall shear stress in the portal vein and vascular abnormalities in portal hypertensive and cirrhotic rodents. Laboratory Investigation; a Journal of Technical Methods and Pathology 90(11): 1558-1572
Zhu, D.C.; Tarumi, T.; Khan, M.Ayaz.; Zhang, R. 2015: Vascular coupling in resting-state fMRI: evidence from multiple modalities. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 35(12): 1910-1920
Song, C.W.; Kang, M.S.; Rhee, J.G.; Levitt, S.H. 1980: Vascular damage and delayed cell death in tumours after hyperthermia. British Journal of Cancer 41(2): 309-312
McMonagle, M.P.; Sarani, B.; Jenoff, J.; Schwab, C.W. 2021: Vascular damage control at the thoracic outlet. Annals of the Royal College of Surgeons of England 103(8): E244-E248
Peng, T.-W.; Zuo, Y.; Chen, J.-G.; Zhang, H.-B.; Zhang, Y.-H.; Xu, G.-Q.; Zhao, S.-C. 2020: Vascular damage-related risk factors for erectile dysfunction in patients with type 2 diabetes mellitus: Analysis based on a nomogram model. Zhonghua Nan Ke Xue 26(5): 399-408
Zhou, Z.; Liao, Y.; Li, L.; Wei, F.; Wang, B.; Wei, Y.; Wang, M.; Cheng, X. 2008: Vascular damages in rats immunized by alpha1-adrenoceptor peptides. Cellular and Molecular Immunology 5(5): 349-356
Chan, W.B.; Chan, N.N.; Lai, C.W.K.; So, W.Y.; Lo, M.K.W.; Lee, K.F.; Chow, C.C.; Metreweli, C.; Chan, J.C.N. 2006: Vascular defect beyond the endothelium in type II diabetic patients with overt nephropathy and moderate renal insufficiency. Kidney International 70(4): 711-716
Hong, S-Beom.; Furihata, M.; Baba, M.; Zbar, B.; Schmidt, L.S. 2006: Vascular defects and liver damage by the acute inactivation of the VHL gene during mouse embryogenesis. Laboratory Investigation; a Journal of Technical Methods and Pathology 86(7): 664-675
Chicoine, L.G.; Rodino-Klapac, L.R.; Shao, G.; Xu, R.; Bremer, W.G.; Camboni, M.; Golden, B.; Montgomery, C.L.; Shontz, K.; Heller, K.N.; Griffin, D.A.; Lewis, S.; Coley, B.D.; Walker, C.M.; Clark, K.Reed.; Sahenk, Z.; Mendell, J.R.; Martin, P.T. 2014: Vascular delivery of rAAVrh74.MCK.GALGT2 to the gastrocnemius muscle of the rhesus macaque stimulates the expression of dystrophin and laminin α2 surrogates. Molecular Therapy: the Journal of the American Society of Gene Therapy 22(4): 713-724
Giatromanolaki, A.; Koukourakis, M.I.; Sivridis, E.; Gatter, K.C.; Trarbach, T.; Folprecht, G.; Shi, M.M.; Lebwohl, D.; Jalava, T.; Laurent, D.; Meinhardt, G.; Harris, A.L. 2012: Vascular density analysis in colorectal cancer patients treated with vatalanib (PTK787/ZK222584) in the randomised CONFIRM trials. British Journal of Cancer 107(7): 1044-1050
Teo, N.B.; Shoker, B.S.; Jarvis, C.; Martin, L.; Sloane, J.P.; Holcombe, C. 2002: Vascular density and phenotype around ductal carcinoma in situ (DCIS) of the breast. British Journal of Cancer 86(6): 905-911
Westphal, J.R.; van't Hullenaar, R.G.; van der Laak, J.A.; Cornelissen, I.M.; Schalkwijk, L.J.; van Muijen, G.N.; Wesseling, P.; de Wilde, P.C.; Ruiter, D.J.; de Waal, R.M. 1997: Vascular density in melanoma xenografts correlates with vascular permeability factor expression but not with metastatic potential. British Journal of Cancer 76(5): 561-570
Ghassemi, F.; Berijani, S.; Roohipoor, R.; Mohebbi, M.; Babeli, A.; Gholizadeh, A.; Sabour, S. 2020: Vascular density of optic nerve head in diabetic retinopathy using optical coherence tomography angiography. International Journal of Retina and Vitreous 6(1): 62
Hannappe, M-Antoine.; Arnould, L.; Méloux, A.; Mouhat, B.; Bichat, F.; Zeller, M.; Cottin, Y.; Binquet, C.; Vergely, C.; Creuzot-Garcher, C.; Guenancia, C. 2020: Vascular density with optical coherence tomography angiography and systemic biomarkers in low and high cardiovascular risk patients. Scientific Reports 10(1): 16718
Rushia, S.N.; Shehab, A.A.S.; Motter, J.N.; Egglefield, D.A.; Schiff, S.; Sneed, J.R.; Garcon, E. 2020: Vascular depression for radiology: a review of the construct, methodology, and diagnosis. World Journal of Radiology 12(5): 48-67
Bhujwalla, Z.M.; Artemov, D.; Natarajan, K.; Ackerstaff, E.; Solaiyappan, M. 2001: Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts. Neoplasia 3(2): 143-153
Geraldes, R.; Esiri, M.M.; Perera, R.; Yee, S.A.; Jenkins, D.; Palace, J.; DeLuca, G.C. 2020: Vascular disease and multiple sclerosis: a post-mortem study exploring their relationships. Brain: a Journal of Neurology 143(10): 2998-3012
Macy, D. 1954: Vascular disease in diabetes mellitus. Delaware Medical Journal 26(5): 110-112
Zacks, S.I. 1962: Vascular disease in diabetes mellitus. Medical Science 12: 373-386
Rico, T.; Marchione, R.; Kirsner, R.S. 2009: Vascular disease in psoriasis. Journal of Investigative Dermatology 129(10): 2327
Roberts, A. 2014: Vascular disease. Beneficial statins underused in PAD. Nature Reviews. Cardiology 11(5): 249
King, A. 2012: Vascular disease. Corticosteroid therapy improves outcomes for Japanese children with Kawasaki disease. Nature Reviews. Cardiology 9(5): 255
Roberts, A. 2014: Vascular disease. Disparities in treatment and mortality from ruptured AAA between England and the USA. Nature Reviews. Cardiology 11(5): 247
Mearns, B.M. 2011: Vascular disease. High plasma renin activity linked to increased risk of death. Nature Reviews. Cardiology 8(6): 303
King, A. 2013: Vascular disease: Atherosclerosis unravelled--clues from ancient civilizations. Nature Reviews. Cardiology 10(5): 240
Lim, G.B. 2017: Vascular disease: Benefits of population screening for vascular risk. Nature Reviews. Cardiology 14(11): 632
Fernández-Ruiz, I. 2016: Vascular disease: Carotid artery stenosis - stenting or endarterectomy?. Nature Reviews. Cardiology 13(4): 181
Huynh, K. 2017: Vascular disease: Cell therapy lowers PAD amputation risk. Nature Reviews. Cardiology 14(3): 130
Razzak, M. 2014: Vascular disease: Clearing the pipes via angiophagy. Nature Reviews. Nephrology 10(5): 243
Ruiz, I.Fernández. 2016: Vascular disease: Combination therapy for PAD. Nature Reviews. Cardiology 13(1): 4
Roberts, A. 2014: Vascular disease: Could AAA screening reduce mortality?. Nature Reviews. Cardiology 11(4): 187
Binning, M.J.; Hopkins, L.Nelson. 2010: Vascular disease: Endovascular treatment of vertebral artery stenosis. Nature Reviews. Cardiology 7(5): 245-246
Lim, G.B. 2012: Vascular disease: Even low-risk individuals can benefit from statin therapy. Nature Reviews. Cardiology 9(7): 371
Lim, G.B. 2011: Vascular disease: Exercise outperforms stenting for claudication in patients with aortoiliac PAD. Nature Reviews. Cardiology 9(1): 5
Lim, G.B. 2015: Vascular disease: Little gain of function after lower leg revascularization in the elderly. Nature Reviews. Cardiology 12(6): 319
Lim, G.B. 2011: Vascular disease: No added benefit of niacin with statins. Nature Reviews. Cardiology 9(1): 3
Huynh, K. 2018: Vascular disease: PCSK9 inhibition in PAD. Nature Reviews. Cardiology 15(1): 4-5
Lim, G.B. 2013: Vascular disease: Peripheral artery disease pandemic. Nature Reviews. Cardiology 10(10): 552-553
Lim, G.B. 2013: Vascular disease: Ramipril improves walking times in patients with PAD. Nature Reviews. Cardiology 10(4): 180
Karthikesalingam, A.; Thompson, M.M. 2013: Vascular disease: Repair of infrarenal aortic aneurysm--the debate is OVER. Nature Reviews. Cardiology 10(3): 122-124
Fernández-Ruiz, I. 2017: Vascular disease: Ticagrelor not superior to clopidogrel for PAD. Nature Reviews. Cardiology 14(1): 4-5
Lim, G.B. 2017: Vascular disease: Treatment of ischaemic vascular disease with 3D-printed vessels. Nature Reviews. Cardiology 14(8): 442-443
Wrighton, K.H. 2017: Vascular disease: Trialling stem cell treatment for vascular disease. Nature Reviews. Nephrology 13(7): 384
Huynh, K. 2016: Vascular disease: Vorapaxar for the treatment of PAD. Nature Reviews. Cardiology 13(4): 184
Cully, M. 2014: Vascular disease: a new way to starve vascular endothelial cells. Nature Reviews. Drug Discovery 13(3): 176-177
King, A. 2013: Vascular disease: aortic plaque--dual therapy for a heterogeneous disease. Nature Reviews. Cardiology 10(7): 366
Osório, J. 2011: Vascular disease: cholesterol-efflux capacity might be the key to the protective effects of HDL. Nature Reviews. Cardiology 8(3): 122
Lim, G.B. 2011: Vascular disease: gene therapy for CLI disappoints. Nature Reviews. Cardiology 8(8): 423
Lederle, F.A. 2009: Vascular disease: is AAA screening worth the cost?. Nature Reviews. Cardiology 6(10): 616-618
Lim, G.B. 2011: Vascular disease: lowering LDL cholesterol reduces atherosclerotic risk in patients with chronic kidney disease. Nature Reviews. Cardiology 8(8): 424
Taylor, A.J.; Bots, M.L.; Kastelein, J.J.P. 2011: Vascular disease: meta-regression of CIMT trials-data in, garbage out. Nature Reviews. Cardiology 8(3): 128-130
Schmitt, C.A. 2011: Vascular disease: now official: smoking promotes peripheral artery disease in women. Nature Reviews. Cardiology 8(8): 423
Rolla, E.H. 1952: Vascular diseases of the brain. El Dia Medico 24(78): 2048-2052
Meyer, H.H. 1958: Vascular diseases of the brain. Annales Universitatis Saraviensis. Medizin 6(3-4): 300-302
Adams, R.D.; Cohen, M.E. 1947: Vascular diseases of the brain. BULLETIN. new England Medical Center Hospital 9(6): 261-273
Adams, R.D.; Cohen, M.E. 1947: Vascular diseases of the brain. BULLETIN. new England Medical Center Hospital 9(4): 180-190
Adams, R.D.; Cohen, M.E. 1947: Vascular diseases of the brain. BULLETIN. new England Medical Center Hospital 9(5): 222; Passim
Ratschow, M. 1956: Vascular diseases, with special consideration of peripheral circulatory disorders. Munchener Medizinische Wochenschrift 98(17): 597-598 Contd
Huynh, K. 2017: Vascular diseases: Shear-thinning biomaterial for endovascular embolization. Nature Reviews. Cardiology 14(2): 67
Oury, P.; Larmurier, X.; Britsch, A. 1946: Vascular disorders during digestive disorders. La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 22: 565-571
Poulsen, J.E. 1952: Vascular disorders in diabetes mellitus. Maanedsskrift for Praktisk Laegegerning Og Social Medicin 30(9): 389-395
Marston, A. 1968: Vascular disorders of the colon. Tijdschrift Voor Gastro-Enterologie 11(4): 396-408
Sersa, G.; Jarm, T.; Kotnik, T.; Coer, A.; Podkrajsek, M.; Sentjurc, M.; Miklavcic, D.; Kadivec, M.; Kranjc, S.; Secerov, A.; Cemazar, M. 2008: Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. British Journal of Cancer 98(2): 388-398
Yin, T.; Liu, Y.; Peeters, R.; Feng, Y.; Yu, J.; Himmelreich, U.; Oyen, R.; Ni, Y. 2017: Vascular disrupting agent in pancreatic and hepatic tumour allografts: observations of location-dependent efficacy by MRI, microangiography and histomorphology. British Journal of Cancer 117(10): 1529-1536
Smolarczyk, R.; Czapla, J.; Jarosz-Biej, M.; Czerwinski, K.; Cichoń, T. 2021: Vascular disrupting agents in cancer therapy. European Journal of Pharmacology 891: 173692
Hinnen, P.; Eskens, F.A.L.M. 2007: Vascular disrupting agents in clinical development. British Journal of Cancer 96(8): 1159-1165
Augenreich, M.; Stickford, J.; Stute, N.; Koontz, L.; Cope, J.; Bennett, C.; Ratchford, S.M. 2020: Vascular dysfunction and oxidative stress caused by acute formaldehyde exposure in female adults. American Journal of Physiology. Heart and Circulatory Physiology 319(6): H1369-H1379
Garoffolo, G.; Pesce, M. 2021: Vascular dysfunction and pathology: focus on mechanical forces. Vascular Biology 3(1): R69-R75
Jeon, Y.K.; Shin, M.J.; Saini, S.K.; Custodero, C.; Aggarwal, M.; Anton, S.D.; Leeuwenburgh, C.; Mankowski, R.T. 2021: Vascular dysfunction as a potential culprit of sarcopenia. Experimental Gerontology 145: 111220
Roura, S.; Bayes-Genis, A. 2009: Vascular dysfunction in idiopathic dilated cardiomyopathy. Nature Reviews. Cardiology 6(9): 590-598
Nguyen Dinh Cat, A.; Callera, G.E.; Friederich-Persson, M.; Sanchez, A.; Dulak-Lis, M.Gabriela.; Tsiropoulou, S.; Montezano, A.C.; He, Y.; Briones, A.M.; Jaisser, F.; Touyz, R.M. 2018: Vascular dysfunction in obese diabetic db/db mice involves the interplay between aldosterone/mineralocorticoid receptor and Rho kinase signaling. Scientific Reports 8(1): 2952
Yim-Yeh, S.; Rahangdale, S.; Nguyen, A.Tu.Duy.; Stevenson, K.E.; Novack, V.; Veves, A.; Malhotra, A. 2011: Vascular dysfunction in obstructive sleep apnea and type 2 diabetes mellitus. Obesity 19(1): 17-22
Ido, Y.; Chang, K.C.; Lejeune, W.S.; Bjercke, R.J.; Reiser, K.M.; Williamson, J.R.; Tilton, R.G. 2001: Vascular dysfunction induced by AGE is mediated by VEGF via mechanisms involving reactive oxygen species, guanylate cyclase, and protein kinase C. Microcirculation 8(4): 251-263
Gerstner, E.R.; Emblem, K.E.; Yen, Y-Fen.; Dietrich, J.; Jordan, J.T.; Catana, C.; Wenchin, K.Lou.; Hooker, J.M.; Duda, D.G.; Rosen, B.R.; Kalpathy-Cramer, J.; Jain, R.K.; Batchelor, T.T. 2020: Vascular dysfunction promotes regional hypoxia after bevacizumab therapy in recurrent glioblastoma patients. Neuro-OncologyAdvances 2(1):Vdaa 157
González Rodríguez, J.F.; Gutiérrez Del Olmo y Galván, A.; Loscos Valerio, J.M.; Nisa Gutiérrez, M.E.; Baki, M.W.; Asteinza Daganzo, M.; Ramírez Armengol, J.A. 1995: Vascular ectasia of the antrum. Gastroenterologia y Hepatologia 18(1): 55; Author Reply 55-6
Boley, S.J.; Sammartano, R.; Brandt, L.J.; Sprayregen, S. 1979: Vascular ectasias of the colon. Surgery Gynecology and Obstetrics 149(3): 353-359
Grases, P.J.; Matos, M.; Wright, H.; Salomón, R. 1986: Vascular ectasias of the colon. G.E.N 40(4): 211-216
Şahin, H.; Güngören, A.; Sezgin, B.; Ün, B.; Şahin, E.Adeviye.; Dolapçioğlu, K.; Bayik, R.Nida. 2020: Vascular effect of levonorgestrel intrauterine system on heavy menstrual bleeding: is it associated with hemodynamic changes in uterine, radial, and spiral arteries?. Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 2020: 1-5
Sauter, H. 1949: Vascular effect of various pharmaceuticals, especially adrenaline and the dihydrogenated secaleal alkaloids in the postpartum human uterus. Schweizerische Medizinische Wochenschrift 79(25): 572-576
Coltamai, L.; Bucher, M.; Maillard, M.P.; Shukla, U.; Bohidar, N.; Haskell, L.; Bertelsen, K.; Fedgchin, M.; Vogt, B.; Burnier, M. 2009: Vascular effects of RWJ-676070, a selective combined V1a/V2 vasopressin receptor antagonist. Clinical Pharmacology and Therapeutics 85(2): 145-148
Movahed, P.; Evilevitch, V.; Andersson, T.L.G.; Jönsson, B.A.G.; Wollmer, P.; Zygmunt, P.M.; Högestätt, E.D. 2005: Vascular effects of anandamide and N-acylvanillylamines in the human forearm and skin microcirculation. British Journal of Pharmacology 146(2): 171-179
Szekanecz, Zán.; Kerekes, Görgy.; Soltész, Pál. 2009: Vascular effects of biologic agents in RA and spondyloarthropathies. Nature Reviews. Rheumatology 5(12): 677-684
Campia, U. 2020: Vascular effects of cancer treatments. Vascular Medicine 25(3): 226-234
Frost, B.R.; Frewin, D.B.; Downey, J.A. 1979: Vascular effects of etilefrine. Further studies to substantiate the predominant indirect sympathomimetic action of this agent. Australian Journal of Experimental Biology and Medical Science 57(4): 443-446
Natali, A.; Nesti, L. 2021: Vascular effects of insulin. Metabolism, Clinical and Experimental 124: 154891
Chataigneau, T.; Schini-Kerth, Vérie.B. 2005: Vascular effects of ovariectomy and chronic oestrogen treatment in rats: controversy or experimental protocol diversity?. British Journal of Pharmacology 144(2): 161-163
Iorga, E.R.; Costin, D.ăn.ț 2020: Vascular emergencies in neuro-ophthalmology. Romanian Journal of Ophthalmology 64(4): 323-332
Pearson, J.D.; Gordon, J.L. 1979: Vascular endothelial and smooth muscle cells in culture selectively release adenine nucleotides. Nature 281(5730): 384-386
Palmer, R.M.; Ashton, D.S.; Moncada, S. 1988: Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333(6174): 664-666
Senzaki, K.; Okada, Y.; Ochi, H.; Ochi, M.; Takei, S.I.; Miura, S.; Igase, M.; Ohyagi, Y. 2021: Vascular endothelial dysfunction associated with severity in multiple sclerosis. Multiple Sclerosis and Related Disorders 54: 103135
Suh, H-S.; Park, Y-W.; Kang, J-H.; Lee, S-H.; Lee, H-S.; Shim, K-W. 2005: Vascular endothelial dysfunction tested by blunted response to endothelium-dependent vasodilation by salbutamol and its related factors in uncomplicated pre-menopausal obese women. International Journal of Obesity 29(2): 217-222
Knapp, M.; Tu, X.; Wu, R. 2019: Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy. Acta Pharmacologica Sinica 40(1): 1-8
Kiseleva, R.Yu.; Greineder, C.F.; Villa, C.H.; Marcos-Contreras, O.A.; Hood, E.D.; Shuvaev, V.V.; DeLisser, H.M.; Muzykantov, V.R. 2018: Vascular endothelial effects of collaborative binding to platelet/endothelial cell adhesion molecule-1 (PECAM-1). Scientific Reports 8(1): 1510
Baker, G.; Bloxham, S.; Laden, J.; Gush, R. 2020: Vascular endothelial function is improved after active mattress use. Journal of Wound Care 29(Sup9a): S18-S25
Jalal, D.I.; Jablonski, K.L.; McFann, K.; Chonchol, M.B.; Seals, D.R. 2012: Vascular endothelial function is not related to serum uric acid in healthy adults. American Journal of Hypertension 25(4): 407-413
Iesato, Y.; Murata, T. 2010: Vascular endothelial growth factor (VEGF). Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 9): 250-254
Bouzoubaa, S.M.; Benlahfid, M.; Sidqui, M.; Aboussaouira, T.; Rifki, C.; Brouillet, S.; Traboulsi, W.; Alfaidy, N.; Benharouga, M. 2020: Vascular endothelial growth factor (VEGF) and Endocrine gland-VEGF (EG-VEGF) are down regulated in head and neck cancer. Clinical Otolaryngology: Official Journal of Ent-Uk ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology and Cervico-Facial Surgery 45(5): 788-795
Harper, M.E.; Glynne-Jones, E.; Goddard, L.; Thurston, V.J.; Griffiths, K. 1996: Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells. British Journal of Cancer 74(6): 910-916
Dall'Era, J.E.; Meacham, R.B.; Mills, J.N.; Koul, S.; Carlsen, S.N.; Myers, J.B.; Koul, H.K. 2008: Vascular endothelial growth factor (VEGF) gene therapy using a nonviral gene delivery system improves erectile function in a diabetic rat model. International Journal of Impotence Research 20(3): 307-314
Long, J.; Hu, Z.; Xue, H.; Wang, Y.; Chen, J.; Tang, F.; Zhou, J.; Liu, L.; Qiu, W.; Zhang, S.; Ouyang, Y.; Ye, Y.; Xu, G.; Li, L.; Zeng, Z. 2019: Vascular endothelial growth factor (VEGF) impairs the motility and immune function of human mature dendritic cells through the VEGF receptor 2-RhoA-cofilin1 pathway. Cancer Science 110(8): 2357-2367
Herrlinger, U.; Wiendl, H.; Renninger, M.; Förschler, H.; Dichgans, J.; Weller, M. 2004: Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic value. British Journal of Cancer 91(2): 219-224
Lee, C.Geun.; Link, H.; Baluk, P.; Homer, R.J.; Chapoval, S.; Bhandari, V.; Kang, M.Jong.; Cohn, L.; Kim, Y.Keun.; McDonald, D.M.; Elias, J.A. 2004: Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nature Medicine 10(10): 1095-1103
Min, C-K.; Kim, S.Y.; Lee, M.J.; Eom, K.S.; Kim, Y.J.; Kim, H.J.; Lee, S.; Cho, S.G.; Kim, D.W.; Lee, J.W.; Min, W.S.; Kim, C.C.; Cho, C.S. 2006: Vascular endothelial growth factor (VEGF) is associated with reduced severity of acute graft-versus-host disease and nonrelapse mortality after allogeneic stem cell transplantation. Bone Marrow Transplantation 38(2): 149-156
Iguchi, A.; Kobayashi, R.; Yoshida, M.; Kobayashi, K.; Matsuo, K.; Kitajima, I.; Maruyama, I. 2001: Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of hepatic veno-occlusive disease (VOD) in stem cell transplantation. Bone Marrow Transplantation 27(11): 1173-1180
Tokunaga, T.; Oshika, Y.; Abe, Y.; Ozeki, Y.; Sadahiro, S.; Kijima, H.; Tsuchida, T.; Yamazaki, H.; Ueyama, Y.; Tamaoki, N.; Nakamura, M. 1998: Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer. British Journal of Cancer 77(6): 998-1002
Chuai, Y.; Rizzuto, I.; Zhang, X.; Li, Y.; Dai, G.; Otter, S.J.; Bharathan, R.; Stewart, A.; Wang, A. 2021: Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer. Cochrane Database of Systematic Reviews 3: Cd013348
Salah, N.Y. 2020: Vascular endothelial growth factor (VEGF), tissue inhibitors of metalloproteinase-1 (TIMP-1) and nail fold capillaroscopy changes in children and adolescents with Gaucher disease; relation to residual disease severity. Cytokine 133: 155120
Kikuchi, R.; Tsuboi, N.; Sada, K.-E.; Nakatochi, M.; Yokoe, Y.; Suzuki, A.; Maruyama, S.; Murohara, T.; Matsushita, T.; Amano, K.; Atsumi, T.; Takasaki, Y.; Ito, S.; Hasegawa, H.; Dobashi, H.; Ito, T.; Makino, H.; Matsuo, S. 2021: Vascular endothelial growth factor (VEGF)-A and VEGF-A165b are associated with time to remission of granulomatosis with polyangiitis in a nationwide Japanese prospective cohort study. Annals of Clinical Biochemistry 58(2): 86-94
Lv, H.; Nan, Z.; Jiang, P.; Wang, Z.; Song, M.; Ding, H.; Liu, D.; Zhao, G.; Zheng, Y.; Hu, Y. 2019: Vascular endothelial growth factor 165 inhibits pro-fibrotic differentiation of stromal cells via the DLL4/Notch4/smad7 pathway. Cell Death and Disease 10(9): 681
Greb, R.R.; Maier, I.; Wallwiener, D.; Kiesel, L. 1999: Vascular endothelial growth factor A (VEGF-A) mRNA expression levels decrease after menopause in normal breast tissue but not in breast cancer lesions. British Journal of Cancer 81(2): 225-231
Darrington, E.; Zhong, M.; Vo, B-Han.; Khan, S.A. 2012: Vascular endothelial growth factor A, secreted in response to transforming growth factor-β1 under hypoxic conditions, induces autocrine effects on migration of prostate cancer cells. Asian Journal of Andrology 14(5): 745-751
Hagberg, C.E.; Falkevall, A.; Wang, X.; Larsson, E.; Huusko, J.; Nilsson, I.; van Meeteren, L.A.; Samen, E.; Lu, L.; Vanwildemeersch, M.; Klar, J.; Genove, G.; Pietras, K.; Stone-Elander, S.; Claesson-Welsh, L.; Ylä-Herttuala, S.; Lindahl, P.; Eriksson, U. 2010: Vascular endothelial growth factor B controls endothelial fatty acid uptake. Nature 464(7290): 917-921
Hu, L.; Shan, Z.; Wang, F.; Gao, X.; Tong, Y. 2021: Vascular endothelial growth factor B exerts lipid-lowering effect by activating AMPK via VEGFR1. Life Sciences 276: 119401
Jia, J.-D.; Jiang, W.-G.; Luo, X.; Li, R.-R.; Zhao, Y.-C.; Tian, G.; Li, Y.-N. 2021: Vascular endothelial growth factor B inhibits insulin secretion in MIN6 cells and reduces Ca2+ and cyclic adenosine monophosphate levels through PI3K/AKT pathway. World Journal of Diabetes 12(4): 480-498
Lu, X.; Hu, S.; Liao, Y.; Zheng, J.; Zeng, T.; Zhong, X.; Liu, G.; Gou, L.; Chen, L. 2020: Vascular endothelial growth factor B promotes transendothelial fatty acid transport into skeletal muscle via histone modifications during catch-up growth. American Journal of Physiology. Endocrinology and Metabolism 319(6): E1031-E1043
Karkkainen, M.J.; Haiko, P.; Sainio, K.; Partanen, J.; Taipale, J.; Petrova, T.V.; Jeltsch, M.; Jackson, D.G.; Talikka, M.; Rauvala, H.; Betsholtz, C.; Alitalo, K. 2004: Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nature Immunology 5(1): 74-80
Weickhardt, A.J.; Williams, D.S.; Lee, C.K.; Chionh, F.; Simes, J.; Murone, C.; Wilson, K.; Parry, M.M.; Asadi, K.; Scott, A.M.; Punt, C.J.A.; Nagtegaal, I.D.; Price, T.J.; Mariadason, J.M.; Tebbutt, N.C. 2015: Vascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancer. British Journal of Cancer 113(1): 37-45
Skalny, A.V.; Mazilina, A.N. 2021: Vascular endothelial growth factor VEGF and metal-ligand homeostasis in the pathogenesis of ischemic stroke. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 121(8 Part 2): 30-34
Ancelin, M.; Chollet-Martin, S.; Hervé, M.Astrid.; Legrand, C.; El Benna, J.; Perrot-Applanat, M. 2004: Vascular endothelial growth factor VEGF189 induces human neutrophil chemotaxis in extravascular tissue via an autocrine amplification mechanism. Laboratory Investigation; a Journal of Technical Methods and Pathology 84(4): 502-512
Dao, D.T.; Nandivada, P.; Vuong, J.T.; Anez-Bustillos, L.; Pan, A.; Kishikawa, H.; Mitchell, P.D.; Baker, M.A.; Fell, G.L.; Martin, T.; Puder, M. 2018: Vascular endothelial growth factor accelerates compensatory lung growth by increasing the alveolar units. Pediatric Research 83(6): 1182-1189
Alon, T.; Hemo, I.; Itin, A.; Pe'er, J.; Stone, J.; Keshet, E. 1995: Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nature Medicine 1(10): 1024-1028
Aldridge, S.E.; Lennard, T.W.J.; Williams, J.R.; Birch, M.A. 2005: Vascular endothelial growth factor acts as an osteolytic factor in breast cancer metastases to bone. British Journal of Cancer 92(8): 1531-1537
Gee, M.F.W.; Tsuchida, R.; Eichler-Jonsson, C.; Das, B.; Baruchel, S.; Malkin, D. 2005: Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid. Oncogene 24(54): 8025-8037
Cvetanovic, M.; Patel, J.M.; Marti, H.H.; Kini, A.R.; Opal, P. 2011: Vascular endothelial growth factor ameliorates the ataxic phenotype in a mouse model of spinocerebellar ataxia type 1. Nature Medicine 17(11): 1445-1447
Ferrara, N.; Ferrara, N. 2010: Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy. Nature Medicine 16(10): 1107-1111
Ria, R.; Roccaro, A.M.; Merchionne, F.; Vacca, A.; Dammacco, F.; Ribatti, D. 2003: Vascular endothelial growth factor and its receptors in multiple myeloma. Leukemia 17(10): 1961-1966
Ohta, Y.; Watanabe, Y.; Murakami, S.; Oda, M.; Hayashi, Y.; Nonomura, A.; Endo, Y.; Sasaki, T. 1997: Vascular endothelial growth factor and lymph node metastasis in primary lung cancer. British Journal of Cancer 76(8): 1041-1045
Ambs, S.; Bennett, W.P.; Merriam, W.G.; Ogunfusika, M.O.; Oser, S.M.; Khan, M.A.; Jones, R.T.; Harris, C.C. 1998: Vascular endothelial growth factor and nitric oxide synthase expression in human lung cancer and the relation to p53. British Journal of Cancer 78(2): 233-239
McGrory, C.L.; Ryan, K.M.; Gallagher, B.; McLoughlin, D.M. 2020: Vascular endothelial growth factor and pigment epithelial-derived factor in the peripheral response to ketamine. Journal of Affective Disorders 273: 380-383
Félétou, M.; Staczek, J.; Duhault, J. 2001: Vascular endothelial growth factor and the in vivo increase in plasma extravasation in the hamster cheek pouch. British Journal of Pharmacology 132(6): 1342-1348
Zelazowska-Rutkowska, B.; Skotnicka, B.; Cylwik, B. 2020: Vascular endothelial growth factor and transforming growth factor β in hypertrophic adenoids in children suffering from otitis media with effusion. Cytokine 133: 155125
Feliers, D. 2009: Vascular endothelial growth factor as a prognostic marker of lupus nephritis. Kidney International 75(12): 1251-1253
Tataryn, N.M.; Singh, V.; Dyke, J.P.; Berk-Rauch, H.E.; Clausen, D.M.; Aronowitz, E.; Norris, E.H.; Strickland, S.; Ahn, H.J. 2021: Vascular endothelial growth factor associated dissimilar cerebrovascular phenotypes in two different mouse models of Alzheimer's Disease. Neurobiology of Aging 107: 96-108
Hayashibara, T.; Fujimoto, T.; Miyanishi, T.; Yamada, Y.; Maita, T.; Kamihira, S.; Tomonaga, M. 1999: Vascular endothelial growth factor at high plasma levels is associated with extranodal involvement in adult T cell leukemia patients. Leukemia 13(10): 1634-1635
Campbell, B.; Chuhran, C.; Lefer, A.M. 2000: Vascular endothelial growth factor attenuates trauma-induced injury in rats. British Journal of Pharmacology 129(1): 71-76
Rico, T.; Green, J.; Kirsner, R.S. 2009: Vascular endothelial growth factor delivery via gene therapy for diabetic wounds: first steps. Journal of Investigative Dermatology 129(9): 2084
Celletti, F.L.; Waugh, J.M.; Amabile, P.G.; Brendolan, A.; Hilfiker, P.R.; Dake, M.D. 2001: Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nature Medicine 7(4): 425-429
Chung, C-Chih.; Lin, Y-Kuo.; Chen, Y-Chang.; Kao, Y-Hsun.; Lee, T-I.; Chen, Y-Jen. 2020: Vascular endothelial growth factor enhances profibrotic activities through modulation of calcium homeostasis in human atrial fibroblasts. Laboratory Investigation; a Journal of Technical Methods and Pathology 100(2): 285-296
Dreyer, C.H.; Kjaergaard, K.; Ding, M.; Qin, L. 2020: Vascular endothelial growth factor for in vivo bone formation: a systematic review. Journal of Orthopaedic Translation 24: 46-57
Awata, T. 2010: Vascular endothelial growth factor gene polymorphisms in susceptibility to coronary artery disease. American Journal of Hypertension 23(9): 938-939
Taimeh, Z.; Loughran, J.; Birks, E.J.; Bolli, R. 2013: Vascular endothelial growth factor in heart failure. Nature Reviews. Cardiology 10(9): 519-530
Pu, J.; Liu, Y.; Gui, S.; Tian, L.; Xu, S.; Song, X.; Zhong, X.; Chen, Y.; Chen, X.; Yu, Y.; Liu, L.; Zhang, H.; Wang, H.; Zhou, C.; Zhao, L.; Xie, P. 2020: Vascular endothelial growth factor in major depressive disorder, schizophrenia, and bipolar disorder: a network meta-analysis. Psychiatry Research 292: 113319
Coradini, D.; Biganzoli, E.; Pellizzaro, C.; Veneroni, S.; Oriana, S.; Ambrogi, F.; Erdas, R.; Boracchi, P.; Daidone, M.G.; Marubini, E. 2003: Vascular endothelial growth factor in node-positive breast cancer patients treated with adjuvant tamoxifen. British Journal of Cancer 89(2): 268-270
Heer, K.; Kumar, H.; Speirs, V.; Greenman, J.; Drew, P.J.; Fox, J.N.; Carleton, P.J.; Monson, J.R.; Kerin, M.J. 1998: Vascular endothelial growth factor in premenopausal women--indicator of the best time for breast cancer surgery?. British Journal of Cancer 78(9): 1203-1207
Fernandez, M.; Bonkovsky, H.L. 2003: Vascular endothelial growth factor increases heme oxygenase-1 protein expression in the chick embryo chorioallantoic membrane. British Journal of Pharmacology 139(3): 634-640
Thau-Zuchman, O.; Shohami, E.; Alexandrovich, A.G.; Leker, R.R. 2010: Vascular endothelial growth factor increases neurogenesis after traumatic brain injury. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 30(5): 1008-1016
Plate, K.H.; Breier, G.; Weich, H.A.; Risau, W. 1992: Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359(6398): 845-848
Ferrara, N.; Chen, H.; Davis-Smyth, T.; Gerber, H.P.; Nguyen, T.N.; Peers, D.; Chisholm, V.; Hillan, K.J.; Schwall, R.H. 1998: Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nature Medicine 4(3): 336-340
Ahn, S.Yoon.; Park, W.Soon.; Kim, Y.Eun.; Sung, D.Kyung.; Sung, S.In.; Ahn, J.Yin.; Chang, Y.Sil. 2018: Vascular endothelial growth factor mediates the therapeutic efficacy of mesenchymal stem cell-derived extracellular vesicles against neonatal hyperoxic lung injury. Experimental and Molecular Medicine 50(4): 26
Chang, J.-H.; Cheng, C.-C.; Lu, Y.-Y.; Chung, C.-C.; Yeh, Y.-H.; Chen, Y.-C.; Higa, S.; Chen, S.-A.; Chen, Y.-J. 2021: Vascular endothelial growth factor modulates pulmonary vein arrhythmogenesis via vascular endothelial growth factor receptor 1/NOS pathway. European Journal of Pharmacology 911: 174547
Li, S.-J.; Kao, Y.-H.; Chung, C.-C.; Cheng, W.-L.; Lin, Y.-K.; Chen, Y.-J. 2021: Vascular endothelial growth factor on Runt-related transcript factor-2 in aortic valve cells. European Journal of Clinical Investigation 51(5): E13470
Koutras, A.K.; Kotoula, V.; Papadimitriou, C.; Dionysopoulos, D.; Zagouri, F.; Kalofonos, H.P.; Kourea, H.P.; Skarlos, D.V.; Samantas, E.; Papadopoulou, K.; Kosmidis, P.; Pectasides, D.; Fountzilas, G. 2014: Vascular endothelial growth factor polymorphisms and clinical outcome in patients with metastatic breast cancer treated with weekly docetaxel. Pharmacogenomics Journal 14(3): 248-255
Lin, T-Hsien.; Su, H-Ming.; Wang, C-Ling.; Voon, W-Chol.; Shin, S-Jang.; Lai, W-Ter.; Sheu, S-Hsiung. 2010: Vascular endothelial growth factor polymorphisms and extent of coronary atherosclerosis in Chinese population with advanced coronary artery disease. American Journal of Hypertension 23(9): 960-966
Takayama, K.; Reynolds, P.N.; Adachi, Y.; Kaliberova, L.; Uchino, J.; Nakanishi, Y.; Curiel, D.T. 2007: Vascular endothelial growth factor promoter-based conditionally replicative adenoviruses for pan-carcinoma application. Cancer Gene Therapy 14(1): 105-116
Mezache, L.; Struckman, H.L.; Greer-Short, A.; Baine, S.; Györke, Sándor.; Radwański, Pław.B.; Hund, T.J.; Veeraraghavan, R. 2020: Vascular endothelial growth factor promotes atrial arrhythmias by inducing acute intercalated disk remodeling. Scientific Reports 10(1): 20463
Luo, J.; Liang, Y.; Kong, F.; Qiu, J.; Liu, X.; Chen, A.; Luxon, B.A.; Wu, H.W.; Wang, Y. 2017: Vascular endothelial growth factor promotes the activation of hepatic stellate cells in chronic schistosomiasis. Immunology and Cell Biology 95(4): 399-407
Lesslie, D.P.; Summy, J.M.; Parikh, N.U.; Fan, F.; Trevino, J.G.; Sawyer, T.K.; Metcalf, C.A.; Shakespeare, W.C.; Hicklin, D.J.; Ellis, L.M.; Gallick, G.E. 2006: Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases. British Journal of Cancer 94(11): 1710-1717
Folpe, A.L.; Veikkola, T.; Valtola, R.; Weiss, S.W. 2000: Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 13(2): 180-185
Terabayashi, T.; Ito, Y.; Mizuno, M.; Suzuki, Y.; Kinashi, H.; Sakata, F.; Tomita, T.; Iguchi, D.; Tawada, M.; Nishio, R.; Maruyama, S.; Imai, E.; Matsuo, S.; Takei, Y. 2015: Vascular endothelial growth factor receptor-3 is a novel target to improve net ultrafiltration in methylglyoxal-induced peritoneal injury. Laboratory Investigation; a Journal of Technical Methods and Pathology 95(9): 1029-1043
Chen, L.; Hamrah, P.; Cursiefen, C.; Zhang, Q.; Pytowski, B.; Streilein, J.Wayne.; Dana, M.Reza. 2004: Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity. Nature Medicine 10(8): 813-815
Jeong, K.H.; Cho, K.-O.; Lee, M.-Y.; Kim, S.Y.; Kim, W.-J. 2021: Vascular endothelial growth factor receptor-3 regulates astroglial glutamate transporter-1 expression via mTOR activation in reactive astrocytes following pilocarpine-induced status epilepticus. Glia 69(2): 296-309
Karkkainen, M.J.; Petrova, T.V. 2000: Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene 19(49): 5598-5605
Bouchentouf, M.; Benabdallah, B.F.; Bigey, P.; Yau, T.M.; Scherman, D.; Tremblay, J.P. 2008: Vascular endothelial growth factor reduced hypoxia-induced death of human myoblasts and improved their engraftment in mouse muscles. Gene Therapy 15(6): 404-414
Makkeyah, S.M.; Elseedawy, M.E.; Abdel-Kader, H.M.; Mokhtar, G.M.; Ragab, I.A. 2021: Vascular endothelial growth factor response with propranolol therapy in patients with infantile hemangioma. Pediatric Hematology and Oncology 2021: 1-10
Greene, J.; Banasr, M.; Lee, B.; Warner-Schmidt, J.; Duman, R.S. 2009: Vascular endothelial growth factor signaling is required for the behavioral actions of antidepressant treatment: pharmacological and cellular characterization. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 34(11): 2459-2468
Guo, D.; Murdoch, C.E.; Xu, H.; Shi, H.; Duan, D.Darrel.; Ahmed, A.; Gu, Y. 2017: Vascular endothelial growth factor signaling requires glycine to promote angiogenesis. Scientific Reports 7(1): 14749
Pfister, C.; Pfrommer, H.; Tatagiba, M.S.; Roser, F. 2012: Vascular endothelial growth factor signals through platelet-derived growth factor receptor β in meningiomas in vitro. British Journal of Cancer 107(10): 1702-1713
Montazeri, L.; Sobat, M.; Kowsari-Esfahan, R.; Rabbani, S.; Ansari, H.; Barekat, M.; Firoozi, S.; Rajabi, S.; Vahdat, S.; Baharvand, H.; Pahlavan, S. 2020: Vascular endothelial growth factor sustained delivery augmented cell therapy outcomes of cardiac progenitor cells for myocardial infarction. Journal of Tissue Engineering and Regenerative Medicine 14(12): 1939-1944
Agarwal, A.; Rochwerg, B.; Lamontagne, Fçois.; Siemieniuk, R.Ac.; Agoritsas, T.; Askie, L.; Lytvyn, L.; Leo, Y-Sin.; Macdonald, H.; Zeng, L.; Amin, W.; Barragan, F.AJ.; Bausch, F.Jacquerioz.; Burhan, E.; Calfee, C.S.; Cecconi, M.; Chanda, D.; Dat, V.Quoc.; De Sutter, A.; Du, B.; Geduld, H.; Gee, P.; Gotte, M.; Harley, N.; Hashimi, M.; Hunt, B.; Jehan, F.; Kabra, S.K.; Kanda, S.; Kim, Y-Jean.; Kissoon, N.; Krishna, S.; Kuppalli, K.; Kwizera, A.; Lisboa, T.; Mahaka, I.; Manai, H.; Mino, G.; Nsutebu, E.; Preller, J.; Pshenichnaya, N.; Qadir, N.; Sabzwar 2020: A living WHO guideline on drugs for covid-19. Bmj 370(6): M3379
Onesto, C.; Hannoun-Lévi, J-M.; Chamorey, E.; Formento, J-L.; Ramaioli, A.; Pagès, G. 2006: Vascular endothelial growth factor-A and Poly(A) binding protein-interacting protein 2 expression in human head and neck carcinomas: correlation and prognostic significance. British Journal of Cancer 94(10): 1516-1523
Luengas-Martinez, A.; Hardman-Smart, J.; Paus, R.; Young, H.S. 2020: Vascular endothelial growth factor-A as a promising therapeutic target for the management of psoriasis. Experimental Dermatology 29(8): 687-698
Bulysheva, A.A.; Hargrave, B.; Burcus, N.; Lundberg, C.G.; Murray, L.; Heller, R. 2016: Vascular endothelial growth factor-A gene electrotransfer promotes angiogenesis in a porcine model of cardiac ischemia. Gene Therapy 23(8-9): 649-656
Amano, T.; Iijima, H.; Shinzaki, S.; Tashiro, T.; Iwatani, S.; Tani, M.; Otake, Y.; Yoshihara, T.; Sugimoto, A.; Egawa, S.; Yamaguchi, S.; Kinoshita, K.; Araki, M.; Hirao, M.; Sakakibara, Y.; Hiyama, S.; Ogawa, H.; Nagaike, K.; Murata, J.; Komori, M.; Okuda, Y.; Kizu, T.; Tsujii, Y.; Hayashi, Y.; Inoue, T.; Takahashi, H.; Mizushima, T.; Morii, E.; Takehara, T. 2021: Vascular endothelial growth factor-A is an Immunohistochemical biomarker for the efficacy of bevacizumab-containing chemotherapy for duodenal and jejunal adenocarcinoma. Bmc Cancer 21(1): 978
Zhao, W-Li.; Mourah, S.; Mounier, N.; Leboeuf, C.; Daneshpouy, M.Ertault.; Legrès, L.; Meignin, V.; Oksenhendler, E.; Maignin, C.Le.; Calvo, F.; Brière, J.; Gisselbrecht, C.; Janin, A. 2004: Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progression. Laboratory Investigation; a Journal of Technical Methods and Pathology 84(11): 1512-1519
Palmer, B.R.; Paterson, M.A.; Frampton, C.M.; Pilbrow, A.P.; Skelton, L.; Pemberton, C.J.; Doughty, R.N.; Ellis, C.J.; Troughton, R.W.; Richards, A.M.; Cameron, V.A. 2021: Vascular endothelial growth factor-A promoter polymorphisms, circulating VEGF-A and survival in acute coronary syndromes. Plos one 16(7): E0254206
Hasegawa, S.; Nakano, T.; Torisu, K.; Tsuchimoto, A.; Eriguchi, M.; Haruyama, N.; Masutani, K.; Tsuruya, K.; Kitazono, T. 2017: Vascular endothelial growth factor-C ameliorates renal interstitial fibrosis through lymphangiogenesis in mouse unilateral ureteral obstruction. Laboratory Investigation; a Journal of Technical Methods and Pathology 97(12): 1439-1452
Lee, A.S.; Lee, J.E.; Jung, Y.J.; Kim, D.H.; Kang, K.P.; Lee, S.; Park, S.K.; Lee, S.Y.; Kang, M.J.; Moon, W.S.; Kim, H.J.; Jeong, Y.B.; Sung, M.J.; Kim, W. 2013: Vascular endothelial growth factor-C and -D are involved in lymphangiogenesis in mouse unilateral ureteral obstruction. Kidney International 83(1): 50-62
Tsurusaki, T.; Kanda, S.; Sakai, H.; Kanetake, H.; Saito, Y.; Alitalo, K.; Koji, T. 1999: Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. British Journal of Cancer 80(1-2): 309-313
Yokoyama, Y.; Charnock-Jones, D.S.; Licence, D.; Yanaihara, A.; Hastings, J.M.; Holland, C.M.; Emoto, M.; Umemoto, M.; Sakamoto, T.; Sato, S.; Mizunuma, H.; Smith, S.K. 2003: Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma. British Journal of Cancer 88(2): 237-244
Gomułka, K.; Liebhart, J.; Lange, A.; Mêdrala, W. 2020: Vascular endothelial growth factor-activated basophils in asthmatics. Postepy Dermatologii i Alergologii 37(4): 584-589
Paquet-Fifield, S.; Levy, S.M.; Sato, T.; Shayan, R.; Karnezis, T.; Davydova, N.; Nowell, C.J.; Roufail, S.; Ma, G.Zhi-Ming.; Zhang, Y-Fang.; Stacker, S.A.; Achen, M.G. 2013: Vascular endothelial growth factor-d modulates caliber and function of initial lymphatics in the dermis. Journal of Investigative Dermatology 133(8): 2074-2084
Kim, H-Joong.; Jang, S.Yi.; Park, J-Il.; Byun, J.; Kim, D-Ik.; Do, Y-Soo.; Kim, J-Mook.; Kim, S.; Kim, B-Moon.; Kim, W-Bae.; Kim, D-Kyung. 2004: Vascular endothelial growth factor-induced angiogenic gene therapy in patients with peripheral artery disease. Experimental and Molecular Medicine 36(4): 336-344
McMullen, M.; Keller, R.; Sussman, M.; Pumiglia, K. 2004: Vascular endothelial growth factor-mediated activation of p38 is dependent upon Src and RAFTK/Pyk2. Oncogene 23(6): 1275-1282
Shi, Y.; Hu, Y.; Cui, B.; Zhuang, S.; Liu, N. 2022: Vascular endothelial growth factor-mediated peritoneal neoangiogenesis in peritoneal dialysis. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 42(1): 25-38
Lucarini, G.; Simonetti, O.; Lazzarini, R.; Giantomassi, F.; Goteri, G.; Offidani, A. 2020: Vascular endothelial growth factor/semaphorin-3A ratio and SEMA3A expression in cutaneous malignant melanoma. Melanoma Research 30(5): 433-442
Lange, C.; Storkebaum, E.; de Almodóvar, C.Ruiz.; Dewerchin, M.; Carmeliet, P. 2016: Vascular endothelial growth factor: a neurovascular target in neurological diseases. Nature Reviews. Neurology 12(8): 439-454
Duff, S.E.; Li, C.; Jeziorska, M.; Kumar, S.; Saunders, M.P.; Sherlock, D.; O'Dwyer, S.T.; Jayson, G.C. 2003: Vascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancy. British Journal of Cancer 89(3): 426-430
Okada, H.; Yoshida, S.; Hara, A.; Ogura, S.; Tomita, H. 2021: Vascular endothelial injury exacerbates coronavirus disease 2019: the role of endothelial glycocalyx protection. Microcirculation 28(3): E12654
Deer, E.; Vaka, V.R.; McMaster, K.M.; Wallace, K.; Cornelius, D.C.; Amaral, L.M.; Cunningham, M.W.; LaMarca, B. 2021: Vascular endothelial mitochondrial oxidative stress in response to preeclampsia: a role for angiotension Ii type 1 autoantibodies. American Journal of Obstetrics and Gynecology Mfm 3(1): 100275
Page, P.S.; Paige, S.; Hanna, A. 2021: Vascular entrapment neuropathy of the tibial nerve within the gastrocnemius muscle. Surgical Neurology International 12: 224
Ernat, J.J.; Wimberly, R.L.; Ho, C.A.; Riccio, A.I. 2020: Vascular examination predicts functional outcomes in supracondylar humerus fractures: a prospective study. Journal of Children's Orthopaedics 14(6): 495-501
Frangov, T.; Dimitrova, V. 1995: Vascular exclusion of the liver. Khirurgiia 48(4): 41-45
Wood, D.; Mollabashy, A. 2020: Vascular extravasation of injectable bioresorbable bone cement during aspiration and injection of calcaneal bone cyst. Proceedings 34(1): 189-190
Singh, A.K.; Gudehithlu, K.P.; Pegoraro, A.A.; Singh, G.K.; Basheerudin, K.; Robey, R.B.; Arruda, J.A.L.; Dunea, G. 2004: Vascular factors altered in glucose-treated mesangial cells and diabetic glomeruli. Changes in vascular factors impair endothelial cell growth and matrix. Laboratory Investigation; a Journal of Technical Methods and Pathology 84(5): 597-606
Fourie, C.M.T.; Botha-Le Roux, S.; Smith, W.; Schutte, A.E.; Breet, Y.; Mels, C.M.C.; Gafane-Matemane, L.F.; Lammertyn, L.; Uys, L.; Burger, A.; Joseph, J.S.; Goswami, N.; De Boever, P.; Strijdom, H. 2020: Vascular function and cardiovascular risk in a HIV infected and HIV free cohort of African ancestry: baseline profile, rationale and methods of the longitudinal EndoAfrica-NWU study. Bmc Infectious Diseases 20(1): 473
Benstead, K.; Moore, J.V. 1988: Vascular function and the probability of skin necrosis after photodynamic therapy: an experimental study. British Journal of Cancer 57(5): 451-454
Moore, J.V.; West, C.M.; Haylett, A.K. 1992: Vascular function and tissue injury in murine skin following hyperthermia and photodynamic therapy, alone and in combination. British Journal of Cancer 66(6): 1037-1043
Tarp, J.B.; Clausen, P.; Celermajer, D.; Christoffersen, C.; Jensen, A.S.; Sørensen, K.; Sillesen, H.; Estensen, M.-E.; Nagy, E.; Holstein-Rathlou, N.-H.; Engstrøm, T.; Feldt-Rasmussen, B.; Søndergaard, L. 2020: Vascular function in adults with cyanotic congenital heart disease. International Journal of Cardiology. Heart and Vasculature 30: 100632
Zimmerli, L.U.; Mark, P.B.; Steedman, T.; Foster, J.E.; Berg, G.A.; Dargie, H.J.; Jardine, A.G.; Delles, C.; Dominiczak, A.F. 2007: Vascular function in patients with end-stage renal disease and/or coronary artery disease: a cardiac magnetic resonance imaging study. Kidney International 71(1): 68-73
Maruhashi, T.; Kajikawa, M.; Kishimoto, S.; Hashimoto, H.; Takaeko, Y.; Yamaji, T.; Harada, T.; Hashimoto, Y.; Han, Y.; Aibara, Y.; Yusoff, F.Mohamad.; Hidaka, T.; Chayama, K.; Nakashima, A.; Goto, C.; Kihara, Y.; Higashi, Y. 2020: Vascular function is further impaired in subjects aged 80 years or older. Hypertension Research: Official Journal of the Japanese Society of Hypertension 43(9): 914-921
Tanaka, A.; Toyoda, S.; Node, K. 2020: Vascular functional tests and preemptive medicine. Hypertension Research: Official Journal of the Japanese Society of Hypertension 2020
Yang, H.; Liu, Z-hua.; Liu, Y-yao.; Lou, C-chun.; Ren, Z-long.; Miyoshi, H. 2010: Vascular gene transfer and drug delivery in vitro using low-frequency ultrasound and microbubbles. Acta Pharmacologica Sinica 31(4): 515-522
Velasco, B.; Ramírez, J.R.; Relloso, M.; Li, C.; Kumar, S.; Lopez-Bote, J.P.; Pérez-Barriocanal, F.; López-Novoa, J.M.; Cowan, P.J.; d'Apice, A.J.; Bernabéu, C. 2001: Vascular gene transfer driven by endoglin and ICAM-2 endothelial-specific promoters. Gene Therapy 8(12): 897-904
Kuliszewski, M.A.; Kobulnik, J.; Lindner, J.R.; Stewart, D.J.; Leong-Poi, H. 2011: Vascular gene transfer of SDF-1 promotes endothelial progenitor cell engraftment and enhances angiogenesis in ischemic muscle. Molecular Therapy: the Journal of the American Society of Gene Therapy 19(5): 895-902
Pelletier-Galarneau, M.; Juneau, D. 2020: Vascular graft infection: Improving diagnosis with functional imaging. Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology 2020
Syedain, Z.H.; Maciver, R.; Tranquillo, R.T. 2020: Vascular grafts and valves that animate, made from decellularized biologically-engineered tissue tubes. Journal of Cardiovascular Surgery 61(5): 577-585
Campani, M.; Guagliano, G.; Martino, R.; Scarabelli, L. 1956: Vascular grafts with fixed heterologous arterial segments. Minerva Cardioangiologica Europea 2(2): 511-513
Reichold, J.; Stampanoni, M.; Lena Keller, A.; Buck, A.; Jenny, P.; Weber, B. 2009: Vascular graph model to simulate the cerebral blood flow in realistic vascular networks. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 29(8): 1429-1443
Koschinsky, T.; Bünting, C.E.; Rütter, R.; Gries, F.A. 1985: Vascular growth factors and the development of macrovascular disease in diabetes mellitus. Hormone and Metabolic Research. Suppl Series 15: 23-27
Ricciardi, C.A.; Gnudi, L. 2021: Vascular growth factors as potential new treatment in cardiorenal syndrome in diabetes. European Journal of Clinical Investigation 51(9): E13579
Heuslein, J.L.; Murrell, K.P.; Leiphart, R.J.; Llewellyn, R.A.; Meisner, J.K.; Price, R.J. 2016: Vascular growth responses to chronic arterial occlusion are unaffected by myeloid specific focal adhesion kinase (FAK) deletion. Scientific Reports 6: 27029
Bedwell, S.F. 1983: Vascular headaches and oral contraceptives. Canadian Family Physician Medecin de Famille Canadien 29: 112-114
Ingo, C.; Kurian, S.; Higgins, J.; Mahinrad, S.; Jenkins, L.; Gorelick, P.; Lloyd-Jones, D.; Sorond, F. 2021: Vascular health and diffusion properties of normal appearing white matter in midlife. Brain Communications 3(2): Fcab 080
Marincowitz, C.; Webster, I.; Westcott, C.; Goswami, N.; de Boever, P.; Seidel, G.; Strijdom, H. 2021: Vascular health assessment with flow-mediated dilatation and retinal image analysis: a pilot study in an adult population from Cape Town. Cardiovascular Journal of Africa 32(3): 133-140
Potente, M.; Mäkinen, T. 2017: Vascular heterogeneity and specialization in development and disease. Nature Reviews. Molecular Cell Biology 18(8): 477-494
Maass, A.; Düzel, S.; Goerke, M.; Becke, A.; Sobieray, U.; Neumann, K.; Lövden, M.; Lindenberger, U.; Bäckman, L.; Braun-Dullaeus, R.; Ahrens, D.; Heinze, H-J.; Müller, N.G.; Düzel, E. 2015: Vascular hippocampal plasticity after aerobic exercise in older adults. Molecular Psychiatry 20(5): 585-593
Chanana, N.; Palmo, T.; Newman, J.H.; Pasha, M.A.Q. 2020: Vascular homeostasis at high-altitude: role of genetic variants and transcription factors. Pulmonary Circulation 10(4): 2045894020913475
Sfyridis, P.; Shatelen, N.; Kalangos, A. 2021: Vascular homografts as bypass grafts for superior vena cava syndrome due to idiopathic fibrosing mediastinitis. Journal of Vascular Surgery Cases and Innovative Techniques 7(2): 335-338
Wilson, A.J. 2004: Vascular hyper-reactivity following arterial balloon injury: distant and delayed effects. British Journal of Pharmacology 142(1): 3-4
Beilin, L.J.; Wade, D.N. 1970: Vascular hyper-reactivity with sodium loading and with deoxycorticosterone induced hypertension in the rat. Nature 227(5263): 1141-1142
Agard, C.; de Mornac, D.; Espitia, O. 2020: Vascular imaging in giant cell arteritis. La Revue du Praticien 70(8): E294-E295
Beheshtian, E.; Pakpoor, J.; Huntley, J.H.; Sahraian, S.; Urrutia, V.; Khan, M.K.; Idowu, O.; Yousem, D.M. 2020: Vascular imaging in the initial evaluation of embolic stroke source. Clinical Imaging 68: 278-282
Mantella, L.E.; Liblik, K.; Johri, A.M. 2021: Vascular imaging of atherosclerosis: Strengths and weaknesses. Atherosclerosis 319: 42-50
Schiebler, M.L.; Fain, S.; van Beek, E. 2022: Vascular imaging of the lung: perspectives on current imaging methods. British Journal of Radiology 95(1132): 20200759
Atsina, K.-B.; Cox, M.; Sedora Roman, N.I.; Pukenas, B.; Parker, L.; Levin, D.C.; Hurst, R.W. 2020: Vascular imaging of the spine in the US Medicare population: Catheter and MR angiography volumes from 2004 to 2016. Neuroradiology Journal 33(4): 318-323
D'Alò, R.; Severini, A. 1967: Vascular impressions on the renal pelvis. La Radiologia Medica 53(3): 225-231
Schnetzke, M.; El Barbari, J.; Schüler, S.; Swartman, B.; Keil, H.; Vetter, S.; Gruetzner, P.A.; Franke, J. 2021: Vascular impulse technology versus elevation for the reduction of swelling of lower extremity joint fractures: results of a prospective randomized controlled study. Bone and Joint Journal 103-B(4): 746-754
Shovlin, C.L.; Vizcaychipi, M.P. 2020: Vascular inflammation and endothelial injury in SARS-CoV-2 infection: the overlooked regulatory cascades implicated by the ACE2 gene cluster. Qjm: Monthly Journal of the Association of Physicians 2020
Romanenko, A.V.; Amelina, I.P.; Solovyeva, E.Y. 2021: Vascular inflammation underlies the development of atherothrombotic stroke. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 121(8 Part 2): 22-29
Keefe, D.T.; Rickard, M.; Manickavachagam, K.; Hannick, J.H.; Fernandez, N.; DeCotiis, K.; Teoh, C.W.; Koyle, M.A.; Lorenzo, A.J. 2020: Vascular inflow after renal transplantation: Does the arteriotomy technique impact early allograft perfusion and function?. Pediatric Transplantation 24(8): E13814
Teh, J.; Kessell, M.; Dissanayake, D.; Wylie, E.J. 2020: Vascular injuries detected on contrast-enhanced mammography following vacuum-assisted breast biopsy. Breast Journal 26(11): 2302-2304
Bertolaccini, L.; Calabrese, F.; Brandolini, J.; Solli, P. 2019: Vascular injuries during VATS lobectomies: keep calm, compress and have a plan. Annals of Translational Medicine 7(1): 19
Bradford, B. 1946: Vascular injuries in battle casualties. West Virginia Medical Journal 42: 105-108
Bradford, B.; Moore, M.J. 1946: Vascular injuries in war. Surgery Gynecology and Obstetrics 83(5): 667-673
Kutscha-Lissberg, E. 1972: Vascular injuries of the extremities. Monatsschrift für Unfallheilkunde Versicherungs- Versorgungs- und Verkehrsmedizin 75(2): 55-60
Downs, A.R. 1982: Vascular injuries of the limbs. Canadian Journal of Surgery. Journal Canadien de Chirurgie 25(2): 174-176
Bolot, F.; Gibert, A.P. 1954: Vascular injuries of the neck. Maroc Medical 33(348): 515-518
Hunt, C.A.; Kingsley, J.R. 2000: Vascular injuries of the upper extremity. Southern Medical Journal 93(5): 466-468
Izzedine, H.; Jhaveri, K.D.; Perazella, M.A. 2020: Vascular injury and COVID-19-related mortality: what lies below the tip of the iceberg?. Clinical Nephrology 94(1): 11-13
Schut, N.H. 2006: Vascular injury mediated by calcineurin inhibitors: contribution of rheological factors?. Kidney International 69(10): 1915
Altoijry, A.; Lindsay, T.F.; Johnston, K.W.; Mamdani, M.; Al-Omran, M. 2021: Vascular injury-related in-hospital mortality in Ontario between 1991 and 2009. Journal of International Medical Research 49(1): 300060520987728
Kuleznewa, J.; Nikitin, B.; Orlova, N.; Lesko, K. 2021: Vascular involvement assessment in patients with hilar cholangiocarcinoma by 128-row multidetector computed tomography. AnnalsofHepato-Biliary-PancreaticSurgery 25(Suppl.1):S408
Graña Gil, J.; Sanchez Meizoso, M.O.; Freire Gonzalez, M.; Galdo Fernandez, B. 1993: Vascular involvement in Behçet's disease. Journal of Rheumatology 20(11): 1991
Espinosa, G.; Cervera, R.; Reverter, J.-C.; Tàssies, D.; Font, J.; Ingelmo, M. 2002: Vascular involvement in Behçet's disease. Israel Medical Association Journal: Imaj 4(8): 614-616
De Vargas, R.M.; da Cruz, M.L.N.; Giarllarielli, M.P.H.; Sano, B.M.; da Silva, G.I.; Zoccal, K.F.; Tefé-Silva, C. 2021: Vascular involvement in Behçet's disease: the immunopathological process. Jornal Vascular Brasileiro 20: E20200170
Hodge, W.T. 1977: Vascular involvement in relapsing polychondritis. Canadian Medical Association Journal 117(2): 127; 129
Coclite, A. 2020: Vascular journey and adhesion mechanics of micro-sized carriers in narrow capillaries. Microvascular Research 132: 104069
Bagaté, K.; Develioglu, L.; Imbs, J.L.; Michel, B.; Helwig, J.J.; Barthelmebs, M. 1999: Vascular kinin B(1) and B(2) receptor-mediated effects in the rat isolated perfused kidney - differential regulations. British Journal of Pharmacology 128(8): 1643-1650
Gyger, M.; Rosenberg, A.; Shamy, A.; Hercz, A.; Caplan, S.; Sebag, I.A.; Brisson, M.L.; Roy, D.C. 2005: Vascular leak syndrome and serositis as an unusual manifestation of chronic graft-versus-host disease in nonmyeloablative transplants. Bone Marrow Transplantation 35(2): 201-203
McDonnell, K.; Bowden, E.T.; Cabal-Manzano, R.; Hoxter, B.; Riegel, A.T.; Wellstein, A. 2005: Vascular leakage in chick embryos after expression of a secreted binding protein for fibroblast growth factors. Laboratory Investigation; a Journal of Technical Methods and Pathology 85(6): 747-755
Gruss, J.D.; Daum, R.; Vogl, J.; Meinel, A. 1971: Vascular lesions in children. Journal de Chirurgie 102(5): 425-432
Friedland, R.; Ben-Amitai, D.; Didkovsky, E.; Feinmesser, M.; Zvulunov, A. 2020: Vascular lesions in genital lichen sclerosus in pediatric patients. Pediatric Dermatology 37(5): 849-852
Nicod, J.L. 1949: Vascular lesions in the silicotic lung and their relationship to tuberculosis. Schweizerische Zeitschrift für Pathologie und Bakteriologie. Revue Suisse de Pathologie et de Bacteriologie 12(2): 157-160
Bassett, R.C. 1953: Vascular lesions of the central nervous system amenable to surgical treatment. A.M.A. Archives of Neurology and Psychiatry 69(3): 385-386
Cook, A.; Wong, D.; McNeela, B. 1998: Vascular loop the loop. Eye 12: 323
Della Rosa, N.; Bertozzi, Nò.; Adani, R. 2020: Vascular malformation and their unpredictable evolution: A true challenge for physicians. ActaBio-Medica:AteneiParmensis 91(3):E2020067
Singh, G.; Banerjee, R.; Varma, M.; Aggarwal, S.K.; Gupta, P. 2020: Vascular malformation of ileum: a possible cause of neonatal intestinal obstruction. Annals of Medicine and Surgery 60: 704-707
De Chiara, J.C. 1954: Vascular malformation of the neck. BOLETIN. Sociedad de Cirugia del Uruguay 25(1): 63-74
Nussbaum, E.S. 2013: Vascular malformations of the brain. Minnesota Medicine 96(5): 40-43
Wiegand, S.; Dietz, A. 2021: Vascular malformations of the head and neck. Laryngo- Rhino- Otologie 100(1): 65-76
Gross, S.W.; Ralston, B.L. 1959: Vascular malformations of the spinal cord. Surgery Gynecology and Obstetrics 108(6): 673-678
Rozsival, V.; Lichy, J. 1961: Vascular malformations of the spinal cord. Sbornik Vedeckych Praci Lekarske Fakulty Karlovy University V Hradci Kralove 4: 497-503
Zieminski, P.; Risse, J.; Legrand, A.; Dufrost, V.; Bal, L.; Settembre, N.; Malikov, Sï.; Jeunemaitre, X.; Wahl, D.; Zuily, Séphane. 2020: Vascular manifestations and kyphoscoliosis due to a novel mutation of PLOD1 gene. Acta Cardiologica 2020: 1-2
Qu, H.; Khalil, R.A. 2020: Vascular mechanisms and molecular targets in hypertensive pregnancy and preeclampsia. American Journal of Physiology. Heart and Circulatory Physiology 319(3): H661-H681
Akiguchi, I.; Yamamoto, Y. 2010: Vascular mechanisms of cognitive impairment: roles of hypertension and subsequent small vessel disease under sympathetic influences. Hypertension Research: Official Journal of the Japanese Society of Hypertension 33(1): 29-31
Versmissen, J.; Power, J.R.; Moslehi, J. 2020: Vascular medicine and cardio-oncology - a new, evolving clinical frontier. Vascular Medicine 25(3): 205-207
Moran, A.; Kim, E.S.H.; Beckman, J.A.; Aday, A.W. 2020: Vascular medicine in the COVID-19 era: the Vanderbilt experience. Journal of Vascular Nursing: Official Publication of the Society for Peripheral Vascular Nursing 38(4): 176-179
Holstein, S.A.; Hohl, R.J. 2009: Vascular medicine: a look forward. Clinical Pharmacology and Therapeutics 86(2): 117-119
Lüscher, T.F. 2020: Vascular medicine: the Cinderella of cardiology back on stage. European Heart Journal 41(26): 2417-2420
Hoffman, C.R.; Golhar, S.R.Y. 2020: Vascular micro-thrombotic disease in pregnancy. Indian Journal of Anaesthesia 64(8): 719-721
Vikram, A.; Kim, Y-Rae.; Kumar, S.; Li, Q.; Kassan, M.; Jacobs, J.S.; Irani, K. 2016: Vascular microRNA-204 is remotely governed by the microbiome and impairs endothelium-dependent vasorelaxation by downregulating Sirtuin1. Nature Communications 7: 12565
Fontaine, J.L.; Foucher, G.; Plot, J.C. 1969: Vascular microanastomosis using mechanical suture apparatus. Comparative study. Acta Oto-Rhino-Laryngologica Belgica 23(6): 315-324
Mohebbi, N.; Abedini, A.; Lashgari, R.; Razavi, F.; Varahram, M.; Kiani, A. 2020: Vascular microthrombosis associated with increased interleukin-6. a severe acute respiratory distress syndrome in COVID-19 patients treated with tocilizumab. Advances in Respiratory Medicine 88(5): 468-469
Billington, W.D. 1966: Vascular migration of transplanted trophoblast in the golden hamster. Nature 211(5052): 988-989
Medrano, M.; Castro-Tejada, G.; Lantigua, R.; Silvestre, G.; Diaz, S.; Mota, P.; Diaz-Garelli, F. 2021: Vascular mild cognitive impairment and its relationship to hemoglobin A1c levels and apolipoprotein e genotypes in the Dominican Republic. Dementia and Neuropsychologia 15(1): 69-78
Wechman, S.L.; Emdad, L.; Sarkar, D.; Das, S.K.; Fisher, P.B. 2020: Vascular mimicry: Triggers, molecular interactions and in vivo models. Advances in Cancer Research 148: 27-67
Fathi Maroufi, N.; Taefehshokr, S.; Rashidi, M.-R.; Taefehshokr, N.; Khoshakhlagh, M.; Isazadeh, A.; Mokarizadeh, N.; Baradaran, B.; Nouri, M. 2020: Vascular mimicry: changing the therapeutic paradigms in cancer. Molecular Biology Reports 47(6): 4749-4765
Michaelson, I.C. 1949: Vascular morphogenesis in the retina of the cat. Journal of Anatomy 83(Part 1): 64
Michaelson, I.C. 1948: Vascular morphogenesis in the retina of the cat. Journal of Anatomy 82(3): 167-174
Kim, T.-H.; Le, D.; Son, T.; Yao, X. 2021: Vascular morphology and blood flow signatures for differential artery-vein analysis in optical coherence tomography of the retina. Biomedical Optics Express 12(1): 367-379
Madhani, M.; Scotland, R.S.; MacAllister, R.J.; Hobbs, A.J. 2003: Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling. British Journal of Pharmacology 139(7): 1289-1296
Biriukov, I.V.; Charnetskiĭ, R.I.; Godzhello, E.A. 1993: Vascular neoplasms of the mediastinum. Khirurgiia 9: 70-76
Nicolai, L.; Leunig, A.; Brambs, S.; Kaiser, R.; Joppich, M.; Hoffknecht, M.-L.; Gold, C.; Engel, A.; Polewka, V.; Muenchhoff, M.; Hellmuth, J.C.; Ruhle, A.; Ledderose, S.; Weinberger, T.; Schulz, H.; Scherer, C.; Rudelius, M.; Zoller, M.; Keppler, O.T.; Zwißler, B.; von Bergwelt-Baildon, M.; Kääb, S.; Zimmer, R.; Bülow, R.D.; von Stillfried, S.; Boor, P.; Massberg, S.; Pekayvaz, K.; Stark, K. 2021: Vascular neutrophilic inflammation and immunothrombosis distinguish severe COVID-19 from influenza pneumonia. Journal of Thrombosis and Haemostasis: Jth 19(2): 574-581
Segers, A.M. 1947: Vascular nevi of the skin; treatment considerations. Prensa Medica Argentina 34(42): 2014-2016
Winkler, I.G.; Barbier, Vérie.; Nowlan, B.; Jacobsen, R.N.; Forristal, C.E.; Patton, J.T.; Magnani, J.L.; Lévesque, J-Pierre. 2012: Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance. Nature Medicine 18(11): 1651-1657
Wang, Q.; He, Z.; Huang, M.; Liu, T.; Wang, Y.; Xu, H.; Duan, H.; Ma, P.; Zhang, L.; Zamvil, S.S.; Hidalgo, J.; Zhang, Z.; O'Rourke, D.M.; Dahmane, N.; Brem, S.; Mou, Y.; Gong, Y.; Fan, Y. 2018: Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2α. Nature Communications 9(1): 559
Andreu-Agulló, C.; Morante-Redolat, Jé.Manuel.; Delgado, A.C.; Fariñas, I. 2009: Vascular niche factor PEDF modulates Notch-dependent stemness in the adult subependymal zone. Nature Neuroscience 12(12): 1514-1523
Hamzah, J.; Jugold, M.; Kiessling, F.; Rigby, P.; Manzur, M.; Marti, H.H.; Rabie, T.; Kaden, S.; Gröne, H-Josef.; Hämmerling, Günter.J.; Arnold, B.; Ganss, R. 2008: Vascular normalization in Rgs5-deficient tumours promotes immune destruction. Nature 453(7193): 410-414
Liu, Z.; Zhao, Q.; Zheng, Z.; Liu, S.; Meng, L.; Dong, L.; Jiang, X. 2021: Vascular normalization in immunotherapy: a promising mechanisms combined with radiotherapy. Biomedicine and PharmacoTherapy 139: 111607
Zhang, H.; Ren, Y.; Tang, X.; Wang, K.; Liu, Y.; Zhang, L.; Li, X.; Liu, P.; Zhao, C.; He, J. 2015: Vascular normalization induced by sinomenine hydrochloride results in suppressed mammary tumor growth and metastasis. Scientific Reports 5: 8888
Zhang, H.; Cao, G.; Ren, W.; Gu, J.; Ji, W.; Zhu, D.; Bao, Y.; Hasimu, A. 2021: Vascular normalization therapy with targeted localized vessel bevacizumab infusion in hepatocellular carcinoma after transarterial chemoembolization failure. Annals of Palliative Medicine 10(8): 9149-9156
Munn, L.L.; Stylianopoulos, T.; Jain, N.K.; Hardin, C.C.; Khandekar, M.J.; Jain, R.K. 2021: Vascular Normalization to Improve Treatment of COVID-19: Lessons from Treatment of Cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 27(10): 2706-2711
Leppkes, M.; Knopf, J.; Naschberger, E.; Lindemann, A.; Singh, J.; Herrmann, I.; Stürzl, M.; Staats, L.éo.; Mahajan, A.; Schauer, C.; Kremer, A.N.; Völkl, S.; Amann, K.; Evert, K.; Falkeis, C.; Wehrfritz, A.; Rieker, R.J.; Hartmann, A.; Kremer, A.E.; Neurath, M.F.; Muñoz, L.E.; Schett, G.; Herrmann, M. 2020: Vascular occlusion by neutrophil extracellular traps in COVID-19. Ebiomedicine 58: 102925
Ratti, F.; Nini, A.; Bertini, R.; Aldrighetti, L. 2021: Vascular occlusion to protect against intraoperative blood loss in liver surgeries: new perspectives on a traditional technique. Hepatobiliary Surgery and Nutrition 10(4): 567-569
Hagenau, F.; Priglinger, S.G. 2021: Vascular occlusions of the retina - relevance for the general physician. MMW Fortschritte der Medizin 163(3): 48-55
Middeke, M.; Nasemann, M.; Nasemann, J. 2021: Vascular ophthalmopathies - an interdisciplinary task. Deutsche Medizinische Wochenschrift 146(13-14): 865-873
Wigglesworth, J.S. 1967: Vascular organization of the human placenta. Nature 216(5120): 1120-1121
Petit, H. 1982: Vascular pain of the face. Larc Medical 2(9): 794 797-8
Pelissier, A. 1987: Vascular pains of the face. L' Information Dentaire 69(34): 2961-2966
Korczyn, A.D. 2015: Vascular parkinsonism--characteristics, pathogenesis and treatment. Nature Reviews. Neurology 11(6): 319-326
Vikkula, M. 2007: Vascular pathologies. Angiogenomics: towards a genetic nosology and understanding of vascular anomalies. European Journal of Human Genetics: Ejhg 15(8): 821-822
Currò, C.T.; Francalanza, I.; Cotroneo, M.; Dell'Aera, C.; Casella, C.; La Spina, P.; Fazio, M.C.; Grillo, F.; Toscano, A.; Musolino, R.F. 2021: Vascular pattern and radiological follow up in a case of pontine warning syndrome. Heliyon 7(6): E07369
Payne, J.G. 1972: Vascular pattern within the normal and regenerating rat spleen. Journal of Physiology 222(1): 28p
Passalidou, E.; Stewart, M.; Trivella, M.; Steers, G.; Pillai, G.; Dogan, A.; Leigh, I.; Hatton, C.; Harris, A.; Gatter, K.; Pezzella, F. 2003: Vascular patterns in reactive lymphoid tissue and in non-Hodgkin's lymphoma. British Journal of Cancer 88(4): 553-559
Gutierrez, W.R.; Bennion, D.M.; Walsh, J.E.; Owen, S.R. 2020: Vascular pedicled flaps for skull base defect reconstruction. Laryngoscope Investigative Otolaryngology 5(6): 1029-1038
van Geel, I.P.; Oppelaar, H.; Rijken, P.F.; Bernsen, H.J.; Hagemeier, N.E.; van der Kogel, A.J.; Hodgkiss, R.J.; Stewart, F.A. 1996: Vascular perfusion and hypoxic areas in RIF-1 tumours after photodynamic therapy. British Journal of Cancer 73(3): 288-293
Addis, D.R.; Aggarwal, S.; Doran, S.F.; Jian, M.-Y.; Ahmad, I.; Kojima, K.; Ford, D.A.; Matalon, S.; Mobley, J.A. 2020: Vascular permeability disruption explored in the proteomes of mouse lungs and human microvascular cells following acute bromine exposure. American Journal of Physiology. Lung Cellular and Molecular Physiology 319(2): L337-L359
Brown, L.F.; Berse, B.; Tognazzi, K.; Manseau, E.J.; Van de Water, L.; Senger, D.R.; Dvorak, H.F.; Rosen, S. 1992: Vascular permeability factor mRNA and protein expression in human kidney. Kidney International 42(6): 1457-1461
Watanabe, Y.; Lee, S.W.; Detmar, M.; Ajioka, I.; Dvorak, H.F. 1997: Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) delays and induces escape from senescence in human dermal microvascular endothelial cells. Oncogene 14(17): 2025-2032
Freund, J.; Miles, A.A.; Mill, P.J.; Wilhelm, D.L. 1958: Vascular permeability factors in the secretion of the guinea pig coagulating gland. Nature 182(4629): 174-175
Mikati, A.G.; Khanna, O.; Zhang, L.; Girard, R.; Shenkar, R.; Guo, X.; Shah, A.; Larsson, H.B.W.; Tan, H.; Li, L.; Wishnoff, M.S.; Shi, C.; Christoforidis, G.A.; Awad, I.A. 2015: Vascular permeability in cerebral cavernous malformations. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 35(10): 1632-1639
Khurana, N.; Yathavan, B.; Jedrzkiewicz, J.; Gill, A.S.; Pulsipher, A.; Alt, J.A.; Ghandehari, H. 2021: Vascular permeability in chronic rhinosinusitis enhances accumulation and retention of nanoscale pegylated liposomes. Nanomedicine: Nanotechnology Biology and Medicine 38: 102453
Pernet-Gallay, K.; Jouneau, P-Henri.; Bertrand, A.; Delaroche, J.; Farion, Régine.; Rémy, C.; Barbier, E.L. 2017: Vascular permeability in the RG2 glioma model can be mediated by macropinocytosis and be independent of the opening of the tight junction. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 37(4): 1264-1275
Malmström, R.E. 2001: Vascular pharmacology of BIIE0246, the first selective non-peptide neuropeptide Y Y(2) receptor antagonist, in vivo. British Journal of Pharmacology 133(7): 1073-1080
Hoi, P.M.; Visintin, C.; Okuyama, M.; Gardiner, S.M.; Kaup, S.S.; Bennett, T.; Baker, D.; Selwood, D.L.; Hiley, C.R. 2007: Vascular pharmacology of a novel cannabinoid-like compound, 3-(5-dimethylcarbamoyl-pent-1-enyl)-N-(2-hydroxy-1-methyl-ethyl)benzamide (VSN16) in the rat. British Journal of Pharmacology 152(5): 751-764
Keiser, J. 2009: Vascular pharmacology: opportunities for intervention. Clinical Pharmacology and Therapeutics 86(2): 124-126
Passalidou, E.; Trivella, M.; Singh, N.; Ferguson, M.; Hu, J.; Cesario, A.; Granone, P.; Nicholson, A.G.; Goldstraw, P.; Ratcliffe, C.; Tetlow, M.; Leigh, I.; Harris, A.L.; Gatter, K.C.; Pezzella, F. 2002: Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas. British Journal of Cancer 86(2): 244-249
D'hondt, S.; Van Damme, T.; Malfait, F. 2018: Vascular phenotypes in nonvascular subtypes of the Ehlers-Danlos syndrome: a systematic review. Genetics in Medicine: Official Journal of the American College of Medical Genetics 20(6): 562-573
Jubb, A.M.; Cesario, A.; Ferguson, M.; Congedo, M.T.; Gatter, K.C.; Lococo, F.; Mulè, A.; Pezzella, F. 2011: Vascular phenotypes in primary non-small cell lung carcinomas and matched brain metastases. British Journal of Cancer 104(12): 1877-1881
Kim, E.; Zhang, J.; Hong, K.; Benoit, N.E.; Pathak, A.P. 2011: Vascular phenotyping of brain tumors using magnetic resonance microscopy (μMRI). Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 31(7): 1623-1636
Folkman, J.; Klagsbrun, M. 1987: Vascular physiology. A family of angiogenic peptides. Nature 329(6141): 671-672
Vanhoutte, P.M. 1987: Vascular physiology: the end of the quest?. Nature 327(6122): 459-460
Strouss, L.; Goldstein, N.D.; Locke, R.; Paul, D.A. 2018: Vascular placental pathology and the relationship between hypertensive disorders of pregnancy and neonatal outcomes in very low birth weight infants. Journal of Perinatology: Official Journal of the California Perinatal Association 38(4): 324-331
Alatalo, J.M.; Little, C.J.; Jägerbrand, A.K.; Molau, U. 2015: Vascular plant abundance and diversity in an alpine heath under observed and simulated global change. Scientific Reports 5: 10197
Sciandrello, S.; Minissale, P.; Giusso Del Galdo, G. 2020: Vascular plant species diversity of Mt. Etna (Sicily): endemicity, insularity and spatial patterns along the altitudinal gradient of the highest active volcano in Europe. Peerj 8: E9875
Edvinsson, L.I.H.; Povlsen, G.Klitgaard. 2011: Vascular plasticity in cerebrovascular disorders. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 31(7): 1554-1571
Molinari, A.C.L.; Leo, E.; Muzzarelli, L.; Rossi, G. 2020: Vascular plug oversizing to treat an endoleak after hybrid surgery of the aortic arch. Interactive Cardiovascular and Thoracic Surgery 31(6): 906-908
Stoltz, J.F. 1983: Vascular potential and thrombosis. Thrombosis Research. Suppl 5: 73-82
Rustum, S.; Neuser, J.; Schmitto, J.D.; Aper, T.; Hanke, J.S.; Haverich, A.; Wilhelmi, M. 2021: Vascular procedures in patients with left ventricular assist devices: single-center experience. Indian Journal of Thoracic and Cardiovascular Surgery 37(5): 514-520
Park, T.Soon.; Zimmerlin, L.; Evans-Moses, R.; Thomas, J.; Huo, J.S.; Kanherkar, R.; He, A.; Ruzgar, N.; Grebe, R.; Bhutto, I.; Barbato, M.; Koldobskiy, M.A.; Lutty, G.; Zambidis, E.T. 2020: Vascular progenitors generated from tankyrase inhibitor-regulated naïve diabetic human iPSC potentiate efficient revascularization of ischemic retina. Nature Communications 11(1): 1195
Dzau, V.J.; Braun-Dullaeus, R.C.; Sedding, D.G. 2002: Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nature Medicine 8(11): 1249-1256
Elgebaly, M.M.; Prakash, R.; Li, W.; Ogbi, S.; Johnson, M.H.; Mezzetti, E.M.; Fagan, S.C.; Ergul, A. 2010: Vascular protection in diabetic stroke: role of matrix metalloprotease-dependent vascular remodeling. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 30(12): 1928-1938
Mastenbroek, T.G.; Karel, M.F.A.; Nagy, M.; Chayoua, W.; Korsten, E.I.J.; Coenen, D.M.; Debets, J.; Konings, J.; Brouns, A.E.; Leenders, P.J.A.; van Essen, H.; van Oerle, R.; Heitmeier, S.; Spronk, H.M.; Kuijpers, M.J.E.; Cosemans, J.M.E.M. 2020: Vascular protective effect of aspirin and rivaroxaban upon endothelial denudation of the mouse carotid artery. Scientific Reports 10(1): 19360
Vinet, A.; Karpoff, L.; Walther, G.; Startun, A.; Obert, P.; Goret, L.; Dauzat, M.; Perez-Martin, A. 2011: Vascular reactivity at rest and during exercise in middle-aged obese men: effects of short-term, low-intensity, exercise training. International Journal of Obesity 35(6): 820-828
Puchlev, A.; Kiprov, D.; Somova, L. 1968: Vascular reactivity in experimental hypertension. Comptes Rendus de l'Academie Bulgare des Sciences: Sciences Mathematiques et Naturelles 21(4): 395-398
Restini, C.B.A.; Fink, G.D.; Watts, S.W. 2021: Vascular reactivity stimulated by TMA and TMAO: Are perivascular adipose tissue and endothelium involved?. Pharmacological Research 163: 105273
Scroop, G.C.; Whelan, R.F. 1968: Vascular reactivity studies in hypertension. Australian Journal of Experimental Biology and Medical Science 46(5): 555-561
Fernandez Cruz, A.; Alves Garcia, A. 1949: Vascular reactivity to different stimuli in pulmonary tuberculosis patients. Medicina 17 Pt 2(1): 9-14
Vincent, J.; Blaschke, T.F.; Hoffman, B.B. 1992: Vascular reactivity to phenylephrine and angiotensin II: comparison of direct venous and systemic vascular responses. Clinical Pharmacology and Therapeutics 51(1): 68-75
Wu, G.; Wu, Y.; Wang, M.; Zhang, W.; Liu, C.; Liang, T. 2021: Vascular reconstruction of segmental intestinal grafts using autologous internal iliac vessels. Gastroenterology Report 9(4): 350-356
Silver, J.R. 1971: Vascular reflexes in spinal shock. Paraplegia 8(4): 231-242
Zelinskaya, I.; Kornushin, O.; Savochkina, E.; Dyachuk, V.; Vasyutina, M.; Galagudza, M.; Toropova, Y. 2021: Vascular region-specific changes in arterial tone in rats with type 2 diabetes mellitus: Opposite responses of mesenteric and femoral arteries to acetylcholine and 5-hydroxytryptamine. Life Sciences 286: 120011
Augustin, H.G.; Kipnis, J. 2021: Vascular rejuvenation is geroprotective. Science 373(6554): 490-491
Gao, Y-Jing.; Zhang, Y.; Hirota, S.; Janssen, L.J.; Lee, R.M.K.W. 2004: Vascular relaxation response to hydrogen peroxide is impaired in hypertension. British Journal of Pharmacology 142(1): 143-149
Farnsworth, R.H.; Lackmann, M.; Achen, M.G.; Stacker, S.A. 2014: Vascular remodeling in cancer. Oncogene 33(27): 3496-3505
Khasanov, A.K.; Bakirov, B.A.; Davletshi, R.A.; Novikova, L.B.; Kudlay, D.A. 2020: Vascular remodeling with violations of intracardiac hemodynamics in patients older age category, combined with the clinical-cluster, neurocognitive and biomarker heterogeneity in multifocal atherosclerosis. Terapevticheskii Arkhiv 92(12): 67-74
Merino García, E.; Borrego Utiel, F.J.é; Polaina Rusillo, M.; García Cortés, M.J.é 2021: Vascular renal resistance index is not related with prognosis in kidney transplantation. Nefrologia 41(1): 69-71
Sawada, S.; Tsuchiya, S.; Kodama, S.; Kurosawa, S.; Endo, A.; Sugawara, H.; Hosaka, S.; Kawana, Y.; Asai, Y.; Yamamoto, J.; Munakata, Y.; Izumi, T.; Takahashi, K.; Kaneko, K.; Imai, J.; Ito, A.; Yasuda, M.; Kunikata, H.; Nakazawa, T.; Katagiri, H. 2020: Vascular resistance of carotid and vertebral arteries is associated with retinal microcirculation measured by laser speckle flowgraphy in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 165: 108240
Gustavsson, M.; Mallard, C.; Vannucci, S.J.; Wilson, M.Ann.; Johnston, M.V.; Hagberg, H. 2007: Vascular response to hypoxic preconditioning in the immature brain. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 27(5): 928-938
Frost, B.R.; Frewin, D.B. 1981: Vascular responses to REN-293 (2-amino-3[3, 5-dihydroxyphenyl]-1-propanol hydrochloride)--a new sympathomimetic agent. Australian Journal of Experimental Biology and Medical Science 59(Pt 2): 179-182
Nakano, K.; Hayashi, T.; Ono, H. 2018: Vascular ring associated with d-transposition of the great arteries: when should we suspect aortic arch anomalies?. Cardiology in the Young 28(12): 1489-1490
Chen, H.-C.; Wu, Y.-C.; Lin, Y.-C. 2021: Vascular ring connector-related aorto-oesophageal fistula of the descending aorta. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 61(1): 238
Sone, H.; Mizuno, S.; Yamada, N. 2005: Vascular risk factors and diabetic neuropathy. New England Journal of Medicine 352(18): 1925-1927; Author Reply 1925-1927
Ponholzer, A.; Temml, C.; Rauchenwald, M.; Madersbacher, S. 2006: Vascular risk factors and erectile dysfunction in a cohort of healthy men. International Journal of Impotence Research 18(5): 489-493
Köbe, T.; Binette, A.P.; Vogel, J.W.; Meyer, P.-F.ço.; Breitner, J.C.S.; Poirier, J.; Villeneuve, S. 2021: Vascular risk factors are associated with a decline in resting-state functional connectivity in cognitively unimpaired individuals at risk for Alzheimer's disease: Vascular risk factors and functional connectivity changes. Neuroimage 231: 117832
Rudkin, A.K.; Lee, A.W.; Chen, C.S. 2010: Vascular risk factors for central retinal artery occlusion. Eye 24(4): 678-681
Béchetoille, A. 1996: Vascular risk factors in glaucoma. Current Opinion in Ophthalmology 7(2): 39-43
Stefan, C.; Cucea, R.; Popescu, A.; Serban, M.M. 1998: Vascular risk factors in glaucoma. Oftalmologia 45(4): 37-44
Batty, G.D.; Hamer, M. 2020: Vascular risk factors, Framingham risk score, and COVID-19: community-based cohort study. Cardiovascular Research 116(10): 1664-1665
Sheahan, C. 2021: Vascular simulation: Unrealized potential. Journal of Vascular Surgery 73(5): 1828
Dezoteux, F.éd.ér.; Mille, B.; Fievet, C.; Moreau, A.-S.; Duhamel, A.; Drumez, E.; Mathieu, D.; Poissy, J.; Staumont-Salle, D.; Buche, S.éb. 2021: Vascular skin manifestations in patients with severe COVID-19 in intensive care units: a monocentric prospective study. European Journal of Dermatology: Ejd 2021
Cozart, M.A.; Phelan, K.D.; Wu, H.; Mu, S.; Birnbaumer, L.; Rusch, N.J.; Zheng, F. 2020: Vascular smooth muscle TRPC3 channels facilitate the inverse hemodynamic response during status epilepticus. Scientific Reports 10(1): 812
Kang, H.; Liu, J.; Sun, A.; Liu, X.; Fan, Y.; Deng, X. 2017: Vascular smooth muscle cell glycocalyx mediates shear stress-induced contractile responses via a Rho kinase (ROCK)-myosin light chain phosphatase (MLCP) pathway. Scientific Reports 7: 42092
Peiró, C.; Angulo, J.; Rodríguez-Mañas, L.; Llergo, J.L.; Vallejo, S.; Cercas, E.; Sánchez-Ferrer, C.F. 1998: Vascular smooth muscle cell hypertrophy induced by glycosylated human oxyhaemoglobin. British Journal of Pharmacology 125(4): 637-644
Li, Y.; Li, H.; Xing, W.; Li, J.; Du, R.; Cao, D.; Wang, Y.; Yang, X.; Zhong, G.; Zhao, Y.; Sun, W.; Liu, C.; Gao, X.; Li, Y.; Liu, Z.; Jin, X.; Zhao, D.; Tan, Y.; Wang, Y.; Liu, S.; Yuan, M.; Song, J.; Chang, Y-Zhong.; Gao, F.; Ling, S.; Li, Y. 2021: Vascular smooth muscle cell-specific miRNA-214 knockout inhibits angiotensin II-induced hypertension through upregulation of Smad7. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 35(11): e21947
Basatemur, G.L.; Jørgensen, H.F.; Clarke, M.C.H.; Bennett, M.R.; Mallat, Z. 2019: Vascular smooth muscle cells in atherosclerosis. Nature Reviews. Cardiology 16(12): 727-744
Yoshioka, S.; Tsukamoto, T.; Chihara, K. 2003: Vascular smooth muscle cells in coronary heart disease. Nihon Rinsho. Japanese Journal of Clinical Medicine 61(Suppl 4): 80-85
Winquist, R.J.; Webb, R.C.; Bohr, D.F. 1982: Vascular smooth muscle in hypertension. Federation Proceedings 41(8): 2387-2393
Wanstall, J.C.; Jeffery, T.K.; Gambino, A.; Lovren, F.; Triggle, C.R. 2001: Vascular smooth muscle relaxation mediated by nitric oxide donors: a comparison with acetylcholine, nitric oxide and nitroxyl ion. British Journal of Pharmacology 134(3): 463-472
Trache, A.; Massett, M.P.; Woodman, C.R. 2020: Vascular smooth muscle stiffness and its role in aging. Current Topics in Membranes 86: 217-253
Tsuboi, M.; Suzuki, H.; Kawai, H.; Ejima, T.; Mitsuishi, F. 2022: Vascular sound visualization system is useful for monitoring and surveillance of vascular access. Journal of Vascular Access 23(3): 390-397
de Cavanagh, E.M.V.; Ferder, Lón.F.; Ferder, M.D.; Stella, Iés.Y.; Toblli, J.E.; Inserra, F. 2010: Vascular structure and oxidative stress in salt-loaded spontaneously hypertensive rats: effects of losartan and atenolol. American Journal of Hypertension 23(12): 1318-1325
Solesvik, O.V.; Rofstad, E.K.; Brustad, T. 1982: Vascular structure of five human malignant melanomas grown in athymic nude mice. British Journal of Cancer 46(4): 557-567
Mugikura, S.; Mori, N.; Takahashi, S. 2022: Vascular supply of the column of fornix. Surgical and Radiologic Anatomy: Sra 44(2): 307-308
Logan, M.S.; Bush, R.L. 2021: Vascular surgeons are health disparities doctors. Journal of Vascular Surgery 74(5): 1437
Calligaro, K.D. 2020: Vascular surgeons should learn how to perform rectus femoris muscle flaps. Journal of Vascular Surgery 72(3): 1058
Merino, I. 2020: Vascular surgery and arterial hypertension. Revista Espanola de Anestesiologia y Reanimacion 67 Suppl. 1: 45-51
Farah, I.; Letoublon, C.; Viorin, L.; Rambeau, J.J.; Magne, J.L.; Delannoy, P.; Guidicelli, H. 1996: Vascular surgery and organ transplantation. Chirurgie; Memoires de l'Academie de Chirurgie 121(5): 381-386
Tinelli, G.; Sica, S.; Minelli, F.; Tshomba, Y. 2020: Vascular surgery education during COVID-19 pandemic. Journal of Vascular Surgery 72(2): 763-764
DePalma, R.G. 1997: Vascular surgery for impotence: a review. International Journal of Impotence Research 9(2): 61-67
Myhre, H.O.; Vasli, S. 1981: Vascular surgery in Norway. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 101(4): 286-288
Sande, E. 1993: Vascular surgery in Norway. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 113(25): 3163
Herman, B.E. 1980: Vascular surgery in the aged. Mount Sinai Journal of Medicine new York 47(2): 215-217
Dos Reis, J.é M.C.; Dos Santos, D.R.; Torres, I.O.; De Luccia, N. 2021: Vascular surgery in the most populous state in the Amazon: socio-professional profile and aspirations of the specialty. Jornal Vascular Brasileiro 20: E20210039
Bandyk, D.F. 2019: Vascular surgery resident education and hands-on training in vascular laboratory testing. Seminars in Vascular Surgery 32(1-2): 41-47
Duncan, A.A.; Power, A.H. 2019: Vascular surgery resident training in Canada. Seminars in Vascular Surgery 32(1-2): 18-20
Sebesta, P. 2009: Vascular surgery today and tomorrow. Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 88(2): 47-49
Anagnostis, P.; Vaitsi, K.; Mintziori, G.; Goulis, D.G.; Mikhailidis, D.P. 2020: Vascular surgical procedures in patients with familial hypercholesterolaemia: is it too late?. Current Medical Research and Opinion 36(8): 1255
Nicolai, L.; Schiefelbein, K.; Lipsky, S.; Leunig, A.; Hoffknecht, M.; Pekayvaz, K.; Raude, B.; Marx, C.; Ehrlich, A.; Pircher, J.; Zhang, Z.; Saleh, I.; Marel, A-Kristina.; Löf, A.; Petzold, T.; Lorenz, M.; Stark, K.; Pick, R.; Rosenberger, G.; Weckbach, L.; Uhl, B.; Xia, S.; Reichel, C.Andreas.; Walzog, B.; Schulz, C.; Zheden, V.; Bender, M.; Li, R.; Massberg, S.; Gaertner, F. 2020: Vascular surveillance by haptotactic blood platelets in inflammation and infection. Nature Communications 11(1): 5778
Perianes, I.; Ruiz, R. 1948: Vascular suture without interruption of blood flow. La Semana Medica 55(1): 16
García-Pedraza, J.é Án.; López, C.; Fernández-González, J.F.; Martín, M.ía.L.; Morán, A.ón.; García-Domingo, M.ón. 2021: Vascular sympathetic neurotransmission and its serotonergic regulation are modified by chronic fluoxetine treatment. Journal of Pharmacological Sciences 147(1): 48-57
Henkemeyer, M.; Rossi, D.J.; Holmyard, D.P.; Puri, M.C.; Mbamalu, G.; Harpal, K.; Shih, T.S.; Jacks, T.; Pawson, T. 1995: Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating protein. Nature 377(6551): 695-701
Rewell, R.E. 1987: Vascular system of the giraffe. Nature 329(6140): 589
Vaideeswar, P.; Yadav, S. 2021: Vascular tangle in the inter-atrial septum - Is it the source of cardiac myxoma?. Indian Journal of Pathology and Microbiology 64(3): 469-471
Mashayekhi, V.; Hoog, C.O.'t.; Oliveira, S. 2019: Vascular targeted photodynamic therapy: a review of the efforts towards molecular targeting of tumor vasculature. Journal of Porphyrins and Phthalocyanines 23(11-12): 1229-1240
Red-Horse, K.; Ferrara, N. 2007: Vascular targeting via caveolae. Nature Biotechnology 25(4): 431-432
Wu, Y.; Essex, D.W. 2020: Vascular thiol isomerases in thrombosis: the yin and yang. Journal of Thrombosis and Haemostasis: Jth 18(11): 2790-2800
Alves, J.Q.; Pernomian, L.; Silva, C.ás.D.; Gomes, M.S.; de Oliveira, A.M.; da Silva, R.S. 2020: Vascular tone and angiogenesis modulation by catecholamine coordinated to ruthenium. Rsc Medicinal Chemistry 11(4): 497-510
Calò, L.A. 2006: Vascular tone control in humans: insights from studies in Bartter's/Gitelman's syndromes. Kidney International 69(6): 963-966
Kang, J.H.; Loomis, S.J.; Yaspan, B.L.; Bailey, J.C.; Weinreb, R.N.; Lee, R.K.; Lichter, P.R.; Budenz, D.L.; Liu, Y.; Realini, T.; Gaasterland, D.; Gaasterland, T.; Friedman, D.S.; McCarty, C.A.; Moroi, S.E.; Olson, L.; Schuman, J.S.; Singh, K.; Vollrath, D.; Wollstein, G.; Zack, D.J.; Brilliant, M.; Sit, A.J.; Christen, W.G.; Fingert, J.; Forman, J.P.; Buys, E.S.; Kraft, P.; Zhang, K.; Allingham, R.R.; Pericak-Vance, M.A.; Richards, J.E.; Hauser, M.A.; Haines, J.L.; Wiggs, J.L.; Pasquale, L.R. 2014: Vascular tone pathway polymorphisms in relation to primary open-angle glaucoma. Eye 28(6): 662-671
Kang, J.H.; Loomis, S.J.; Yaspan, B.L.; Bailey, J.C.; Weinreb, R.N.; Lee, R.K.; Lichter, P.R.; Budenz, D.L.; Liu, Y.; Realini, T.; Gaasterland, D.; Gaasterland, T.; Friedman, D.S.; McCarty, C.A.; Moroi, S.E.; Olson, L.; Schuman, J.S.; Singh, K.; Vollrath, D.; Wollstein, G.; Zack, D.J.; Brilliant, M.; Sit, A.J.; Christen, W.G.; Fingert, J.; Forman, J.P.; Buys, E.S.; Kraft, P.; Zhang, K.; Allingham, R.R.; Pericak-Vance, M.A.; Richards, J.E.; Hauser, M.A.; Haines, J.L.; Wiggs, J.L.; Pasquale, L.R. 2014: Vascular tone pathway polymorphisms in relation to primary open-angle glaucoma. Eye 28(6): 662-671
Farooq, J.; Lee, J.Y. 2021: Vascular tortuosity in endovascular mechanical thrombectomy. Brain Circulation 7(1): 3-7
An, S.; Kim, T.; Oh, C.Wan.; Bang, J.Seung.; Lee, S.Un.; Heo, J. 2019: Vascular tortuosity of the internal carotid artery is related to the RNF213 c.14429G > A variant in moyamoya disease. Scientific Reports 9(1): 8614
Herrmann, J. 2020: Vascular toxic effects of cancer therapies. Nature Reviews. Cardiology 17(8): 503-522
Neves, K.B.; Montezano, A.C.; Lang, N.N.; Touyz, R.M. 2020: Vascular toxicity associated with anti-angiogenic drugs. Clinical Science 134(18): 2503-2520
Dinh, K.; Manuel, L.; Somers, M.; Vicaretti, M. 2021: Vascular tracheobronchial compression syndrome secondary to contained ruptured thoracic aortic aneurysm. Journal of Surgical Case Reports 5: Rjab 147
Cartland, Sân.P.; Lin, R.C.Y.; Genner, S.; Patil, M.S.; Martínez, G.J.; Barraclough, J.Y.; Gloss, B.; Misra, A.; Patel, S.; Kavurma, M.M. 2020: Vascular transcriptome landscape of Trail -/- mice: Implications and therapeutic strategies for diabetic vascular disease. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 34(7): 9547-9562
Siedlinski, M.; Nosalski, R.; Szczepaniak, P.; Ludwig-Gałęzowska, A.H.; Mikołajczyk, T.; Filip, M.; Osmenda, G.; Wilk, G.; Nowak, Mł.; Wołkow, Pł.; Guzik, T.J. 2017: Vascular transcriptome profiling identifies Sphingosine kinase 1 as a modulator of angiotensin II-induced vascular dysfunction. Scientific Reports 7: 44131
Xing, Z.; Wu, S.; Zhao, C.; Bai, Y.; Jin, D.; Yin, M.; Liu, H.; Fan, Y. 2021: Vascular transplantation with dual-biofunctional ePTFE vascular grafts in a porcine model. Journal of Materials Chemistry. B 9(36): 7409-7422
Naz, E. 1946: Vascular trauma and their consequences. Zeitschrift für Unfallmedizin und Berufskrankheiten. Revue de Medecine des Accidents et des Maladies Professionelles 39(2): 117-136
Clark, S. 1996: Vascular trauma in civilian practice. Annals of the Royal College of Surgeons of England 78(2): 155
Varani, J.; Perone, P.; Warner, R.L.; Dame, M.K.; Kang, S.; Fisher, G.J.; Voorhees, J.J. 2008: Vascular tube formation on matrix metalloproteinase-1-damaged collagen. British Journal of Cancer 98(10): 1646-1652
Wertheimer, P.; Mansuy, L. 1945: Vascular tumor of the cranial vault. Lyon Chirurgical 40: 661
Du, W.; Gerald, D.; Perruzzi, C.A.; Rodriguez-Waitkus, P.; Enayati, L.; Krishnan, B.; Edmonds, J.; Hochman, M.L.; Lev, D.C.; Phung, T.L. 2013: Vascular tumors have increased p70 S6-kinase activation and are inhibited by topical rapamycin. Laboratory Investigation; a Journal of Technical Methods and Pathology 93(10): 1115-1127
Upton, J.; Coombs, C. 1995: Vascular tumors in children. Hand Clinics 11(2): 307-337
Hosoda, S.; Sasaki, M. 1994: Vascular tumors of the intestine. Nihon Rinsho. Japanese Journal of Clinical Medicine Suppl 6: 440-442
Rolik, L.K. 1956: Vascular tumors of the mediastinum. Voprosy Onkologii 2(5): 592-597
Hilke, H.; Schulte-Brinkmann, W. 1958: Vascular tumors of the mediastinum. Zentralblatt für Chirurgie 83(36): 1741-1755
Lacombe, H.; Chouard, C.H. 1984: Vascular tumors of the neck. Journal Francais d'Oto-Rhino-Laryngologie; Audiophonologie Chirurgie Maxillo-Faciale 33(10): 513-528
Wazny, V.; Siau, A.; Wu, K.X.; Cheung, C. 2020: Vascular underpinning of COVID-19. Open Biology 10(8): 200208
Shantsila, A.; Dwivedi, G.; Shantsila, E.; Steeds, R.P.; Beevers, G.; Lip, G.Y.H. 2012: Vascular ventricular coupling in patients with malignant phase hypertension: the West Birmingham malignant hypertension project. Hypertension Research: Official Journal of the Japanese Society of Hypertension 35(7): 725-728
Cortese, F.; Cecere, A.; Maria Cortese, A.; Andriani, A.; Truncellito, L.; Valente, F.; Giordano, P.; Matteo Ciccone, M. 2020: Vascular, cardiac and renal target organ damage associated to arterial hypertension: which noninvasive tools for detection?. Journal of Human Hypertension 34(6): 420-431
Wang, T.; Yuan, F.; Chen, Z.; Zhu, S.; Chang, Z.; Yang, W.; Deng, B.; Que, R.; Cao, P.; Chao, Y.; Chan, L.; Pan, Y.; Wang, Y.; Xu, L.; Lyu, Q.; Chan, P.; Yenari, M.A.; Tan, E.-K.; Wang, Q. 2020: Vascular, inflammatory and metabolic risk factors in relation to dementia in Parkinson's disease patients with type 2 diabetes mellitus. Aging 12(15): 15682-15704
Guliaev, S.M. 2021: Vascular, molecular and cellular mechanisms of development of cognitive impairments after occlusion of carotid arteries. Angiologiia i Sosudistaia Khirurgiia 27(2): 11-16
Swamy, K. 2021: Vascular-immuno-phenotypic (VIP) model for locally advanced and oligo-metastatic cancer: a hypothesis. Medical Hypotheses 152: 110618
Zhang, Z.; Zheng, Y.; Ham, B-Kook.; Chen, J.; Yoshida, A.; Kochian, L.V.; Fei, Z.; Lucas, W.J. 2016: Vascular-mediated signalling involved in early phosphate stress response in plants. Nature Plants 2: 16033
Yancopoulos, G.D.; Davis, S.; Gale, N.W.; Rudge, J.S.; Wiegand, S.J.; Holash, J. 2000: Vascular-specific growth factors and blood vessel formation. Nature 407(6801): 242-248
Vorobiev, V.; Adriouach, S.; Crowe, L.A.; Lenglet, S.éb.; Thomas, A.él.; Chauvin, A.-S.; Allémann, E. 2021: Vascular-targeted micelles as a specific MRi contrast agent for molecular imaging of fibrin clots and cancer cells. European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik E.V 158: 347-358
Byrne, A.T.; O'Connor, A.E.; Hall, M.; Murtagh, J.; O'Neill, K.; Curran, K.M.; Mongrain, K.; Rousseau, J.A.; Lecomte, R.; McGee, S.; Callanan, J.J.; O'Shea, D.F.; Gallagher, W.M. 2009: Vascular-targeted photodynamic therapy with BF2-chelated Tetraaryl-Azadipyrromethene agents: a multi-modality molecular imaging approach to therapeutic assessment. British Journal of Cancer 101(9): 1565-1573
Imai, S.; Tahara, N.; Igata, S.; Tahara, A.; Bekki, M.; Sugiyama, Y.; Maeda-Ogata, S.; Honda, A.; Otsuka, H.; Ushijima, T.; Okabe, Y.; Kaida, H.; Abe, T.; Tanaka, H.; Fukumoto, Y.; Tayama, E. 2021: Vascular/perivascular inflammation in IgG4-related disease. Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology 2021
Luk, M.H.; Yee, A.H.-F.; Yau, R.; Ho, K.W.-Y.; Lam, Y.-L. 2020: Vascularised bone graft is an effective technique for extracortical bone bridging to combat cemented megaprosthesis loosening at the bone-implant junction. Journal of Orthopaedic Surgery 28(3): 2309499020958167
Honeyman, C.; Stark, H.L.; Fries, C.A.; Gorantla, V.S.; Davis, M.R.; Giele, H. 2021: Vascularised composite allotransplantation in solid organ transplant recipients: a systematic review. Journal of Plastic Reconstructive and Aesthetic Surgery: Jpras 74(2): 316-326
Chinsamy, A.; Cerda, I.; Powell, J. 2016: Vascularised endosteal bone tissue in armoured sauropod dinosaurs. Scientific Reports 6: 24858
Shankar, P.; Bradshaw, S.E.; Ang, A.; Rennie, I.G.; Snead, D.R.; Snead, M.P. 2007: Vascularised epiretinal membrane associated with vasoproliferative tumour. Eye 21(7): 1003-1004
Panigrahi, T.K.; Maharaj, R.C.; Nanda, D.P. 2020: Vascularised fibular graft in the management of non-union of fracture shaft of radius: a less ventured entity. Ghana Medical Journal 54(4): 284-286
Boulton, M.E.; Foreman, D.; McLeod, D. 1996: Vascularised vitreoretinopathy: the role of growth factors. Eye 10: 691-696
Bernsen, H.J.; Rijken, P.F.; Oostendorp, T.; van der Kogel, A.J. 1995: Vascularity and perfusion of human gliomas xenografted in the athymic nude mouse. British Journal of Cancer 71(4): 721-726
Hylton, N.M. 2001: Vascularity assessment of breast lesions with gadolinium-enhanced MR imaging. Magnetic Resonance Imaging Clinics of North America 9(2): 321
Orsida, B.E.; Li, X.; Hickey, B.; Thien, F.; Wilson, J.W.; Walters, E.H. 1999: Vascularity in asthmatic airways: relation to inhaled steroid dose. Thorax 54(4): 289-295
Lung, P.F.C.; Fang, C.; Jaffer, O.S.; Deganello, A.; Shah, A.; Hedayati, V.; Obaro, A.; Yusuf, G.T.; Huang, D.Y.; Sellars, M.E.; Quinlan, D.J.; Sidhu, P.S. 2020: Vascularity of Intra-testicular Lesions: Inter-observer Variation in the Assessment of Non-neoplastic Versus Neoplastic Abnormalities After Vascular Enhancement with Contrast-Enhanced Ultrasound. Ultrasound in Medicine and Biology 46(11): 2956-2964
Zhou, L.; Gao, M.; Fu, W.; Wang, Y.; Luo, D.; Chang, K.; Chen, M. 2020: Three-dimensional DNA tweezers serve as modular DNA intelligent machines for detection and regulation of intracellular microRNA. Science Advances 6(22): Eabb 0695
Später, T.; Menger, M.D.; Laschke, M.W. 2021: Vascularization Strategies for Porous Polyethylene Implants. Tissue Engineering. Part B Reviews 27(1): 29-38
Nazzaro, G.; Calzari, P.; Passoni, E.; Vaienti, S.; Moltrasio, C.; Barbareschi, M.; Muratori, S.; Veraldi, S.; Marzano, A.V. 2021: Vascularization and fibrosis are important ultrasonographic tools for assessing response to adalimumab in hidradenitis suppurativa: Prospective study of 32 patients. Dermatologic Therapy 34(1): E14706
Najdanović, J.G.; Cvetković, V.J.; Stojanović, S.T.; Vukelić-Nikolić, M.Đ; Živković, J.M.; Najman, S.J. 2021: Vascularization and osteogenesis in ectopically implanted bone tissue-engineered constructs with endothelial and osteogenic differentiated adipose-derived stem cells. World Journal of Stem Cells 13(1): 91-114
Li, D.; Cheng, P.; Jiang, H.; Cao, T.; Wang, J.; Gao, Y.; Lin, Y.; Wang, C.; Zhang, S.; Li, J.; Liu, B.; Song, Y.; Yang, L.; Pei, G. 2018: Vascularization converts the lineage fate of bone mesenchymal stem cells to endothelial cells in tissue-engineered bone grafts by modulating FGF2-RhoA/ROCK signaling. Cell Death and Disease 9(10): 959
Moreira, H.R.; Marques, A.P. 2022: Vascularization in skin wound healing: where do we stand and where do we go?. Current Opinion in Biotechnology 73: 253-262
Cardoso De Castro, J. 1945: Vascularization is ovarian alpingo. Revista Medica Municipal 6: 124-152
Shahin, H.; Elmasry, M.; Steinvall, I.; Söberg, F.; El-Serafi, A. 2020: Vascularization is the next challenge for skin tissue engineering as a solution for burn management. Burns and Trauma 8: Tkaa 022
Bulliard, A.; Delarue, J.; Mignot, J. 1956: Vascularization of cancers of the large intestine. La Presse Medicale 64(94): 2164-2167
Lambert, P.B. 1971: Vascularization of skin grafts. Nature 232(5308): 279-280
Barahona, R.; Gorena, N.M. 1947: Vascularization of the cardiac valves; frequency and interpretation. Revista Sudamericana de Morfologia 5(1): 43-64
Castro Correia, J. 1957: Vascularization of the choroid. Acta Anatomica 31(2): 238-245
Fournier, D.E.; Kiser, P.K.; Shoemaker, J.K.; Battié, M.C.; Séguin, C.A. 2020: Vascularization of the human intervertebral disc: a scoping review. Jor Spine 3(4): E1123
Stenstrom, J.D. 1948: Vascularization of the myocardial capillary bed by arterialization of the cardiac veins; an experimental study. Canadian Medical Association Journal 59(5): 420-426
De Busscher, G. 1947: Vascularization of the ulcerative stomach. Gastroenterologia 72(3-4): 154-200
Isolan, G.R.; Marrone, A.ôn.C.H.; Marrone, L.C.P.; Stefani, M.A.; da Costa, J.C.; Telles, J.P.M.; Choi, G.G.; da Silva, S.A.; Rabelo, N.íc.N.; Figueiredo, E.G. 2021: Vascularization of the uncus - Anatomical study and clinical implications. Surgical Neurology International 12: 393
Cadenat, H.; Combelles, R.; Barthelemy, R.; Fabie, M. 1974: Vascularization of the upper jaw. Its consequences in orthopedic surgery. Revue de Stomatologie et de Chirurgie Maxillo-Faciale 75(1): 139-141
Terracol, J.; Guerrier, Y. 1956: Vascularization of the vocal cord. Les Annales d'Oto-Laryngologie 73(6): 407-423
Apelgren, P.; Amoroso, M.; Säljö, K.; Montelius, M.; Lindahl, A.; Stridh Orrhult, L.; Gatenholm, P.; Kölby, L. 2021: Vascularization of tissue engineered cartilage - Sequential in vivo MRi display functional blood circulation. Biomaterials 276: 121002
Amirsadeghi, A.; Jafari, A.; Eggermont, L.J.; Hashemi, S.-S.; Bencherif, S.A.; Khorram, M. 2020: Vascularization strategies for skin tissue engineering. Biomaterials Science 8(15): 4073-4094
Pet, M.A. 2021: Vascularized Bone Flaps for Carpal Reconstruction. Missouri Medicine 118(2): 147-152
Kawasaki, K.; Nemoto, T.; Kubo, K.; Tomita, K.; Inagaki, K. 2020: Vascularized Bone Grafting for Scaphoid Nonunion with Humpback Deformity: the Surgical Technique. Journal of Wrist Surgery 9(6): 528-534
Skochdopole, A.J.; Wagner, R.D.; Davis, M.J.; Raj, S.; Winocour, S.J.; Ropper, A.E.; Xu, D.S.; Bohl, M.A.; Reece, E.M. 2021: Vascularized Bone Grafts in Spinal Reconstruction: An Overview of Nomenclature and Indications. Seminars in Plastic Surgery 35(1): 50-53
Shockcor, N.; Buckingham, E.B.; Hassanein, W.; Dhru, U.; Khalifeh, A.; Uluer, M.; Woodall, J.; Brazio, P.; Drachenberg, C.; Nam, A.J.; Barth, R.N. 2021: Vascularized Bone Marrow Cellular Depletion or Discontinuity Abrogates Protection of Vascularized Composite Allografts in Nonhuman Primates. Transplantation Direct 7(2): E659
Li, X.; Lu, L.; Gong, X.; Jiang, Z. 2020: Vascularized Capitate Transposition for the Treatment of Stage IIIB Kienböck Disease. Journal of Hand Surgery 45(11): 1085.E1-1085.E11
Boswell-Patterson, C.A.; Hétu, M.-F.; Kearney, A.; Pang, S.C.; Tse, M.Y.; Herr, J.E.; Spence, M.; Zhou, J.; Johri, A.M. 2021: Vascularized Carotid Atherosclerotic Plaque Models for the Validation of Novel Methods of Quantifying Intraplaque Neovascularization. Journal of the American Society of Echocardiography: Official Publication of the American Society of Echocardiography 34(11): 1184-1194
Johnson, J.; Naqvi, S.; Jain, K.; Karni, R.J.; Ho, T. 2021: Vascularized Clavicular Bone with Supraclavicular Artery Island Flap for Oromandibular Reconstruction. Journal of Craniofacial Surgery 32(2): 765-767
Ramly, E.P.; Berman, Z.P.; Diep, G.K.; Alfonso, A.R.; Kimberly, L.L.; Gelb, B.E.; Rodriguez, E.D. 2020: Vascularized Composite Allotransplantation 2.0: the Future Is now. Plastic and Reconstructive Surgery 146(3): 386e-387e
Jacoby, A.; Cohen, O.; Gelb, B.E.; Ceradini, D.J.; Rodriguez, E.D. 2021: Vascularized Composite Allotransplantation and Immunobiology: the Next Frontier. Plastic and Reconstructive Surgery 147(6): 1092e-1093e
Gray, K.M.; Peterson, J.M.; Padilla, P.L.; Smith, J.M.; Zapata-Sirvent, R.ón.L.; Branski, L.K.; Norbury, W.B.; Dziewulski, P. 2021: Vascularized Composite Allotransplantation in Burn Reconstruction: Systematic Review and Meta-analysis. Journal of Burn Care and Research: Official Publication of the American Burn Association 42(3): 465-472
Ramly, E.P.; Berman, Z.P.; Diep, G.K.; Alfonso, A.R.; Kimberly, L.L.; Rodriguez, E.D. 2020: Vascularized Composite Allotransplantation in a Post-COVID-19 Pandemic World. Plastic and Reconstructive Surgery 146(3): 394e-395e
Moris, D.; Wang, J.; Selim, M.A.; Song, M.; Stempora, L.; Parker, W.; Kirk, A.D.; Cendales, L.C. 2021: Vascularized composite allotransplants as a mechanistic model for allograft rejection - an experimental study. Transplant International: Official Journal of the European Society for Organ Transplantation 34(3): 572-584
Chandler, L.; Pourtaheri, N.; Maniskas, S.; Ahmad, M.; Lopez, J.; Steinbacher, D.M. 2020: Vascularized Composite Parietal Bone Flap for Immediate Reconstruction of a Hemi-Maxillectomy Defect in an Infant. Journal of Craniofacial Surgery 31(8): 2334-2338
Boulanger, E.; Philippakis, E.; Chehaibou, I. 2021: Vascularized Epiretinal Proliferation Associated with Lamellar Macular Hole. OPHTHALMOLOGY. Retina 5(4): 373
Hashimoto, H.; Kageyama, T.; Sakai, H.; Tsukuura, R. 2020: Vascularized Genitofemoral Nerve Flap Based on the Deep Branch of the Superficial Circumflex Iliac Artery. Journal of Reconstructive Microsurgery 36(3): E1-E2
Hassani, C.; Tran, K.; Palmer, S.L.; Patel, K.M. 2020: Vascularized Lymph Node Transfer: a Primer for the Radiologist. Radiographics: a Review Publication of the Radiological Society of North America Inc 40(4): 1073-1089
McAvoy, M.; Doloff, J.C.; Khan, O.F.; Rosen, J.; Langer, R.; Anderson, D.G. 2020: Vascularized Muscle Flap to Reduce Wound Breakdown During Flexible Electrode-Mediated Functional Electrical Stimulation After Peripheral Nerve Injury. Frontiers in Neurology 11: 644
Winocour, S.J.; Xue, E.Y.; Bohl, M.A.; Farrokhi, F.; Davis, M.J.; Abu-Ghname, A.; Ropper, A.E.; Reece, E.M. 2021: Vascularized Occipital Bone Grafting: Indications, Techniques, Clinical Outcomes, and Alternatives. Seminars in Plastic Surgery 35(1): 14-19
Medda, S.; King, M.A.; Runyan, C.M.; Frino, J. 2021: Vascularized Pedicled Fibula for Pediatric Tibia Reconstruction. Journal of Orthopaedic Trauma 35(Suppl 2): S48-S49
Winocour, S.J.; Agrawal, N.; Wagner, K.M.; Davis, M.J.; Abu-Ghname, A.; Shekher, R.; Raber, M.R.; Bohl, M.A.; Ropper, A.E.; Reece, E.M. 2021: Vascularized Rib Bone Grafting: Indications, Techniques, and Clinical Outcomes. Seminars in Plastic Surgery 35(1): 31-36
Reece, E.M.; O'Neill, R.C.; Davis, M.J.; Abu-Ghname, A.; Ropper, A.E.; Bohl, M.; Xu, D.S.; Winocour, S.J. 2021: Vascularized Scapular Bone Grafting: Indications, Techniques, Clinical Outcomes, and Alternatives. Seminars in Plastic Surgery 35(1): 25-30
Deng, A.D.; Innocenti, M.; Arora, R.; Gabl, M.; Tang, J.B. 2020: Vascularized Small-Bone Transfers for Fracture Nonunion and Bony Defects. Clinics in Plastic Surgery 47(4): 501-520
Patel, N.V.; Khatri, D.; D'Amico, R.; Abrams, M.; Reichman, N.; Filippi, C.G.; Anderson, T.; Ratzon, F.; Wong, T.; Fralin, S.; Li, M.; Faltings, L.; Langer, D.J.; Boockvar, J.A. 2020: Vascularized Temporoparietal Fascial Flap: a Novel Surgical Technique to Bypass the Blood-Brain Barrier in Glioblastoma. World Neurosurgery 143: 38-45
Takebe, T.; Sekine, K.; Enomura, M.; Koike, H.; Kimura, M.; Ogaeri, T.; Zhang, R-Ran.; Ueno, Y.; Zheng, Y-Wen.; Koike, N.; Aoyama, S.; Adachi, Y.; Taniguchi, H. 2013: Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 499(7459): 481-484
Petrella, G.; Tosi, D.; Pantaleoni, F.; Adani, R. 2021: Vascularized bone grafts for post-traumatic defects in the upper extremity. Archives of Plastic Surgery 48(1): 84-90
Tsukamoto, Y.; Akagi, T.; Akashi, M. 2020: Vascularized cardiac tissue construction with orientation by layer-by-layer method and 3D printer. Scientific Reports 10(1): 5484
Loro, A.; Hodges, A.; Galiwango, G.W.; Loro, F. 2021: Vascularized fibula flap in the management of segmental bone loss following osteomyelitis in children at a Ugandan hospital. Journal of Bone and Joint Infection 6(6): 179-187
Shi, Y.; Sun, L.; Wang, M.; Liu, J.; Zhong, S.; Li, R.; Li, P.; Guo, L.; Fang, A.; Chen, R.; Ge, W.-P.; Wu, Q.; Wang, X. 2020: Vascularized human cortical organoids (vOrganoids) model cortical development in vivo. Plos Biology 18(5): E3000705
Jarvis, N.R.; Torres, R.A.; Avila, F.R.; Forte, A.J.; Rebecca, A.M.; Teven, C.M. 2021: Vascularized omental lymphatic transplant for upper extremity lymphedema: a systematic review. Cancer Reports 4(4): E1370
Rogozinski, J.; Johnson, R.M. 2020: Vascularized tendon graft to the central slip using a finger fillet flap. Journal of Surgical Case Reports 6: Rjaa 192
Barrera-Ochoa, S.; Sapage, R.; Alabau-Rodriguez, S.; Muñoz-Perdomo, T.; Knörr, J.; Soldado, F. 2022: Vascularized ulnar periosteal pedicled flap for forearm nonunion in children. Journal of Hand Surgery European Volume 47(2): 157-163
Pillunat, K.R.; Pillunat, L.E. 2021: Vasculat treatment concepts in glaucoma patients. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 118(5): 431-438
Masum, M.A.; Ichii, O.; Elewa, Y.H.A.; Otani, Y.; Namba, T.; Kon, Y. 2020: Vasculature-Associated Lymphoid Tissue: a Unique Tertiary Lymphoid Tissue Correlates with Renal Lesions in Lupus Nephritis Mouse Model. Frontiers in Immunology 11: 595672
Tesfamariam, B. 2021: Vasculature-on-chip for Assessment of Bioresorbable Scaffolds and Endothelial Barrier Integrity. Journal of Cardiovascular Pharmacology 78(4): 515-522
Carneiro, D.R.; Rebelo, O.; Matos, A.; Baldeiras, I.ês.; Almendra, L.; Fernandes, C.; Negrão, L.ís.; Almeida, M.R.ár.; Matias, F.; Brás, J.é; Guerreiro, R.; Santo, G.C. 2021: Vasculitic peripheral neuropathy in deficiency of adenosine deaminase 2. Neuromuscular Disorders: Nmd 31(9): 891-895
Vega, L.E.; Espinoza, L.R. 2020: Vasculitides in HIV Infection. Current Rheumatology Reports 22(10): 60
Ryan, T.J. 1977: Vasculitis. Practitioner 218(1307): 682-688
Kappert, A. 1976: Vasculitis. VASA. Zeitschrift für Gefasskrankheiten 5(4): 285-286
Lawley, T.J.; Kubota, Y. 1990: Vasculitis. Dermatologic Clinics 8(4): 681-687
Danieli, G. 1987: Vasculitis. Giornale di Clinica Medica 68(6-7): 325-334
Klüken, N. 1967: Vasculitis. Actualites Cardiologiques et Angeiologiques Internationales 16(4): 315-317
Herreman, G. 1981: Vasculitis. Annales de Medecine Interne 132(2): 138-147
Rothschild, B. 1984: Vasculitis. Primary Care 11(2): 325-339
Wisłowska, M. 1994: Vasculitis. Polski Tygodnik Lekarski 49(16-17): 393-396
Małdyk, H. 1994: Vasculitis. Polskie Archiwum Medycyny Wewnetrznej 91(5): 395-401
Puett, D.W. 1995: Vasculitis. Bulletin on the Rheumatic Diseases 44(7): 4-8
Berlit, P. 1996: Vasculitis. Therapeutische Umschau. Revue Therapeutique 53(7): 559-567
Villiger, P.M. 2001: Vasculitis. Praxis 90(6): 193-196
Abdou, N.I. 2002: Vasculitis. Clinical Allergy and Immunology 16: 435-447
Morović-Vergles, J. 2001: Vasculitis. Reumatizam 48(2): 14-18
Vilotijevic, R.; Strinic, F.; Masulovic, M.; Milovic, K. 1959: Vasculitis. La Presse Medicale 67(22): 898
Ongley, R.C. 1987: Vasculitis. Canadian Family Physician Medecin de Famille Canadien 33: 2335-2340
Muso, E.; Arimura, Y. 2016: Vasculitis. Nihon Jinzo Gakkai Shi 58(1): 5-11
Parreau, S.; Liozon, E.; Lacroix, P. 2021: Vasculitis After Influenza Vaccination. Journal of Clinical Rheumatology: Practical Reports on Rheumatic and Musculoskeletal Diseases 27(8s): S674-S676
Zhang, X.; Furth, E.E.; Tondon, R. 2020: Vasculitis Involving the Gastrointestinal System Is Often Incidental but Critically Important. American Journal of Clinical Pathology 154(4): 536-552
Blech, B.; Meyer, M.; Goodman, B.; Knox, M.; Aslam, F.; Schmitt, A.; Grill, M. 2021: Vasculitis Presenting as Autonomic Failure. Neurologist 26(4): 117-121
Esperança-Martins, M.; Evangelista, V.; Fernandes, S.ão.; Almeida, R. 2021: Vasculitis and Breast Cancer: Mind the Hint. Case Reports in Oncology 14(1): 550-560
Becker, K.; Beythien, G.; de Buhr, N.; Stanelle-Bertram, S.; Tuku, B.; Kouassi, N.M.; Beck, S.; Zickler, M.; Allnoch, L.; Gabriel, G.ül.; von Köckritz-Blickwede, M.; Baumgärtner, W. 2021: Vasculitis and Neutrophil Extracellular Traps in Lungs of Golden Syrian Hamsters with SARS-CoV-2. Frontiers in Immunology 12: 640842
Roquelaure, D.; Rossi, D.C.; Ambresin, A.; Guex-Crosier, Y. 2019: Vasculitis and Retrofoveal Choroidal Neovessels in a Case of Multifocal Pattern Dystrophy. Klinische Monatsblatter für Augenheilkunde 236(4): 523-525
Geier, C.B.; Farmer, J.R.; Foldvari, Z.; Ujhazi, B.; Steininger, J.; Sleasman, J.W.; Parikh, S.; Dilley, M.A.; Pai, S.-Y.; Henderson, L.; Hazen, M.; Neven, B.; Moshous, D.; Sharapova, S.O.; Mihailova, S.; Yankova, P.; Naumova, E.; Özen, S.; Byram, K.; Fernandez, J.; Wolf, H.M.; Eibl, M.M.; Notarangelo, L.D.; Calabrese, L.H.; Walter, J.E. 2020: Vasculitis as a Major Morbidity Factor in Patients with Partial RAG Deficiency. Frontiers in Immunology 11: 574738
Roupie, A.L.; Guedon, A.; Terrier, B.; Lahuna, C.; Jachiet, V.; Regent, A.; de Boysson, H.; Carrat, F.; Seguier, J.; Terriou, L.; Versini, M.; Queyrel, V.; Groh, M.; Benhamou, Y.; Maurier, F.; Ledoult, E.; Clech, L.L.; D'Aveni, M.; Rossignol, J.; Galland, J.; Willems, L.; Chiche, N.J.; Peterlin, P.; Roux-Sauvat, M.; Parcelier, A.; Wemeau, M.; Lambert, M.; Belizna, C.; Puechal, X.; Swiader, L.; Cohen-Valensi, R.; Noc, V.ér.; Dao, E.; Thepot, S.; de Frémont, G.ég.M.; Tanguy-Schmidt, A.; Koka, A.M.; Bussone, G.; Philipponnet, C.; Konate, A.; Cavaille, G.; Guilpain, P.; Allain, J.-S.éb.; Broner, J.; Solary, E.; Ruivard, M.; de Renzis, B.; Corm, S.él.; Baati, N.; Schleinitz, N.; Ponsoye, M.; Stamatoullas-Bastard, A.; Ades, L.; Dellal, 2020: Vasculitis associated with myelodysplastic syndrome and chronic myelomonocytic leukemia: French multicenter case-control study. Seminars in Arthritis and Rheumatism 50(5): 879-884
Elgengehy, F.T.; Gamal, S.M.; Sobhy, N.; Siam, I.; Soliman, A.M.; Elhady, G.W.; Gheita, T.A. 2021: Vasculitis damage index in Behçet's disease. Advances in Rheumatology 61(1): 33
Höper, L.; Skoog, E.; Stenson, M.; Grankvist, A.; Wass, L.; Olsen, B.ör.; Nilsson, K.; Mårtensson, A.; Söderlind, J.; Sakinis, A.; Wennerås, C. 2021: Vasculitis due to Candidatus Neoehrlichia mikurensis: a Cohort Study of 40 Swedish Patients. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 73(7): E2372-E2378
Gadola, S.D.; Gross, W.L. 2012: Vasculitis in 2011: the renaissance of granulomatous inflammation in AAV. Nature Reviews. Rheumatology 8(2): 74-76
Sposito, F.; McNamara, P.S.; Hedrich, C.M. 2020: Vasculitis in Cystic Fibrosis. Frontiers in Pediatrics 8: 585275
Gilliam, J.H.; Challa, V.R.; Agudelo, C.A.; Albertson, D.A.; Huntley, C.C. 1981: Vasculitis involving muscle associated with Crohn's colitis. Gastroenterology 81(4): 787-790
Bousser, M.G.; Mas, J.L. 1989: Vasculitis of the central nervous system. La Revue du Praticien 39(23): 2037-2040
Aukrust, P.; Torp, R.; Bjønnes, J. 1988: Vasculitis of the central nervous system. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 108(33): 3094-3096
Calabrese, L.H. 1995: Vasculitis of the central nervous system. Rheumatic Diseases Clinics of North America 21(4): 1059-1076
Cobeta García, J.C.; López-Longo, F.J.; Monteagudo Sáez, I. 1989: Vasculitis of the central nervous system and giant cell arteritis. Medicina Clinica 92(13): 516-517
Waldendorf, M.; Samtleben, W.; Gurland, H.J. 1993: Vasculitis of the kidney. Der Internist 34(7): 659-666
Travis, W.D.; Fleming, M.V. 1996: Vasculitis of the lung. Pathology 4(1): 23-41
Barranco, C. 2016: Vasculitis syndromes: 16S RNA sequencing sheds light on Behçet disease. Nature Reviews. Rheumatology 12(8): 436
Loricera, J.; Blanco, R. 2018: Vasculitis syndromes: A closer look at skin involvement in vasculitis. Nature Reviews. Rheumatology 14(4): 186-187
Carney, E.F. 2012: Vasculitis syndromes: AAV encompasses two major genetically distinct conditions with different autoantibody specificities. Nature Reviews. Rheumatology 8(9): 502
Mackie, S.L.; Dasgupta, B. 2014: Vasculitis syndromes: Dealing with increased vascular risk and mortality in GCA. Nature Reviews. Rheumatology 10(5): 264-265
Barranco, C. 2016: Vasculitis syndromes: Diagnostic and prognostic roles for T-cell markers in Kawasaki disease. Nature Reviews. Rheumatology 12(10): 562
Collison, J. 2016: Vasculitis syndromes: Dysfunctional CD8 TREG cells implicated in GCA. Nature Reviews. Rheumatology 12(6): 314
Watts, R.A. 2010: Vasculitis syndromes: Inducing remission in ANCA-positive vasculitis: time to RAVE?. Nature Reviews. Rheumatology 6(3): 127-128
Buckland, J. 2012: Vasculitis syndromes: Insights into the role of IL-21 in GCA. Nature Reviews. Rheumatology 8(2): 63
Barranco, C. 2016: Vasculitis syndromes: Kawasaki disease is IL-1β-mediated. Nature Reviews. Rheumatology 12(12): 693
Bosch, X.; Mirapeix, E. 2009: Vasculitis syndromes: LAMP-2 illuminates pathogenesis of ANCA glomerulonephritis. Nature Reviews. Nephrology 5(5): 247-249
Onuora, S. 2017: Vasculitis syndromes: Loss of immunoinhibitory checkpoint implicated in GCA. Nature Reviews. Rheumatology 13(3): 129
Collison, J. 2016: Vasculitis syndromes: New ANCA assays put through their paces. Nature Reviews. Rheumatology 12(10): 560
Cid, M.C.; Aróstegui, J.I. 2014: Vasculitis syndromes: New insights into the molecular basis of systemic vasculitis. Nature Reviews. Rheumatology 10(6): 323-324
González-Gay, M.A.; Rodríguez-Valverde, V. 2010: Vasculitis syndromes: Not losing sight is the issue in GCA management. Nature Reviews. Rheumatology 6(8): 440-441
Collison, J. 2017: Vasculitis syndromes: Notch one up for the endothelium. Nature Reviews. Rheumatology 13(9): 512
Onuora, S. 2015: Vasculitis syndromes: PR3 on apoptotic cells promotes inflammation in GPA. Nature Reviews. Rheumatology 11(12): 683
Rutgers, A.; Kallenberg, C.G.M. 2011: Vasculitis syndromes: Peripheral neuropathy in AAV--when vasculitis hits a nerve. Nature Reviews. Rheumatology 8(3): 127-128
Tarzi, R.; Pusey, C. 2013: Vasculitis syndromes: RAVE about rituximab in ANCA vasculitis?. Nature Reviews. Nephrology 9(11): 628-629
Collison, J. 2017: Vasculitis syndromes: Rituximab for adult-onset IgA vasculitis. Nature Reviews. Rheumatology 13(12): 694
McHugh, J. 2017: Vasculitis syndromes: Shared genetic risk for Behçet disease and Crohn's disease. Nature Reviews. Rheumatology 13(4): 197
Leah, E. 2010: Vasculitis syndromes: Silence is golden as epigenetic mechanisms are blamed for autoantigen expression in ANCA vasculitis. Nature Reviews. Rheumatology 6(11): 614
Leah, E. 2011: Vasculitis syndromes: T cells turned killer by IL-15 attack the endothelium in GPA. Nature Reviews. Rheumatology 7(6): 314
Koster, M.J.; Warrington, K.J. 2017: Vasculitis syndromes: Tocilizumab - a new frontier for GCA therapy. Nature Reviews. Rheumatology 13(12): 700-701
Shipman, L. 2016: Vasculitis syndromes: Tocilizumab safe and effective for PMR. Nature Reviews. Rheumatology 12(7): 374
Onuora, S. 2017: Vasculitis syndromes: Ultrasonography in GCA assessment. Nature Reviews. Rheumatology 13(12): 695
Bacon, P.A.; Sanderson, T. 2013: Vasculitis syndromes: Vasculitis assessments--what do patients think?. Nature Reviews. Rheumatology 9(11): 641-642
Mearns, B.M. 2014: Vasculitis syndromes: phase III trial of infliximab in Kawasaki disease. Nature Reviews. Rheumatology 10(4): 198
Watts, R. 2009: Vasculitis syndromes: vasculitis therapy--between Scylla and Charybdis. Nature Reviews. Rheumatology 5(4): 183-184
Nachman, P.H. 2009: Vasculitis syndromes: which maintenance therapy for ANCA vasculitis?. Nature Reviews. Nephrology 5(5): 254-256
Torp, C.K.; Brüner, M.; Keller, K.K.; Brouwer, E.; Hauge, E.-M.; McGonagle, D.; Kragstrup, T.W. 2021: Vasculitis therapy refines vasculitis mechanistic classification. Autoimmunity Reviews 20(6): 102829
Boyce, N.W. 1993: Vasculitis--an overview. Australian Family Physician 22(12): 2130; 2133-2136
Carney, E.F. 2017: Vasculitis: Abberrant glycosylation alters MPO antigenicity. Nature Reviews. Nephrology 13(4): 194
Hoffman, G.S. 2020: Vasculitis: Again, Changing the Standard of Care. Annals of Internal Medicine 173(3): 235-236
Kelsey, R. 2013: Vasculitis: Epitope specificity responsible for MPO-ANCA pathogenicity. Nature Reviews. Nephrology 9(6): 310
Guillevin, Lïc. 2017: Vasculitis: Mepolizumab for eosinophilic granulomatosis with polyangiitis. Nature Reviews. Rheumatology 13(9): 518-519
Onuora, S. 2018: Vasculitis: New insights into risk factors for GPA. Nature Reviews. Rheumatology 14(5): 248
Carney, E.F. 2014: Vasculitis: Potential role of an anti-moesin autoantibody in MPO-AAV. Nature Reviews. Nephrology 10(2): 65
Fervenza, F.C.; Specks, U. 2013: Vasculitis: Refining phenotypes in ANCA-associated vasculitis. Nature Reviews. Nephrology 9(1): 6-8
Allison, S.J. 2012: Vasculitis: Renal involvement in granulomatosis with polyangiitis-role of ANCA isotype and Fc receptor genotype. Nature Reviews. Nephrology 8(2): 63
Tarzi, R.M.; Pusey, C.D. 2011: Vasculitis: Risks and rewards of treating elderly patients with vasculitis. Nature Reviews. Nephrology 7(5): 253-255
Schönermarck, U.; de Groot, K. 2011: Vasculitis: Rituximab: effective in ANCA-associated vasculitis?. Nature Reviews. Nephrology 7(1): 6-8
Kelsey, R. 2013: Vasculitis: Validating the new classification system for ANCA-associated GN. Nature Reviews. Nephrology 9(8): 433
Fervenza, F.C.; Specks, U. 2012: Vasculitis: Will LAMP enlighten us about ANCA-associated vasculitis?. Nature Reviews. Nephrology 8(6): 318-320
Hoffman, G.S.; Calabrese, L.H. 2014: Vasculitis: determinants of disease patterns. Nature Reviews. Rheumatology 10(8): 454-462
McGregor, J.G.; Falk, R.J. 2012: Vasculitis: the elusive optimal induction strategy for vasculitis. Nature Reviews. Nephrology 8(4): 195-196
Krause, I.; Weinberger, A. 2002: Vasculo-Behçet's disease. Israel Medical Association Journal: Imaj 4(8): 636-637
Presa, J.L.; Saravia, F.; Bagi, Z.; Filosa, J.A. 2020: Vasculo-Neuronal Coupling and Neurovascular Coupling at the Neurovascular Unit: Impact of Hypertension. Frontiers in Physiology 11: 584135
Blinder, Y.J.; Freiman, A.; Raindel, N.; Mooney, D.J.; Levenberg, S. 2015: Vasculogenic dynamics in 3D engineered tissue constructs. Scientific Reports 5: 17840
Park, K.; Goldstein, I.; Andry, C.; Siroky, M.B.; Krane, R.J.; Azadzoi, K.M. 1997: Vasculogenic female sexual dysfunction: the hemodynamic basis for vaginal engorgement insufficiency and clitoral erectile insufficiency. International Journal of Impotence Research 9(1): 27-37
Brow, S.L.; Seftel, A.D.; Strohl, K.P.; Herbener, T.E. 2000: Vasculogenic impotence and cavernosal oxygen tension. International Journal of Impotence Research 12(1): 19-22
Glina, S. 2000: Vasculogenic impotence and cavernosal oxygen tension. International Journal of Impotence Research 12(2): 131-132
Hendrix, M.J.C.; Seftor, E.A.; Hess, A.R.; Seftor, R.E.B. 2003: Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nature Reviews. Cancer 3(6): 411-421
Scavelli, C.; Nico, B.; Cirulli, T.; Ria, R.; Di Pietro, G.; Mangieri, D.; Bacigalupo, A.; Mangialardi, G.; Coluccia, A.M.L.; Caravita, T.; Molica, S.; Ribatti, D.; Dammacco, F.; Vacca, A. 2008: Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma. Oncogene 27(5): 663-674
Williamson, S.C.; Metcalf, R.L.; Trapani, F.; Mohan, S.; Antonello, J.; Abbott, B.; Leong, H.Sun.; Chester, C.P.E.; Simms, N.; Polanski, R.; Nonaka, D.; Priest, L.; Fusi, A.; Carlsson, F.; Carlsson, A.; Hendrix, M.J.C.; Seftor, R.E.B.; Seftor, E.A.; Rothwell, D.G.; Hughes, A.; Hicks, J.; Miller, C.; Kuhn, P.; Brady, G.; Simpson, K.L.; Blackhall, F.H.; Dive, C. 2016: Vasculogenic mimicry in small cell lung cancer. Nature Communications 7: 13322
Mirshahi, P.; Rafii, A.; Vincent, L.; Berthaut, A.; Varin, R.; Kalantar, G.; Marzac, C.; Calandini, O.A.; Marie, J-P.; Soria, C.; Soria, J.; Mirshahi, M. 2009: Vasculogenic mimicry of acute leukemic bone marrow stromal cells. Leukemia 23(6): 1039-1048
Treps, L.; Faure, S.éb.; Clere, N. 2021: Vasculogenic mimicry, a complex and devious process favoring tumorigenesis - Interest in making it a therapeutic target. Pharmacology and Therapeutics 223: 107805
He, X.; You, J.; Ding, H.; Zhang, Z.; Cui, L.; Shen, X.; Bian, X.; Liu, Y.; Chen, J. 2021: Vasculogenic mimicry, a negative indicator for progression free survival of lung adenocarcinoma irrespective of first line treatment and epithelial growth factor receptor mutation status. Bmc Cancer 21(1): 132
Toledo-Flores, D.; Williamson, A.; Schwarz, N.; Fernando, S.; Dimasi, C.; Witt, T.A.; Nguyen, T.M.; Puranik, A.S.; Chue, C.D.; Delacroix, S.; Spoon, D.B.; Bonder, C.S.; Bursill, C.A.; Di Bartolo, B.A.; Nicholls, S.J.; Simari, R.D.; Psaltis, P.J. 2019: Vasculogenic properties of adventitial Sca-1 + CD45 + progenitor cells in mice: a potential source of vasa vasorum in atherosclerosis. Scientific Reports 9(1): 7286
Shimada, T.; Habara, S.; Tanaka, H.; Kadota, K. 2020: Vasculopathy After Transradial Catheterization in a Scleroderma Patient. Circulation Journal: Official Journal of the Japanese Circulation Society 84(9): 1608
Nader, E.; Conran, N.; Romana, M.; Connes, P. 2021: Vasculopathy in Sickle Cell Disease: from Red Blood Cell Sickling to Vascular Dysfunction. Comprehensive Physiology 11(2): 1785-1803
Chang, K.Hee.; Nayak, R.C.; Roy, S.; Perumbeti, A.; Wellendorf, A.M.; Bezold, K.Y.; Pirman, M.; Hill, S.E.; Starnes, J.; Loberg, A.; Zhou, X.; Inagami, T.; Zheng, Y.; Malik, P.; Cancelas, J.A. 2015: Vasculopathy-associated hyperangiotensinemia mobilizes haematopoietic stem cells/progenitors through endothelial AT₂R and cytoskeletal dysregulation. Nature Communications 6: 5914
Pedrelli, M.; Parini, P.; Kindberg, J.; Arnemo, J.M.; Bjorkhem, I.; Aasa, U.; Westerståhl, M.; Walentinsson, A.; Pavanello, C.; Turri, M.; Calabresi, L.; Öörni, K.; Camejo, G.ér.; Fröbert, O.; Hurt-Camejo, E. 2021: Vasculoprotective properties of plasma lipoproteins from brown bears (Ursus arctos). Journal of Lipid Research 62: 100065
Sakurada, M.; Yoshimoto, T.; Sekizawa, N.; Hirono, Y.; Suzuki, N.; Hirata, Y. 2010: Vasculoprotective effect of cilostazol in aldosterone-induced hypertensive rats. Hypertension Research: Official Journal of the Japanese Society of Hypertension 33(3): 229-235
Sulistyowati, E.; Jan, R.-L.; Liou, S.-F.; Chen, Y.-F.; Wu, B.-N.; Hsu, J.-H.; Yeh, J.-L. 2020: Vasculoprotective effects of Centella asiatica, Justicia gendarussa and Imperata cylindrica decoction via the NOXs-ROS-NF-κB pathway in spontaneously hypertensive rats. Journal of Traditional and Complementary Medicine 10(4): 378-388
Dunea, G. 2004: Vasculorama. Journal of Vascular Access 5(2): 47-48
Dunea, G. 2001: Vasculorama. Journal of Vascular Access 2(4): 137-138
Dunea, G. 2003: Vasculorama. Journal of Vascular Access 4(3): 81-82
Dunea, G. 2003: Vasculorama. Journal of Vascular Access 4(4): 123-124
Dunea, G. 2003: Vasculorama. Journal of Vascular Access 4(2): 37-38
Kaur, B.; Brat, D.J.; Devi, N.S.; Van Meir, E.G. 2005: Vasculostatin, a proteolytic fragment of brain angiogenesis inhibitor 1, is an antiangiogenic and antitumorigenic factor. Oncogene 24(22): 3632-3642
Lynch, M.; Heinen, S.; Markham-Coultes, K.; O'Reilly, M.; Van Slyke, P.; Dumont, D.J.; Hynynen, K.; Aubert, I. 2021: Vasculotide restores the blood-brain barrier after focused ultrasound-induced permeability in a mouse model of Alzheimer's disease. International Journal of Medical Sciences 18(2): 482-493
Singh, S.; Mohanty, R.R. 2021: Vasculotoxic snakebite envenomation: Management challenges in pregnancy. Obstetric Medicine 14(3): 190-192
Kirichenko, Y.Y.; Belenkov, Y.N.; Privalova, E.V.; Naymann, Y.I.; Gitel, E.P.; Novikova, O.V.; Ilgisonis, I.S. 2020: Vasculotoxicity of Chemotherapy: Assessment оf Endothelial Dysfunction Biomarkers' Levels in Gastric Cancer Patients. Kardiologiia 60(5): 1069
Subhadarshani, S.; Gupta, V.; Purohit, A.; Sethuraman, G. 2020: Vascultis Unravelling Hairy Cell Leukemia. Indian Journal of Hematology and Blood Transfusion: An Official Journal of Indian Society of Hematology and Blood Transfusion 36(2): 438-440
Kendrick, J.S.; Rubin, G.L. 1986: Vasectomies performed by private physicians, United States, 1980 to 1984. Fertility and Contraception 46(3): 528-530
Yang, F.; Dong, L.; Zhang, X.; Li, J.; Tan, K.; Li, Y.; Yu, X. 2020: Vasectomy and male sexual dysfunction risk: a systematic review and meta-analysis. Medicine 99(37): E22149
Lesko, S.M.; Louik, C.; Vezina, R.; Rosenberg, L.; Shapiro, S. 1999: Vasectomy and prostate cancer. Journal of Urology 161(6): 1848-1852; Discussion: 1852-1853
Khan, M.A.; Partin, A.W. 2004: Vasectomy and prostate cancer. Reviews in Urology 6(1): 46-47
Shang, Y.; Han, G.; Li, J.; Zhao, J.; Cui, D.; Liu, C.; Yi, S. 2015: Vasectomy and prostate cancer risk: a meta-analysis of cohort studies. Scientific Reports 5: 9920
Dennis, L.K.; Dawson, D.V.; Resnick, M.I. 2002: Vasectomy and the risk of prostate cancer: a meta-analysis examining vasectomy status, age at vasectomy, and time since vasectomy. Prostate Cancer and Prostatic Diseases 5(3): 193-203
Goldstein, M.; Girardi, S.K. 1997: Vasectomy and vasectomy reversal. Current Therapy in Endocrinology and Metabolism 6: 371-380
Brannigan, R.E. 2021: Vasectomy and vasectomy reversal: a comprehensive approach to the evolving spectrum of care. Fertility and Sterility 115(6): 1363-1364
Hoffman, K.; Howell, S.; Schwandt, M.; Fritz, J. 2002: Vasectomy as a birth control modality for captive chimpanzees. Lab Animal 31(8): 45-48
Blandy, J.P. 1973: Vasectomy as a method of family limitation. Midwife and Health Visitor 8(5): 161-165
Amory, J.K.; Jessen, J.W.; Muller, C.; Berger, R.E. 2010: Vasectomy by epithelial curettage without suture or cautery: a pilot study in humans. Asian Journal of Andrology 12(3): 315-321
Lorenzini, M.S.; Lorenzini, F.; Bezerra, C.íc.A. 2021: Vasectomy re-reversal: effectiveness and parameters associated with its success. International Braz J Urol: Official Journal of the Brazilian Society of Urology 47(3): 544-548
Dubin, J.M.; White, J.; Ory, J.; Ramasamy, R. 2021: Vasectomy reversal vs. sperm retrieval with in vitro fertilization: a contemporary, comparative analysis. Fertility and Sterility 115(6): 1377-1383
Yahyazadeh, S.R.; Sadighi Gilani, M.A.; Karimi, A. 2021: Vasectomy reversal: Unilateral versus bilateral vasovasostomy. Andrologia 53(9): E14178
Sokal, D.C. 2010: Vasectomy techniques--need for better occlusion methods. Asian Journal of Andrology 12(3): 442-443
Guzelburc, V.; Baran, C.; Yafi, F.A.; Cakir, A.; Kiremit, M.Can.; Boz, M.Yucel.; Horuz, R.; Guven, S.; Hellstrom, W.J.G.; Albayrak, S. 2019: Vasectomy with vessel sealing device: comparison of different diameters. International Journal of Impotence Research 31(1): 20-24
Honda, G.D.; Bernstein, L.; Ross, R.K.; Greenland, S.; Gerkins, V.; Henderson, B.E. 1988: Vasectomy, cigarette smoking, and age at first sexual intercourse as risk factors for prostate cancer in middle-aged men. British Journal of Cancer 57(3): 326-331
Torres Gómez, F.J. 2020: Vasectomy: Vas deferens with cellular atypia seminal vesicle type. Archivos Espanoles de Urologia 73(9): 860-861
Schmidt, S.S. 1980: Vasectomy: efficacy of placing the cut vas in different fascial planes. Fertility and Sterility 34(3): 292-293
Schaffer, G. 1948: Vaseline Effect on Wound Healing. Nordisk Medicin 37(6): 261-263
Pertsovskiĭ, M.N. 1971: Effect of health-resort treatment on some biochemical indices in atherosclerotic cardiosclerosis. Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 35(6): 495-497
Lopez de la Garma 1972: Lumbago and previous condition in industrial accidents. Acta Orthopaedica Belgica 35(3): 614-616
Sultan, A.; Hassan, M.; Choudhry, M.S.; Shahani, B.; Ali, M. 2021: Vasitis Nodosa: a Rare Diagnosis for Inguinal Swelling. Cureus 13(3): E13759
Zehnder, M. 1948: Vaskoymogram and vascular flow. Helvetica Chirurgica Acta 15(1): 65-72
Day, M.; Bonnet, K.; Schlundt, D.G.; DeBaun, M.; Sharma, D. 2020: Vaso-Occlusive Pain and Menstruation in Sickle Cell Disease: a Focus Group Analysis. Women's Health Reports 1(1): 36-46
Drew, P.A.; Shearman, D.J. 1985: Vaso-active intestinal peptide: a neurotransmitter which reduces human NK cell activity and increases Ig synthesis. Australian Journal of Experimental Biology and Medical Science 63: 313-318
Elion, J.E.; Brun, M.; Odièvre, M-Heléne.; Lapouméroulie, C.L.; Krishnamoorthy, R. 2004: Vaso-occlusion in sickle cell anemia: role of interactions between blood cells and endothelium. Hematology Journal: the Official Journal of the European Haematology Association 5 Suppl. 3: S195-S198
Koo, E.B.; Blessing, N.W.; Tran, A.Q.; Al-Sadah, Z.; Alabiad, C.R. 2020: Vaso-occlusive Infarction of the Lateral Orbital Wall with Ipsilateral Temporalis Muscle Ischemia. Journal of Pediatric Ophthalmology and Strabismus 57: E78-E81
Brat, D.J.; Van Meir, E.G. 2004: Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma. Laboratory Investigation; a Journal of Technical Methods and Pathology 84(4): 397-405
Shah, N.R.; Bhor, M.; Latremouille-Viau, D.; Kumar Sharma, V.; Puckrein, G.A.; Gagnon-Sanschagrin, P.; Khare, A.; Kumar Singh, M.; Serra, E.; Davidson, Mïl.; Xu, L.; Guerin, A. 2020: Vaso-occlusive crises and costs of sickle cell disease in patients with commercial, Medicaid, and Medicare insurance - the perspective of private and public payers. Journal of Medical Economics 23(11): 1345-1355
Santos, F.áv.L.S.; Slavov, S.N.; Bezerra, R.S.; Santos, E.V.; Silva-Pinto, A.C.; Morais, A.L.L.; Sá, M.B.; Ubiali, E.ên.M.A.; De Santis, G.C.; Covas, D.T.; Kashima, S. 2020: Vaso-occlusive crisis in a sickle cell patient after transfusion-transmitted dengue infection. Transfusion 60(9): 2139-2143
Angerer, M.P.M.; Neuburger, M.; Hille, K.; Horn, P.C. 2021: Vaso-occlusive retinitis following intravitreal injection of brolucizumab. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 118(10): 1048-1050
Acheson, J.F.; Gregson, R.M.; Merry, P.; Schulenburg, W.E. 1991: Vaso-occlusive retinopathy in the primary anti-phospholipid antibody syndrome. Eye 5: 48-55
Laubry, C.; Louvel, J. 1947: Vaso-training and polyangeies. Archivos del Instituto de Cardiologia de Mexico 17(6): 761-774
McDowell, K.P.; Berthiaume, A.ée.-A.; Tieu, T.; Hartmann, D.A.; Shih, A.Y. 2021: VasoMetrics: unbiased spatiotemporal analysis of microvascular diameter in multi-photon imaging applications. Quantitative Imaging in Medicine and Surgery 11(3): 969-982
Huaringa-Marcelo, J.; Huaman, M.R.; Brañez-Condorena, A.; Villacorta-Landeo, P.; Pinto-Ruiz, D.F.; Urday-Ipanaqué, D.; García-Gomero, D.; Montes-Teves, P.; Lozano Miranda, A. 2021: Vasoactive Agents for the Management of Acute Variceal Bleeding: a Systematic Review and Meta-analysis. Journal of Gastrointestinal and Liver Diseases: Jgld 30(1): 110-121
Sridharan, K.; Sivaramakrishnan, G. 2019: Vasoactive Agents for the Management of Variceal Bleeding: a Mixed Treatment Comparison Network Meta-analysis and Trial Sequential Analysis of Randomized Clinical Trials. Drug Research 69(9): 487-495
Dakhel, A.; Engström, G.; Melander, O.; Acosta, S.; Fatemi, S.; Gottsäter, A.; Zarrouk, M. 2021: Vasoactive Biomarkers Associated with Long-Term Incidence of Symptomatic Peripheral Arterial Disease and Mortality. Angiology 72(6): 550-555
Zverev, A.А; Leonov, N.V.; Аnikina, Т А; Zefirov, Т L. 2020: Vasoactive Intestinal Peptide Changes the Frequency and Force of Myocardial Contraction in Rats. Bulletin of Experimental Biology and Medicine 169(6): 787-790
Frye, Börn.C.; Meiss, F.; von Bubnoff, D.; Zissel, G.; Müller-Quernheim, J. 2020: Vasoactive Intestinal Peptide in Checkpoint Inhibitor-Induced Pneumonitis. New England Journal of Medicine 382(26): 2573-2574
Merech, F.; Soczewski, E.; Hauk, V.; Paparini, D.; Ramhorst, R.; Vota, D.; Pérez Leirós, C. 2019: Vasoactive Intestinal Peptide induces glucose and neutral amino acid uptake through mTOR signalling in human cytotrophoblast cells. Scientific Reports 9(1): 17152
Vota, D.; Paparini, D.; Hauk, V.; Toro, Aén.; Merech, F.; Varone, C.; Ramhorst, R.; Pérez Leirós, C. 2016: Vasoactive Intestinal Peptide modulates trophoblast-derived cell line function and interaction with phagocytic cells through autocrine pathways. Scientific Reports 6: 26364
Wolthuis, A.; Boes, A.; Rodemann, H.P.; Grond, J. 1992: Vasoactive agents affect growth and protein synthesis of cultured rat mesangial cells. Kidney International 41(1): 124-131
Brennan, C.A.; Osei-Bonsu, P.; McClenaghan, R.E.; Nassar, A.; Forget, P.; Kaye, C.; Ramsay, G. 2021: Vasoactive agents in acute mesenteric ischaemia in critical care.  a systematic review. F1000research 10: 453
Hicks, R.C.; Golledge, J.; Mir-Hasseine, R.; Powell, J.T. 1996: Vasoactive effects of fibrinogen on saphenous vein. Nature 379(6568): 818-820
Adrien, N.; Petersen, J.M.; Parker, S.E.; Werler, M.M. 2020: Vasoactive exposures and risk of amniotic band syndrome and terminal transverse limb deficiencies. Birth Defects Research 112(14): 1074-1084
Egido, J. 1996: Vasoactive hormones and renal sclerosis. Kidney International 49(2): 578-597
Korkmaz, O.T.; Arkan, S.; Öncü-Kaya, E.M.; Ateş, N.; Tunçel, N.şe. 2021: Vasoactive intestinal peptide (VIP) conducts the neuronal activity during absence seizures: GABA seems to be the main mediator of VIP. Neuroscience Letters 765: 136268
Duan, J.-X.; Guan, X.-X.; Yang, H.-H.; Mei, W.-X.; Chen, P.; Tao, J.-H.; Li, Q.; Zhou, Y. 2021: Vasoactive intestinal peptide attenuates bleomycin-induced murine pulmonary fibrosis by inhibiting epithelial-mesenchymal transition: Restoring autophagy in alveolar epithelial cells. International Immunopharmacology 101(Part B): 108211
Carrión, M.; Ramos-Leví, A.M.; Seoane, I.V.; Martínez-Hernández, R.; Serrano-Somavilla, A.; Castro, D.; Juarranz, Y.; González-Álvaro, I.; Gomariz, R.P.; Marazuela, Mónica. 2020: Vasoactive intestinal peptide axis is dysfunctional in patients with Graves' disease. Scientific Reports 10(1): 13018
Hamnett, R.; Crosby, P.; Chesham, J.E.; Hastings, M.H. 2019: Vasoactive intestinal peptide controls the suprachiasmatic circadian clock network via ERK1/2 and DUSP4 signalling. Nature Communications 10(1): 542
Chedid, P.; Boussetta, T.; Dang, P.M-C.; Belambri, S.A.; Marzaioli, V.; Fasseau, M.; Walker, F.; Couvineau, A.; El-Benna, J.; Marie, J-C. 2017: Vasoactive intestinal peptide dampens formyl-peptide-induced ROS production and inflammation by targeting a MAPK-p47 phox phosphorylation pathway in monocytes. Mucosal Immunology 10(2): 332-340
Haberl, I.; Frei, K.; Ramsebner, R.; Doberer, D.; Petkov, V.; Albinni, S.; Lang, I.; Lucas, T.; Mosgoeller, W. 2007: Vasoactive intestinal peptide gene alterations in patients with idiopathic pulmonary arterial hypertension. European Journal of Human Genetics: Ejhg 15(1): 18-22
Seoane, I.V.; Martínez, C.; García-Vicuña, R.; Ortiz, A.M.; Juarranz, Y.; Talayero, V.C.; González-Álvaro, I.; Gomariz, R.P.; Lamana, A. 2018: Vasoactive intestinal peptide gene polymorphisms, associated with its serum levels, predict treatment requirements in early rheumatoid arthritis. Scientific Reports 8(1): 2035
Isaka, M.; Ueno, H. 2021: Vasoactive intestinal peptide in canine portosystemic shunt in the absence of portal hypertension. Open Veterinary Journal 11(1): 39-41
Vetrini, F.; Brunetti-Pierri, N.; Palmer, D.J.; Bertin, T.; Grove, N.C.; Finegold, M.J.; Ng, P. 2010: Vasoactive intestinal peptide increases hepatic transduction and reduces innate immune response following administration of helper-dependent Ad. Molecular Therapy: the Journal of the American Society of Gene Therapy 18(7): 1339-1345
Hermel, M.; Jones, D.; Olson, C.; Sherman, M.; Srivastava, A. 2021: Vasoactive intestinal peptide producing pheochromocytoma and intracardiac thrombosis. Rare Tumors 13: 20363613211007792
Pincus, D.W.; DiCicco-Bloom, E.M.; Black, I.B. 1990: Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts. Nature 343(6258): 564-567
Shankar, N.; Linzay, C.; Rowe, K. 2020: Vasoactive intestinal peptide-oma causing refractory diarrhea in a young woman. Proceedings 33(4): 641-643
Miller, R.J. 1980: Vasoactive intestinal polypeptide (VIP). Medical Biology 58(4): 179-181
Yamaguchi, K.; Otsubo, K.; Haniuda, C.; Miyoshi, S.; Abe, K.; Ohnami, S. 1995: Vasoactive intestinal polypeptide (VIP). Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Su Pt 2: 626-630
Watanabe, S. 1999: Vasoactive intestinal polypeptide (VIP). Nihon Rinsho. Japanese Journal of Clinical Medicine 57 Suppl: 329-331
Iwanaga, T. 2002: Vasoactive intestinal polypeptide (VIP). Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 6): 35-38
Watanabe, S.-I. 2005: Vasoactive intestinal polypeptide (VIP). Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 8): 502-504
Watanabe, S.-i. 2010: Vasoactive intestinal polypeptide (VIP). Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 7): 541-543
Cormio, L.; Gesualdo, L.; Maiorano, E.; Bettocchi, C.; Palumbo, F.; Traficante, A.; Schena, F.P.; Selvaggi, F.P. 2005: Vasoactive intestinal polypeptide (VIP) is not an androgen-dependent neuromediator of penile erection. International Journal of Impotence Research 17(1): 23-26
Lundberg, J.M.; Hedlund, B.; Bartfai, T. 1982: Vasoactive intestinal polypeptide enhances muscarinic ligand binding in cat submandibular salivary gland. Nature 295(5845): 147-149
Aton, S.J.; Colwell, C.S.; Harmar, A.J.; Waschek, J.; Herzog, E.D. 2005: Vasoactive intestinal polypeptide mediates circadian rhythmicity and synchrony in mammalian clock neurons. Nature Neuroscience 8(4): 476-483
Simon, R.A.; Barazanji, N.; Jones, M.P.; Bednarska, O.; Icenhour, A.; Engström, M.; Hamilton, J.Paul.; Keita, Åsa.V.; Walter, S. 2021: Vasoactive intestinal polypeptide plasma levels associated with affective symptoms and brain structure and function in healthy females. Scientific Reports 11(1): 1406
Miller, L.E.; Laughon, M.M.; Clark, R.H.; Zimmerman, K.O.; Hornik, C.P.; Aleem, S.; Brian Smith, P.; Greenberg, R.G. 2021: Vasoactive medications in extremely low gestational age neonates during the first postnatal week. Journal of Perinatology: Official Journal of the California Perinatal Association 2021
Wallengren, J. 1997: Vasoactive peptides in the skin. Journal of Investigative Dermatology. Symposium Proceedings 2(1): 49-55
Kaddoura, R.; Elmoheen, A.; Badawy, E.; Eltawagny, M.F.; Seif, M.A.; Bashir, K.; Salam, A.M. 2021: Vasoactive pharmacologic therapy in cardiogenic shock: a critical review. Journal of Drug Assessment 10(1): 68-85
Foresti, R.; Hammad, J.; Clark, J.E.; Johnson, T.R.; Mann, B.E.; Friebe, A.; Green, C.J.; Motterlini, R. 2004: Vasoactive properties of CORM-3, a novel water-soluble carbon monoxide-releasing molecule. British Journal of Pharmacology 142(3): 453-460
Hollenberg, M.; Pruett, R.; Thal, A. 1963: Vasoactive substances liberated by prolonged bubble oxygenation. Journal of Thoracic and Cardiovascular Surgery 45: 402-411
Jha, A.; Zilahi, G.; Rhodes, A. 2021: Vasoactive therapy in shock. Bja Education 21(7): 270-277
Torpoco Rivera, D.M.; Garcia, R.U.; Aggarwal, S. 2021: Vasoactive-ventilation-renal score: a reliable prognostic index for perioperative outcomes following congenital heart surgery in adults. Cardiology in the Young 31(5): 762-768
Mohammed, R.; Dias-Guichot, R.; van der Sterren, S.; Blanco, C.E.; Cogolludo, A.L.; Villamor, E. 2020: Vasoactivity of magnesium sulfate in chicken ductus arteriosus. Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 71(5)
Bayona, Hán.; Valencia, Mía.Camila.; Peña, Aélica.; Ramírez, N.; Martínez, C. 2021: Vasoconstricción cerebral fatal, presentación inusual de una enfermedad inusual. Biomedica: Revista del Instituto Nacional de Salud 41(2): 225-233
Mandel, Y.; Manivanh, R.; Dalal, R.; Huie, P.; Wang, J.; Brinton, M.; Palanker, D. 2013: Vasoconstriction by electrical stimulation: new approach to control of non-compressible hemorrhage. Scientific Reports 3: 2111
Krnjević, K. 1973: Vasoconstriction by noradrenaline in the brain. Nature: new Biology 242(121): 244
Mendoza-Baumgart, M.Irene.; Pravetoni, M.; Sparber, S.B. 2004: Vasoconstriction caused by cocaine is enhanced by sodium salicylate: is inducible nitric oxide synthase mRNA related?. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 29(7): 1294-1300
Schuijt, M.P.; de Vries, Ré.; Saxena, P.R.; Schalekamp, M.A.D.H.; Danser, A.H.Jan. 2002: Vasoconstriction is determined by interstitial rather than circulating angiotensin II. British Journal of Pharmacology 135(1): 275-283
McMillan, M.R.; Burnstock, G.; Haworth, S.G. 1999: Vasoconstriction of intrapulmonary arteries to P2-receptor nucleotides in normal and pulmonary hypertensive newborn piglets. British Journal of Pharmacology 128(3): 549-555
Whittle, B.J.; Kauffman, G.L.; Moncada, S. 1981: Vasoconstriction with thromboxane A2 induces ulceration of the gastric mucosa. Nature 292(5822): 472-474
Froehlich, F. 1947: Vasoconstrictive and vasodilator syndrome followed by diffuse bruises with cubital typography; healing by perihumeral sympathectomy. Le Progres Medical 75(20): 516-519
Shin, H.Kyoung.; Dunn, A.K.; Jones, P.B.; Boas, D.A.; Moskowitz, M.A.; Ayata, C. 2006: Vasoconstrictive neurovascular coupling during focal ischemic depolarizations. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 26(8): 1018-1030
Riser; Becq; Dardenne 1947: Vasoconstrictive substances in the blood of arterial hypertensives studied by transfusion. La Presse Medicale 55(4): 37
Riser; Becq; Dardenne 1946: Vasoconstrictive substances in the blood of arterial hypertensives studied by transfusion. Toulouse Medical 47(9): 502-504
Janssen, L.J.; Premji, M.; Netherton, S.; Coruzzi, J.; Lu-Chao, H.; Cox, P.G. 2001: Vasoconstrictor actions of isoprostanes via tyrosine kinase and Rho kinase in human and canine pulmonary vascular smooth muscles. British Journal of Pharmacology 132(1): 127-134
Maguire, J.J.; Kuc, R.E.; Davenport, A.P. 2001: Vasoconstrictor activity of novel endothelin peptide, ET-1(1 - 31), in human mammary and coronary arteries in vitro. British Journal of Pharmacology 134(6): 1360-1366
Burdick, K.H.; Child, K.J.; English, A.F.; Gilbert, H.G.; Hewitt, A.; Woollett, E.A. 1968: Vasoconstrictor and systemic activities of topical steroids. Archives of Dermatology 98(6): 684-686
Donnet, V.; Zwirn, P.; Ardisson, J.L. 1955: Vasoconstrictor centers and chlorpromazine; dissociation of central effects and peripheral risks. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 149(3-4): 377-378
Chadderdon, S.M.; Belcik, J.T.; Bader, L.; Kievit, P.; Grove, K.L.; Lindner, J.R. 2016: Vasoconstrictor eicosanoids and impaired microvascular function in inactive and insulin-resistant primates. International Journal of Obesity 40(10): 1600-1603
Ziyal, R.; Ziganshin, A.U.; Nickel, P.; Ardanuy, U.; Mutschler, E.; Lambrecht, G.; Burnstock, G. 1997: Vasoconstrictor responses via P2X-receptors are selectively antagonized by NF023 in rabbit isolated aorta and saphenous artery. British Journal of Pharmacology 120(5): 954-960
Tazzeo, T.; Miller, J.; Janssen, L.J. 2003: Vasoconstrictor responses, and underlying mechanisms, to isoprostanes in human and porcine bronchial arterial smooth muscle. British Journal of Pharmacology 140(4): 759-763
Mills, T.M.; Chitaley, K.; Lewis, R.W. 2001: Vasoconstrictors in erectile physiology. International Journal of Impotence Research 13 Suppl. 5: S29-S34
Brant, B.; Armstrong, R.P.; Vetto, R.M. 1968: Vasodepressor factor in declamp shock production. Surgical Forum 19: 22-23
McMillan, M.R.; Burnstock, G.; Haworth, S.G. 1999: Vasodilatation of intrapulmonary arteries to P2-receptor nucleotides in normal and pulmonary hypertensive newborn piglets. British Journal of Pharmacology 128(3): 543-548
Sedan-Bauby, S.; Poinso, R.; Sedan, J. 1952: Vasodilatator therapy with monoethanol amine nicotinate of post-hemorrhagic acute optic neuritis. Revue d'Oto-Neuro-Ophtalmologie 24(5): 271-274
Wang, H.; Li, S.; Wang, X.; He, C.; Wang, T.; Wang, Y.; Guo, W. 2020: Vasodilation activity of dipfluzine metabolites in isolated rat basilar arteries and their underlying mechanisms. Environmental Toxicology and Pharmacology 79: 103430
Seth, R.; Badran, K.W.; Cedars, E.; Plonowska, K.; Benjamin, T.; Saggi, S.; Knott, P.D.; Heaton, C.M.; Blackwell, K.E. 2021: Vasodilation by Verapamil-Nitroglycerin Solution in Microvascular Surgery. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 164(1): 104-109
Chidsey, C.A. 1970: Vasodilation in treatment of hypertension. New England Journal of Medicine 282(19): 1102-1103
Chidsey, C.A. 1970: Vasodilation in treatment of hypertension. New England Journal of Medicine 282(19): 1102
Retan, J.W. 1970: Vasodilation in treatment of hypertension. New England Journal of Medicine 282(19): 1103
Chidsey, C.A. 1970: Vasodilation in treatment of hypertension. New England Journal of Medicine 282(19): 1103
Tamaki, T.; Kiyomoto, K.; He, H.; Tomohiro, A.; Nishiyama, A.; Aki, Y.; Kimura, S.; Abe, Y. 1996: Vasodilation induced by vasopressin V2 receptor stimulation in afferent arterioles. Kidney International 49(3): 722-729
Haberkorn, S.M.; Haberkorn, S.I.; Bönner, F.; Kelm, M.; Hopkin, G.; Petersen, S.E. 2021: Vasodilator Myocardial Perfusion Cardiac Magnetic Resonance Imaging Is Superior to Dobutamine Stress Echocardiography in the Detection of Relevant Coronary Artery Stenosis: a Systematic Review and Meta-Analysis on their Diagnostic Accuracy. Frontiers in Cardiovascular Medicine 8: 630846
Copp, S. 1949: Vasodilator Therapy for Cerebral Vascular Disease. MonatsschriftfürPsychiatrieundNeurologie 117(4-6): 213
Ho, W-S.Vanessa.; Hiley, C.Robin. 2003: Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery. British Journal of Pharmacology 138(7): 1320-1332
Kim, D.H.; Han, D.; Kim, J.; Park, H.C.; Lee, Y.-K.; Shin, D.G.; Kang, M.-K.; Cho, J.R.; Choi, S.; Lee, N. 2021: Vasodilator agents improve hemodialysis vascular access patency: a population-based study from Korea. Medicine 100(40): E27439
Romeuf 1947: Vasodilator and anesthetic reactions, local or remote, determined by subcutaneous injections of thermal gases from Royat. Archives des Maladies du Coeur et des Vaisseaux 40(1): 46-49
Oudot, J. 1947: Vasodilator arterial infusions during surgical edemas. La Presse Medicale 55(72): 834-836
Coffman, J.D. 1979: Vasodilator drugs for peripheral vascular disease. New England Journal of Medicine 301(3): 159-160
Cook, C.D. 1979: Vasodilator drugs for peripheral vascular disease. New England Journal of Medicine 301(3): 159
Coffman, J.D. 1975: Vasodilator drugs in peripheral vascular disease. American Journal of Hospital Pharmacy 32(12): 1276-1281
Karpman, H.L. 1966: Vasodilator drugs in peripheral vascular disease. Canadian Medical Association Journal 94(9): 457
Brown, K.W.; Baird, R.J. 1966: Vasodilator drugs in peripheral vascular disease. Canadian Medical Association Journal 94(9): 458
Koch-Weser, J. 1974: Vasodilator drugs in the treatment of hypertension. Archives of Internal Medicine 133(6): 1017-1027
Shirai, M.; Shimouchi, A.; Ikeda, S.; Ninomiya, I.; Sunagawa, K.; Kangawa, K.; Matsuo, H. 1997: Vasodilator effects of adrenomedullin on small pulmonary arteries and veins in anaesthetized cats. British Journal of Pharmacology 121(4): 679-686
Porteri, E.; Rizzoni, D.; De Ciuceis, C.; Boari, G.E.M.; Platto, C.; Pilu, A.; Miclini, M.; Agabiti Rosei, C.; Bulgari, G.; Agabiti Rosei, E. 2010: Vasodilator effects of red wines in subcutaneous small resistance artery of patients with essential hypertension. American Journal of Hypertension 23(4): 373-378
Pérez-Vizcaíno, F.; Cogolludo, A.L.; Zaragozá-Arnáez, F.; Fajardo, S.; Ibarra, M.; López-López, J.G.; Tamargo, J. 1999: Vasodilator effects of sodium nitroprusside, levcromakalim and their combination in isolated rat aorta. British Journal of Pharmacology 128(7): 1419-1426
Behuliak, M.; Pintérová, Mária.; Kuneš, J.; Zicha, J. 2011: Vasodilator efficiency of endogenous prostanoids, Ca²⁺-activated K⁺ channels and nitric oxide in rats with spontaneous, salt-dependent or NO-deficient hypertension. Hypertension Research: Official Journal of the Japanese Society of Hypertension 34(8): 968-975
Goldberg, M.R.; Sushak, C.S.; Rockhold, F.W.; Thompson, W.L. 1988: Vasodilator monotherapy in the treatment of hypertension: comparative efficacy and safety of pinacidil, a potassium channel opener, and prazosin. Clinical Pharmacology and Therapeutics 44(1): 78-92
Karpinski, E.; Barton, S.; Schachter, M. 1971: Vasodilator nerve fibres to the submaxillary gland of the cat. Nature 232(5306): 122-124
Rich, S. 1980: Vasodilator therapy for pulmonary hypertension. New England Journal of Medicine 302(22): 1260-1261
Chatterjee, K.; Swan, H.J. 1974: Vasodilator therapy in acute myocardial infarction. Modern Concepts of Cardiovascular Disease 43(11): 119-124
Mason, D.T. 1981: Vasodilator therapy in congestive heart failure. Annals of the Academy of Medicine Singapore 10(4 Suppl): 36-42
Katila, M.; Luomanmäki, K. 1980: Vasodilator therapy in congestive heart failure. Duodecim; Laaketieteellinen Aikakauskirja 96(5): 430-443
Durel, P. 1949: Vasodilator therapy in dermatology. Bruxelles Medical 29(50): 3591
Kubo, S.H. 1994: Vasodilator therapy in heart failure. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 13(4): S122-S125
Woroszylska, M. 1983: Vasodilator treatment of chronic heart failure. Kardiologia Polska 26(10): 741-751
Arevalo, C.; White, R.J.; Le, T.; Lachant, D. 2021: Vasodilator use in precapillary pulmonary hypertension with end stage kidney disease: a single center experience. Respiratory Medicine 188: 106596
Ito, Y.; Ohno, K.; Morikawa, Y.; Tomizawa, A.; Mizuno, M.; Sugidachi, A. 2018: Vasodilator-stimulated phosphoprotein (VASP) is not a major mediator of platelet aggregation, thrombogenesis, haemostasis, and antiplatelet effect of prasugrel in rats. Scientific Reports 8(1): 9955
Xiang, X.; Wang, Y.; Zhang, H.; Piao, J.; Muthusamy, S.; Wang, L.; Deng, Y.; Zhang, W.; Kuang, R.; Billadeau, D.D.; Huang, S.; Lai, J.; Urrutia, R.; Kang, N. 2018: Vasodilator-stimulated phosphoprotein promotes liver metastasis of gastrointestinal cancer by activating a β1-integrin-FAK-YAP1/TAZ signaling pathway. Npj Precision Oncology 2(1): 2
Zsotér, T.T. 1983: Vasodilators. Canadian Medical Association Journal 129(5): 424-428; 432
Domingo, E.; Lupón Rosés, J. 1988: Vasodilators and cardiac insufficiency. Medicina Clinica 90(3): 110-111
Mannarino, T.; Gaudieri, V.; Acampa, W. 2022: Vasodilators and myocardial blood flow by CZT cameras: make us see further. Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology 29(1): 123-125
Su, K.Y.; Sharma, M.; Kim, H.J.; Kaganov, E.; Hughes, I.; Abdeen, M.H.; Ng, J.H.K. 2021: Vasodilators for primary Raynaud's phenomenon. Cochrane Database of Systematic Reviews 5: Cd006687
Krasuski, R.A.; Griffin, B.P. 2006: Vasodilators in aortic regurgitation. New England Journal of Medicine 354(3): 300-303; Author Reply 300-303
Afshinnia, F. 2006: Vasodilators in aortic regurgitation. New England Journal of Medicine 354(3): 300-303; Author Reply 300-303
Martin, A.J. 1979: Vasodilators in senile dementia. British Medical Journal 2(6194): 866
Huysmans, F.T.; Thien, T.A. 1989: Vasodilators in the treatment of hypertension. Nederlands Tijdschrift Voor Geneeskunde 133(12): 595-599
Osterziel, K.J.; Julius, S. 1982: Vasodilators in the treatment of hypertension. Comprehensive Therapy 8(11): 43-52
Bojić, M.G.ć; Todorović, L.; Santrač, A.; Mian, M.Y.; Sharmin, D.; Cook, J.M.; Savić, M.M. 2021: Vasodilatory effects of a variety of positive allosteric modulators of GABAA receptors on rat thoracic aorta. European Journal of Pharmacology 899: 174023
Tao, L.; Chen, L.; Pei, Y.; Ma, P.; Xu, Q.; Wang, J.; Yu, Y.; Cheng, J.; Zhou, R. 2021: Vasodilatory effects of betaine on isolated rat pulmonary artery rings. Die Pharmazie 76(10): 499-502
Xue, X.; Gao, W.; Sun, B.; Xu, Y.; Han, B.; Wang, F.; Zhang, Y.; Sun, J.; Wei, J.; Lu, Z.; Zhu, Y.; Sato, Y.; Sekido, Y.; Miao, Y.; Kondo, Y. 2013: Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma. Oncogene 32(13): 1724-1734
Song, K-Moon.; Kim, W.Jean.; Choi, M-Ji.; Kwon, K-Dong.; Limanjaya, A.; Ghatak, K.; Ock, J.; Yin, G.Nan.; Sato, Y.; Hong, S-Sun.; Ryu, J-Kan.; Suh, J-Kyu. 2021: Vasohibin-1 rescues erectile function through up-regulation of angiogenic factors in the diabetic mice. Scientific Reports 11(1): 1114
Robles, J.Pablo.; Zamora, M.; Velasco-Bolom, Jé.Luis.; Tovar, M.; Garduño-Juárez, Rón.; Bertsch, T.; Martínez de la Escalera, G.; Triebel, J.; Clapp, C. 2018: Vasoinhibin comprises a three-helix bundle and its antiangiogenic domain is located within the first 79 residues. Scientific Reports 8(1): 17111
Ortiz, G.; Ledesma-Colunga, M.G.; Wu, Z.; García-Rodrigo, J.F.; Adan, N.; Martínez de la Escalera, G.; Clapp, C. 2020: Vasoinhibin reduces joint inflammation, bone loss, and the angiogenesis and vasopermeability of the pannus in murine antigen-induced arthritis. Laboratory Investigation; a Journal of Technical Methods and Pathology 100(8): 1068-1079
Vizkelety, G. 1948: Vasoligation. ActaUrologica 2(3-4): 132
Hadriche-Jarraya, H.; Limam, F.; Aouani, E.; Amri, M.; Mokni, M. 2021: Vasomodulatory effects of semi-purified fractions of garlic aqueous extract on chick chorioallantoic membrane. Pakistan Journal of Pharmaceutical Sciences 34(3): 943-949
Aalkjaer, C.; Nilsson, H. 2005: Vasomotion: cellular background for the oscillator and for the synchronization of smooth muscle cells. British Journal of Pharmacology 144(5): 605-616
Boquet, P.; Lehoult, Y. 1948: Vasomotor Action of a Typhic Bacillus Extract. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 142(3-4): 165-167
Ryu, K.J.; Park, H.; Park, J.S.; Lee, Y.W.; Kim, S.Y.; Kim, H.; Jeong, Y.; Kim, Y.J.; Yi, K.W.; Shin, J.H.; Hur, J.Y.; Kim, T. 2020: Vasomotor Symptoms: more than Temporary Menopausal Symptoms. Journal of Menopausal Medicine 26(3): 147-153
Isidoro-García, L.ía.; Villalpando, D.M.; Ferrer, M. 2021: Vasomotor action of androgens in the mesenteric artery of hypertensive rats. Role of perivascular innervation. Plos one 16(2): E0246254
Corboz, J.R. 1948: Vasomotor active substances and speed of blood flow in humans. Helvetica Physiologica et Pharmacologica Acta 6(2): 247-257
Corboz, J.R. 1948: Vasomotor active substances and speed of blood flow in humans. Helvetica Physiologica et Pharmacologica Acta 6(1): C16
Granati, A. 1947: Vasomotor alterations of the hands in workers working with pneumatic hammers. Il Policlinico. Sezione Pratica 54(37): 981-983
Hanssen, A.; Palmisano, E.M.; Hanssen, D.A.; Hanssen, R.A.; Daes, J.E. 2020: Vasomotor changes in abdominal skin after endoscopic subcutaneous/Preaponeurotic Repair of Diastasis Recti (REPA). International Journal of Surgery Case Reports 75: 182-184
Islam, M.Z.; Sawatari, Y.; Kojima, S.; Kiyama, Y.; Nakamura, M.; Sasaki, K.; Otsuka, M.; Obi, T.; Shiraishi, M.; Miyamoto, A. 2020: Vasomotor effects of 5-hydroxytryptamine, histamine, angiotensin II, acetylcholine, noradrenaline, and bradykinin on the cerebral artery of bottlenose dolphin (Tursiops truncatus). Journal of Veterinary Medical Science 82(10): 1456-1463
Hardebo, J.E.; Kåhrström, J.; Owman, C.; Salford, L.G. 1987: Vasomotor effects of neurotransmitters and modulators on isolated human pial veins. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 7(5): 612-618
Islam, M.Z.; Kojima, S.; Sameshima, M.; Obi, T.; Yamazaki-Himeno, E.; Shiraishi, M.; Miyamoto, A. 2021: Vasomotor effects of noradrenaline, 5-hydroxytryptamine, angiotensin II, bradykinin, histamine, and acetylcholine on the bat (Rhinolophus ferrumequinum) basilar artery. Comparative Biochemistry and Physiology. Toxicology and Pharmacology: Cbp 250: 109190
Brousse, V.; Connes, P. 2020: Vasomotor hyperresponsiveness in SCD. Blood 136(10): 1120-1121
Dumont, L. 1949: Vasomotor influence of estradiol. Archives Internationales de Physiologie et de Biochimie 57(1): 112
Malmejac, J.; Chardon, G.; Neverre, G.; Gross, A. 1955: Vasomotor innervation of the adrenal gland. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 149(7-8): 679-681
Zhu, D.; Chung, H.-F.; Dobson, A.J.; Pandeya, N.; Anderson, D.J.; Kuh, D.; Hardy, R.; Brunner, E.J.; Avis, N.E.; Gold, E.B.; El Khoudary, S.R.; Crawford, S.L.; Mishra, G.D. 2020: Vasomotor menopausal symptoms and risk of cardiovascular disease: a pooled analysis of six prospective studies. American Journal of Obstetrics and Gynecology 223(6): 898.E1-898.E16
Le Lourd, R.; Clarac, F. 1952: Vasomotor phenomena of pleural epilepsy. Journal de Medecine de Bordeaux et du Sud-Ouest 129(1): 19-24
D'Anna, L. 1967: Vasomotor reflexes obtained by peripheral stimulation. Revista de la Sociedad Argentina de Biologia 43(1): 51-57
Krog, J.; Reite, O.B.; Fjellheim, P. 1969: Vasomotor responses in the growing antlers of the reindeer, Rangifer tarandus. Nature 223(5201): 99-100
Dacey, R.G.; Bassett, J.E.; Takayasu, M. 1988: Vasomotor responses of rat intracerebral arterioles to vasoactive intestinal peptide, substance P, neuropeptide Y, and bradykinin. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 8(2): 254-261
Nasr, A.; Matthews, K.A.; Brooks, M.M.; McConnell, D.S.; Orchard, T.J.; Billheimer, J.; Rader, D.J.; El Khoudary, S.R. 2020: Vasomotor symptoms and lipids/lipoprotein subclass metrics in midlife women: Does level of endogenous estradiol matter? the SWAN HDL Ancillary Study. Journal of Clinical Lipidology 14(5): 685-694.E2
Genazzani, A.R.; Gambacciani, M. 2011: Vasomotor symptoms and negative affect: time to act. Menopause 18(12): 1265-1266
Lim, Q.H.; Lim, L.L. 2021: Vasomotor symptoms in menopause: modifying the unmodifiable. Bjog: An International Journal of Obstetrics and Gynaecology 128(3): 614
Lombard, P. 1946: Vasomotor syndromes of fractures of the lower extremity of the humerus; Volkman syndrome; 3 nerve syndrome. Afrique Francaise Chirurgicale 4: 253-257
Chang, P.; Zhang, X.; Chen, W.; Zhang, J.; Wang, J.; Wang, X.; Yu, J.; Zhu, X. 2021: Vasonatrin peptide, a synthetic natriuretic peptide, attenuates myocardial injury and oxidative stress in isoprenaline-induced cardiomyocyte hypertrophy. Peptides 137: 170474
Walters, M.; Reid, J. 2000: Vasopeptidase inhibition: cardiovascular therapy for the new millennium?. Journal of Human Hypertension 14(9): 537-539
Barnes, T.J.; Hockstein, M.A.; Jabaley, C.S. 2020: Vasoplegia after cardiopulmonary bypass: a narrative review of pathophysiology and emerging targeted therapies. Sage Open Medicine 8: 2050312120935466
Ali, J.M.; Patel, S.; Catarino, P.; Vuylsteke, A.; Pettit, S.; Bhagra, S.; Kydd, A.; Lewis, C.; Parameshwar, J.; Kaul, P.; Sudarshan, C.; Tsui, S.; Jenkins, D.; Abu-Omar, Y.; Berman, M. 2020: Vasoplegia following heart transplantation and left ventricular assist device explant is not associated with inferior outcomes. Journal of Thoracic Disease 12(5): 2426-2434
Sathianathan, S.; Bhat, G.; Dowling, R. 2021: Vasoplegia from Continuous Flow Left Ventricular Assist Devices. Current Cardiology Reports 23(8): 101
Emmanuel, S.; Pearman, M.; Jansz, P.; Hayward, C.S. 2022: Vasoplegia in patients following ventricular assist device explant and heart transplantation. Perfusion 37(2): 152-161
Gomes, W.J.; Carvalho, A.C.; Palma, J.H.; Gonçalves, I.; Buffolo, E. 1994: Vasoplegic syndrome: a new dilemma. Journal of Thoracic and Cardiovascular Surgery 107(3): 942-943
Urakabe, S.; Shirai, D.; Takamitsu, Y. 1972: Vasopressin. Saishin Igaku. Modern Medicine 27(5): 868-876
Hays, R.M.; Levine, S.D. 1974: Vasopressin. Kidney International 6(5): 307-322
Murase, T.; Yoshida, T. 1972: Vasopressin. Horumon to Rinsho. Clinical Endocrinology 20(10): 805-807
Ota, K.; Kimura, T. 2000: Vasopressin. Nihon Rinsho. Japanese Journal of Clinical Medicine 58(Suppl 1): 80-84
Saito, T. 2000: Vasopressin. Nihon Rinsho. Japanese Journal of Clinical Medicine 58(Suppl 1): 442-446
Castoldi, C. 1956: Vasopressin. Bollettino Chimico Farmaceutico 95(11): 483-486
Nanamatsu, A.; Mori, T.; Ando, F.; Furusho, T.; Mandai, S.; Susa, K.; Sohara, E.; Rai, T.; Uchida, S. 2021: Vasopressin Induces Urinary Uromodulin Secretion by Activating PKA (Protein Kinase A). Hypertension 77(6): 1953-1963
Nakamura, K.; Nakano, H.; Naraba, H.; Mochizuki, M.; Takahashi, Y.; Sonoo, T.; Hashimoto, H.; Abe, T.; Hayakawa, M.; Yamakawa, K. 2021: Vasopressin Loading for Refractory Septic Shock: a Preliminary Analysis of a Case Series. Frontiers in Medicine 8: 644195
Bussi, I.L.; Sanchez, R.E.A.; de la Iglesia, H.O. 2020: Vasopressin Neurons: Master Integrators of time and Homeostasis. Trends in Neurosciences 43(11): 839-841
Kawada, T.; Shiraishi, A.; Matsubara, S.; Hozumi, A.; Horie, T.; Sasakura, Y.; Satake, H. 2021: Vasopressin Promoter Transgenic and Vasopressin Gene-Edited Ascidian, Ciona intestinalis Type a (Ciona robusta): Innervation, Gene Expression Profiles, and Phenotypes. Frontiers in Endocrinology 12: 668564
Agorastos, A.; Sommer, A.; Heinig, A.; Wiedemann, K.; Demiralay, C.ün. 2020: Vasopressin Surrogate Marker Copeptin as a Potential Novel Endocrine Biomarker for Antidepressant Treatment Response in Major Depression: a Pilot Study. Frontiers in Psychiatry 11: 453
Wersinger, S.R.; Ginns, E.I.; O'Carroll, A-M.; Lolait, S.J.; Young, W.S. 2002: Vasopressin V1b receptor knockout reduces aggressive behavior in male mice. Molecular Psychiatry 7(9): 975-984
Meijer, E.; Gansevoort, R.T. 2020: Vasopressin V2 receptor antagonists in autosomal dominant polycystic kidney disease: efficacy, safety, and tolerability. Kidney International 98(2): 289-293
van der Zee, S.; Thompson, A.; Zimmerman, R.; Lin, J.; Huan, Y.; Braskett, M.; Sciacca, R.R.; Landry, D.W.; Oliver, J.A. 2007: Vasopressin administration facilitates fluid removal during hemodialysis. Kidney International 71(4): 318-324
Gomes, D.A.; de Almeida Beltrão, R.L.; de Oliveira Junior, F.M.; da Silva Junior, J.é C.; de Arruda, E.P.íc.C.; Lira, E.C.; da Rocha, M.J.é A. 2021: Vasopressin and copeptin release during sepsis and septic shock. Peptides 136: 170437
Chebib, F.T.; Sussman, C.R.; Wang, X.; Harris, P.C.; Torres, V.E. 2015: Vasopressin and disruption of calcium signalling in polycystic kidney disease. Nature Reviews. Nephrology 11(8): 451-464
Wakamatsu, S.; Nonoguchi, H.; Ikebe, M.; Machida, K.; Izumi, Y.; Memetimin, H.; Nakayama, Y.; Nakanishi, T.; Kohda, Y.; Tomita, K. 2009: Vasopressin and hyperosmolality regulate NKCC1 expression in rat OMCD. Hypertension Research: Official Journal of the Japanese Society of Hypertension 32(6): 481-487
Andersen, L.W.; Sindberg, B.; Holmberg, M.; Isbye, D.; Kjærgaard, J.; Zwisler, S.T.; Darling, S.ør.; Larsen, J.M.; Rasmussen, B.S.; Løfgren, B.; Lauridsen, K.G.; Pælestik, K.B.; Sølling, C.; Kjærgaard, A.G.; Due-Rasmussen, D.; Folke, F.; Charlot, M.G.; Iversen, K.; Schultz, M.; Wiberg, S.; Jepsen, R.M.H.G.; Kurth, T.; Donnino, M.; Kirkegaard, H.; Granfeldt, A. 2021: Vasopressin and methylprednisolone for in-hospital cardiac arrest - Protocol for a randomized, double-blind, placebo-controlled trial. Resuscitation Plus 5: 100081
Meijer, E.; de Jong, P.E.; Gansevoort, R.T. 2010: Vasopressin and microalbuminuria: is it vasopressin per se or is it salt intake?. Kidney International 77(9): 832-833
Møller, M. 2021: Vasopressin and oxytocin beyond the pituitary in the human brain. Handbook of Clinical Neurology 180: 7-24
Dayanithi, G.; Forostyak, O.; Forostyak, S.; Kayano, T.; Ueta, Y.; Verkhratsky, A. 2018: Vasopressin and oxytocin in sensory neurones: expression, exocytotic release and regulation by lactation. Scientific Reports 8(1): 13084
Sipos, E.; Török, Bána.; Barna, Ián.; Engelmann, M.; Zelena, Dóra. 2020: Vasopressin and post-traumatic stress disorder. Stress 2020: 1-14
Savić, B.; Martin, A.; Mecawi, A.Souza.; Bukumirić, Z.; Antunes-Rodrigues, Jé.; Murphy, D.; Šarenac, O.; Japundžić-Žigon, N. 2020: Vasopressin and v1br gene expression is increased in the hypothalamic pvn of borderline hypertensive rats. Hypertension Research: Official Journal of the Japanese Society of Hypertension 43(11): 1165-1174
Urbach, J.; Goldsmith, S.R. 2021: Vasopressin antagonism in heart failure: a review of the hemodynamic studies and major clinical trials. Therapeutic Advances in Cardiovascular Disease 15: 1753944720977741
Ruiz-Ramos, J.ús.; Ramírez, P.; Broch, M.ía.J.ús.; Gordon, M.ón.; Villarreal, E.; Pinos, A.; Sosa, M.; Castellanos-Ortega, Ál. 2020: Vasopressin antagonist efficacy and safety in volume-overloaded critically ill patients: a new therapeutic alternative. European Journal of Hospital Pharmacy: Science and Practice 27(3): 157-161
Piani, F.; Reinicke, T.; Lytvyn, Y.; Melena, I.; Lovblom, L.E.; Lai, V.; Tse, J.; Cham, L.; Orszag, A.; Perkins, B.A.; Cherney, D.Z.I.; Bjornstad, P. 2021: Vasopressin associated with renal vascular resistance in adults with longstanding type 1 diabetes with and without diabetic kidney disease. Journal of Diabetes and its Complications 35(3): 107807
Fill Malfertheiner, S.; Bataiosu-Zimmer, E.; Michel, H.; Fouzas, S.; Bernasconi, L.; Bührer, C.; Wellmann, S. 2021: Vasopressin but not Oxytocin Responds to Birth Stress in Infants. Frontiers in Neuroscience 15: 718056
Stark, R.I.; Daniel, S.S.; Husain, M.K.; Sanocka, U.M.; Zubrow, A.B.; James, L.S. 1984: Vasopressin concentration in amniotic fluid as an index of fetal hypoxia: mechanism of release in sheep. Pediatric Research 18(9): 835-841
Kawada, A.; Nagasawa, M.; Murata, A.; Mogi, K.; Watanabe, K.; Kikusui, T.; Kameda, T. 2019: Vasopressin enhances human preemptive strike in both males and females. Scientific Reports 9(1): 9664
Mühlethaler, M.; Dreifuss, J.J.; Gähwiler, B.H. 1982: Vasopressin excites hippocampal neurones. Nature 296(5859): 749-751
Patel, A.; Beauchesne, A.; Bredenkamp, N.; McGloin, R.; Stabler, S.N.; Boyce, K. 2020: Vasopressin for Septic Shock in a Medical-Surgical Intensive Care Unit. Canadian Journal of Hospital Pharmacy 73(3): 209-215
Otubo, A.; Kawakami, N.; Maejima, S.; Ueda, Y.; Morris, J.F.; Sakamoto, T.; Sakamoto, H. 2020: Vasopressin gene products are colocalised with corticotrophin-releasing factor within neurosecretory vesicles in the external zone of the median eminence of the Japanese macaque monkey (Macaca fuscata). Journal of Neuroendocrinology 32(8): E12875
McNamara, P.J.; Engelberts, D.; Finelli, M.; Adeli, K.; Kavanagh, B.P. 2014: Vasopressin improves survival compared with epinephrine in a neonatal piglet model of asphyxial cardiac arrest. Pediatric Research 75(6): 738-748
Balik, M.; Novotny, A.; Suk, D.; Matousek, V.; Maly, M.; Brozek, T.; Tavazzi, G. 2020: Vasopressin in Patients with Septic Shock and Dynamic Left Ventricular Outflow Tract Obstruction. Cardiovascular Drugs and Therapy 34(5): 685-688
Choong, K. 2016: Vasopressin in Pediatric Critical Care. Journal of Pediatric Intensive Care 5(4): 182-188
Torres, V.E. 2009: Vasopressin in chronic kidney disease: an elephant in the room?. Kidney International 76(9): 925-928
Loomba, R.S.; Flores, S.; Bronicki, R. 2021: Vasopressin in neonatal hypertrophic cardiomyopathy: do perceived benefits translate to clinical outcome?. Journal of Perinatology: Official Journal of the California Perinatal Association 2021
Mogyorosi, A. 2008: Vasopressin in septic shock. New England Journal of Medicine 358(25): 2737; Author Reply 2737-2738
Webb, A.J.; Seisa, M.O.; Nayfeh, T.; Wieruszewski, P.M.; Nei, S.D.; Smischney, N.J. 2020: Vasopressin in vasoplegic shock: a systematic review. World Journal of Critical Care Medicine 9(5): 88-98
Gluck, S.; Al-Awqati, Q. 1980: Vasopressin increases water permeability in inducing pores. Nature 284(5757): 631-632
Pedersen, N.B.; Hofmeister, M.V.; Rosenbaek, L.L.; Nielsen, J.; Fenton, R.A. 2010: Vasopressin induces phosphorylation of the thiazide-sensitive sodium chloride cotransporter in the distal convoluted tubule. Kidney International 78(2): 160-169
Zink, C.F.; Kempf, L.; Hakimi, S.; Rainey, C.A.; Stein, J.L.; Meyer-Lindenberg, A. 2011: Vasopressin modulates social recognition-related activity in the left temporoparietal junction in humans. Translational Psychiatry 1: E3
Vezzi, V.; Ambrosio, C.; Grò, M.Cristina.; Molinari, P.; Süral, Gökçe.; Costa, T.; Onaran, H.Ongun.; Cotecchia, S. 2020: Vasopressin receptor 2 mutations in the nephrogenic syndrome of inappropriate antidiuresis show different mechanisms of constitutive activation for G protein coupled receptors. Scientific Reports 10(1): 9111
Lutz, W.; Sanders, M.; Salisbury, J.; Lolait, S.; O'Carroll, A.M.; Kumar, R. 1993: Vasopressin receptor-mediated endocytosis in cells transfected with V1-type vasopressin receptors. Kidney International 43(4): 845-852
Bichet, D.G. 1996: Vasopressin receptors in health and disease. Kidney International 49(6): 1706-1711
Rohr, K.E.; Telega, A.; Savaglio, A.; Evans, J.A. 2021: Vasopressin regulates daily rhythms and circadian clock circuits in a manner influenced by sex. Hormones and Behavior 127: 104888
Mancinelli, R.; Franchitto, A.; Glaser, S.; Vetuschi, A.; Venter, J.; Sferra, R.; Pannarale, L.; Olivero, F.; Carpino, G.; Alpini, G.; Onori, P.; Gaudio, E. 2016: Vasopressin regulates the growth of the biliary epithelium in polycystic liver disease. Laboratory Investigation; a Journal of Technical Methods and Pathology 96(11): 1147-1155
Stockand, J.D. 2010: Vasopressin regulation of renal sodium excretion. Kidney International 78(9): 849-856
Nakazato, Y.; Douglas, W.W. 1974: Vasopressin release from the isolated neurohypophysis induced by a calcium ionophore, X-537A. Nature 249(456): 479-481
Ausiello, D.A.; Skorecki, K.L.; Verkman, A.S.; Bonventre, J.V. 1987: Vasopressin signaling in kidney cells. Kidney International 31(2): 521-529
Brown, D.; Orci, L. 1983: Vasopressin stimulates formation of coated pits in rat kidney collecting ducts. Nature 302(5905): 253-255
Gaeggeler, H-Peter.; Guillod, Y.; Loffing-Cueni, D.; Loffing, J.; Rossier, B.C. 2011: Vasopressin-dependent coupling between sodium transport and water flow in a mouse cortical collecting duct cell line. Kidney International 79(8): 843-852
Pietras, R.J. 1976: Vasopressin-induced redistribution of binding sites for concanavalin A at the surface of epithelial cells from urinary bladder. Nature 264(5588): 774-776
Handler, J.S. 1981: Vasopressin-prostaglandin interactions in the regulation of epithelial cell permeability to water. Kidney International 19(6): 831-838
Antoniou, L.D.; Burke, T.J.; Robinson, R.R.; Clapp, J.R. 1973: Vasopressin-related alterations of sodium reabsorption in the loop of Henle. Kidney International 3(1): 6-13
Vestermark, S. 1963: Vasopressin-resistant diabetes insipidus. Nordisk Medicin 69: 636-639
Ogawa, K.; Suga, H.; Ozone, C.; Sakakibara, M.; Yamada, T.; Kano, M.; Mitsumoto, K.; Kasai, T.; Kodani, Y.; Nagasaki, H.; Yamamoto, N.; Hagiwara, D.; Goto, M.; Banno, R.; Sugimura, Y.; Arima, H. 2018: Vasopressin-secreting neurons derived from human embryonic stem cells through specific induction of dorsal hypothalamic progenitors. Scientific Reports 8(1): 3615
Levine, S.D.; Franki, N.; Einhorn, R.; Hays, R.M. 1976: Vasopressin-stimulated movement of drugs and uric acid across the toad urinary bladder. Kidney International 9(1): 30-35
Borie, A.él.M.; Muscatelli, F.ço.; Desarménien, M.G.; Jeanneteau, F. 2021: Vasopressin: An effective treatment for autism spectrum disorders?. Medecine Sciences: M/S 37(10): 848-850
Buijs, R.M.; Hurtado-Alvarado, G.; Soto-Tinoco, E. 2021: Vasopressin: An output signal from the suprachiasmatic nucleus to prepare physiology and behaviour for the resting phase. Journal of Neuroendocrinology 33(7): E12998
Flanigan, M.J. 2007: Vasopressin: a look at dialysis hypertension and autonomic dysfunction. Kidney International 71(4): 285-287
Knepper, M.A.; Star, R.A. 2008: Vasopressin: friend or foe?. Nature Medicine 14(1): 14-16
Nicola, A.C.; Ferreira, L.B.; Mata, M.M.; Vilhena-Franco, T.; Leite, C.M.; Martins, A.B.; Antunes-Rodrigues, J.é; Poletini, M.O.; Dornelles, R.C.ás.M. 2021: Vasopressinergic Activity of the Suprachiasmatic Nucleus and mRNA Expression of Clock Genes in the Hypothalamus-Pituitary-Gonadal Axis in Female Aging. Frontiers in Endocrinology 12: 652733
Macfarlane, W.V.; Kinne, R.; Walmsley, C.M.; Siebert, B.D.; Peter, D. 1967: Vasopressins and the increase of water and electrolyte excretion by sheep, cattle and camels. Nature 214(5092): 979-981
Taylor, A.; Jones, T.; Forehand, C.C.; Smith, S.E.; Dykes, H.; Newsome, A.S. 2022: Vasopressor Discontinuation Order in Septic Shock with Reduced Left Ventricular Function. Journal of Pharmacy Practice 35(6): 879-885
Wiley, B.M.; Eckman, P.M.; Jentzer, J.C. 2021: Vasopressor Load: Sounding the Alarm in Management of Cardiogenic Shock Associated with Acute Myocardial Infarction. Critical Care Medicine 49(5): 865-869
Emmanuel, S.; Pearman, M.; Jansz, P.; Hayward, C. 2020: Vasopressor Requirement in Patients Undergoing Ventricular Assist Device Explant and Heart Transplant. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 39(4s): S345
Einav, S.; Helviz, Y.; Ippolito, M.; Cortegiani, A. 2021: Vasopressor and inotrope treatment for septic shock: An umbrella review of reviews. Journal of Critical Care 65: 65-71
Goradia, S.; Sardaneh, A.A.; Narayan, S.W.; Penm, J.; Patanwala, A.E. 2021: Vasopressor dose equivalence: a scoping review and suggested formula. Journal of Critical Care 61: 233-240
Dargent, A.; Quintin, L.; Jacquier, M.; Fournel, I.; Quenot, J.-P. 2020: Vasopressor for refractory septic shock: dexmedetomidine could help decrease norepinephrine requirements. Minerva Anestesiologica 86(8): 885-886
Pillay-Fuentes Lorente, V.; Van Rensburg, R.; Cloete, D.A.; Lahri, S.; Decloedt, E.H. 2020: Vasopressor therapy in atypical antipsychotic overdose. South African Medical Journal 110(10): 1003-1005
Levy, B.; Klein, T.; Kimmoun, A. 2020: Vasopressor use in cardiogenic shock. Current Opinion in Critical Care 26(4): 411-416
Jesani, S.; Elkattawy, S.; Noori, M.A.M.; Ayad, S.; Abuaita, S.; Gergis, K.; Elkattawy, O.; Garg, V. 2021: Vasopressor-Induced Digital Ischemia. Cureus 13(7): E16595
Wieruszewski, P.M.; Nelson, S.; Wittwer, E.D.; Leung, J.G. 2020: Vasopressor-Refractory Shock from Clozapine Overdose Treated with Synthetic Angiotensin Ii Infusion. Critical Care Explorations 2(9): E0185
Puntillo, F.; Giglio, M.; Pasqualucci, A.; Brienza, N.; Paladini, A.; Varrassi, G. 2020: Vasopressor-Sparing Action of Methylene Blue in Severe Sepsis and Shock: a Narrative Review. Advances in Therapy 37(9): 3692-3706
Rohm, C.L.; Gadidov, B.; Ray, H.E.; Mannino, S.F.; Prasad, R. 2021: Vasopressors and Inotropes as Predictors of Mortality in Acute Severe Cardiogenic Shock Treated with the Impella Device. Cardiovascular Revascularization Medicine: Including Molecular Interventions 31: 71-75
Shi, R.; Hamzaoui, O.; De Vita, N.; Monnet, X.; Teboul, J.-L. 2020: Vasopressors in septic shock: which, when, and how much?. Annals of Translational Medicine 8(12): 794
Dhillon, N.K.; Huang, R.; Mason, R.; Melo, N.; Margulies, D.R.; Ley, E.J.; Barmparas, G. 2020: Vasopressors in traumatic brain injury: Quantifying their effect on mortality. American Journal of Surgery 220(6): 1498-1502
Keller, M.; Magunia, H. 2021: Vasopressors: Physiology, Pharmacology and Clinical Applications. Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie: Ains 56(6): 400-413
Boulton, M.E.; McLeod, D.; Garner, A. 1988: Vasoproliferative retinopathies: clinical, morphogenetic and modulatory aspects. Eye 2 Suppl: S124-S139
Rundle, P.; Shields, J.A.; Shields, C.L.; Singh, A.D.; Peairs, R. 2000: Vasoproliferative tumour of the ocular fundus associated with Waardenburg's syndrome. Eye 14: 105-106
Jain, K.; Berger, A.R.; Yucil, Y.H.; McGowan, H.D. 2003: Vasoproliferative tumours of the retina. Eye 17(3): 364-368
Harris, A.; Ciulla, T.A.; Kagemann, L.; Zarfati, D.; Martin, B. 2000: Vasoprotection as neuroprotection for the optic nerve. Eye 14: 473-475
Pribylova, N.N.; Yakovleva, M.V.; Pribylov, C.A.; Barbashina, T.A.; Gavriljuk, E.V.; Mal, G.S.; Pribylov, V.S. 2021: Vasoprotective effects hypotensive therapy in patients with coronary heart disease combined with chronic kidney disease stage 2-3 after coronary stenting. Kardiologiia 61(8): 14-22
Lind, L.; Zethelius, B.; Sundbom, M.; Edén Engström, B.; Karlsson, F.A. 2009: Vasoreactivity is rapidly improved in obese subjects after gastric bypass surgery. International Journal of Obesity 33(12): 1390-1395
Cho, J.M.; Shiu, Y.-T.; Symons, J.D.; Lee, T. 2020: Vasoreactivity of the Murine External Jugular Vein and Carotid Artery. Journal of Vascular Research 57(5): 291-301
Brenner, R.; Peréz, G.J.; Bonev, A.D.; Eckman, D.M.; Kosek, J.C.; Wiler, S.W.; Patterson, A.J.; Nelson, M.T.; Aldrich, R.W. 2000: Vasoregulation by the beta1 subunit of the calcium-activated potassium channel. Nature 407(6806): 870-876
Kots, A.Y.; Grafov, M.A.; Khropov, Y.V.; Betin, V.L.; Belushkina, N.N.; Busygina, O.G.; Yazykova, M.Y.; Ovchinnikov, I.V.; Kulikov, A.S.; Makhova, N.N.; Medvedeva, N.A.; Bulargina, T.V.; Severina, I.S. 2000: Vasorelaxant and antiplatelet activity of 4,7-dimethyl-1,2, 5-oxadiazolo[3,4-d]pyridazine 1,5,6-trioxide: role of soluble guanylate cyclase, nitric oxide and thiols. British Journal of Pharmacology 129(6): 1163-1177
Tan, C.Shan.; Tew, W.Yin.; Jingying, C.; Yam, M.Fei. 2021: Vasorelaxant effect of 5,7,4'- Trihydroxyflavanone (Naringenin) via endothelium dependent, potassium and calcium channels in Sprague Dawley rats: Aortic ring model. Chemico-BiologicalInteractions 2021: 109620
Keeble, J.; Al-Swayeh, O.A.; Moore, P.K. 2001: Vasorelaxant effect of nitric oxide releasing steroidal and nonsteroidal anti-inflammatory drugs. British Journal of Pharmacology 133(7): 1023-1028
Yam, M.Fei.; Tan, C.Shan.; Shibao, R. 2018: Vasorelaxant effect of sinensetin via the NO/sGC/cGMP pathway and potassium and calcium channels. Hypertension Research: Official Journal of the Japanese Society of Hypertension 41(10): 787-797
Manshor, N.M.; Razali, N.; Jusoh, R.R.; Asmawi, M.Z.; Mohamed, N.; Zainol, S.; Altaf, R.; Dewa, A. 2020: Vasorelaxant effect of water fraction of Labisia Pumila and its mechanisms in spontaneously hypertensive rats aortic ring preparation. International Journal of Cardiology. Hypertension 4: 100024
Amerini, S.; Filippi, S.; Parenti, A.; Ledda, F.; Ziche, M. 1997: Vasorelaxant effects induced by the antiangiogenic drug linomide in aortic and saphenous vein preparations of the rabbit. British Journal of Pharmacology 122(8): 1739-1745
Bumjung, K.; Cheolmin, J.; Somin, L.; Hanna, C.; Kwang-Woo, K.; Inhye, H.; Ho-Young, C.; Kyungjin, L. 2020: Vasorelaxant effects of 50 commonly used traditional herbal prescriptions on isolated rat aortic rings. Journal of Traditional Chinese Medicine 40(4): 629-639
Muscará, M.N.; Lovren, F.; McKnight, W.; Dicay, M.; del Soldato, P.; Triggle, C.R.; Wallace, J.L. 2001: Vasorelaxant effects of a nitric oxide-releasing aspirin derivative in normotensive and hypertensive rats. British Journal of Pharmacology 133(8): 1314-1322
Kagota, S.; Morikawa, K.; Ishida, H.; Chimoto, J.; Maruyama-Fumoto, K.; Yamada, S.; Shinozuka, K. 2021: Vasorelaxant effects of benzodiazepines, non-benzodiazepine sedative-hypnotics, and tandospirone on isolated rat arteries. European Journal of Pharmacology 892: 173744
Hoi, P.Man.; Hiley, C.Robin. 2006: Vasorelaxant effects of oleamide in rat small mesenteric artery indicate action at a novel cannabinoid receptor. British Journal of Pharmacology 147(5): 560-568
Myers, P.R.; Minor, R.L.; Guerra, R.; Bates, J.N.; Harrison, D.G. 1990: Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 345(6271): 161-163
Sailaja, G.Rajan.; Sriramavaratharajan, V.; Murugan, R.; Mallavarapu, G.Rao.; Chellappan, D.Raj. 2021: Vasorelaxant property of Plectranthus vettiveroides root essential oil and its possible mechanism. Journal of Ethnopharmacology 274:: 114048
Fodem, C.; Nguelefack-Mbuyo, E.P.; Ndjenda Ii, M.K.; Kamanyi, A.; Nguelefack, T.él.B. 2021: Vasorelaxant-Mediated Antihypertensive Effect of the Leaf Aqueous Extract from Stephania abyssinica (Dillon and A. Rich) Walp (Menispermaceae) in Rat. Biomed Research International 2021: 4730341
Yasutsune, T.; Kawakami, N.; Hirano, K.; Nishimura, J.; Yasui, H.; Kitamura, K.; Kanaide, H. 1999: Vasorelaxation and inhibition of the voltage-operated Ca2+ channels by FK506 in the porcine coronary artery. British Journal of Pharmacology 126(3): 717-729
Foudi, N.; Kotelevets, L.; Louedec, L.; Leséche, G.; Henin, D.; Chastre, E.; Norel, X. 2008: Vasorelaxation induced by prostaglandin E2 in human pulmonary vein: role of the EP4 receptor subtype. British Journal of Pharmacology 154(8): 1631-1639
Morone, P.J.; Yan, W.; Adcock, J.; Komalavilas, P.; Mocco, J.; Thompson, R.C.; Brophy, C.; Cheung-Flynn, J. 2021: Vasorelaxing cell permeant phosphopeptide mimetics for subarachnoid hemorrhage. European Journal of Pharmacology 900: 174038
Balasekaran, N.; Soelar, S.A.; Anbarasen, L.; Cham, C.Y.; Rajandram, R.; Sia, S.F. 2021: Vasospasm and delayed cerebral ischaemia in patients with spontaneous subarachnoid haemorrhage (aneurysmal and pretruncal non-aneurysmal): a centre's perspective. Medical Journal of Malaysia 76(1): 17-23
Ivanidze, J.; Sanelli, P.C. 2021: Vasospasm: Role of Imaging in Detection and Monitoring Treatment. Neuroimaging Clinics of North America 31(2): 147-155
Weir, B. 2020: Vasospasm: does it cause infarction and poor outcome?. Journal of Neurosurgery 134(3): 1006-1011
Jiang, M.; Kaplan, R.M.; Peigh, G.; Cheema, B.; Sawicki, K.T.; Pfenniger, A.; Davidson, L.; Kim, S.S. 2020: Vasospastic Arrest:: a Heart-Stopping Case of Prinzmetal Angina. JACC. Case Reports 2(4): 611-614
Maruta, S.; Usami, K.; Tajiri, K.; Otani, M.; Hiraya, D.; Watabe, H.; Hoshi, T.; Sato, A.; Ieda, M. 2021: Vasospastic angina in a chronic myeloid leukemia patient treated with nilotinib. Cardio-Oncology 7(1): 31
Kula, S. 2008: Vasospastic angina mimicking inferior myocardial infarction due to high dose cyclophosphamide for bone marrow transplantation conditioning. Anadolu Kardiyoloji Dergisi: Akd 8(6): 463-4; Author Reply 464
Petrakopoulou, P.; Franz, W.M.; Boekstegers, P.; Weis, M. 2005: Vasospastic angina pectoris associated with Churg-Strauss syndrome. Nature Clinical Practice. Cardiovascular Medicine 2(9): 484-9; Quiz 490
Bernard, K.; Bogliolo, Séphanie.; Ehrenfeld, J. 2005: Vasotocin and vasopressin stimulation of the chloride secretion in the human bronchial epithelial cell line, 16HBE14o-. British Journal of Pharmacology 144(8): 1037-1050
Singh, V.; Chaube, R.; Joy, K.P. 2021: Vasotocin stimulates maturation-inducing hormone, oocyte maturation and ovulation in the catfish Heteropneustes fossilis: Evidence for a preferential calcium involvement. Theriogenology 167: 51-60
Hasan, I.; Arshad, A.; Rahim, N.A.; Soo, P.Y. 2020: Vasovagal reaction among whole blood donors in Hospital Pulau Pinang. a statistical-epidemiological study. Asian Journal of Transfusion Science 14(1): 28-32
Dalile, B.; Verbeke, K.; Van Oudenhove, L. 2021: Vasovagal reactions following venepuncture result in aberrant stress-induced cortisol levels. Psychoneuroendocrinology 128: 105220
Wang, A.-P.; Zheng, J.; Wang, C.; Cai, H.; Mao, D.-A.; Lin, P.; Li, F.; Luo, H.-Y.; Xiong, J.-J.; Liu, L.-Q. 2020: Vasovagal syncope or postural orthostatic tachycardia syndrome in children with neurological symptoms at disease onset: a clinical analysis of 88 cases. Zhongguo Dang Dai Er Ke Za Zhi 22(5): 488-493
Kamar, S.; Hallit, S.; Chamandi, S. 2021: Vasovagal syncope related to pain procedures in a pain clinic at a tertiary Lebanese hospital between 2016 and 2019. Bmc Research Notes 14(1): 133
Yarbro, E.S.; Howards, S.S. 1987: Vasovasostomy. Urologic Clinics of North America 14(3): 515-526
Scholtmeijer, R.J. 1982: Vasovasostomy. Nederlands Tijdschrift Voor Geneeskunde 126(30): 1373-1374
Grzelak, T.; Tyszkiewicz-Nwafor, M.; Dutkiewicz, A.; Mikulska, A.A.; Dmitrzak-Weglarz, M.; Slopien, A.; Czyzewska, K.; Paszynska, E. 2021: Vaspin (but not neuropeptide B or neuropeptide W) as a possible predictor of body weight normalization in anorexia nervosa. Archives of Medical Science: Ams 17(2): 376-381
Zhang, D.; Zhu, H.; Zhan, E.; Wang, F.; Liu, Y.; Xu, W.; Liu, X.; Liu, J.; Li, S.; Pan, Y.; Wang, Y.; Cao, W. 2021: Vaspin Mediates the Intraorgan Crosstalk Between Heart and Adipose Tissue in Lipoatrophic Mice. Frontiers in Cell and Developmental Biology 9: 647131
Rueda-Gotor, J.; López-Mejías, R.; Remuzgo-Martínez, S.; Pulito-Cueto, V.ón.; Corrales, A.; Lera-Gómez, L.; Portilla, V.; González-Mazón, Íñi.; Blanco, R.; Expósito, R.; Mata, C.; Llorca, J.; Hernández-Hernández, V.; Rodríguez-Lozano, C.; Barbarroja, N.; Castro, R.O.; Vicente, E.; Fernández-Carballido, C.; Martínez-Vidal, M.ía.P.; Castro-Corredor, D.; Anino-Fernández, J.ín.; Peiteado, D.; Plasencia-Rodríguez, C.; Galíndez-Agirregoikoa, E.; García-Vivar, M.ía.L.; Gualillo, O.; Quevedo-Abeledo, J.C.; Castañeda, S.; Ferraz-Amaro, I.án.; González-Gay, M.Á; Genre, F. 2021: Vaspin in atherosclerotic disease and cardiovascular risk in axial spondyloarthritis: a genetic and serological study. Arthritis Research and Therapy 23(1): 111
Körner, A.; Neef, M.; Friebe, D.; Erbs, S.; Kratzsch, J.; Dittrich, K.; Blüher, S.; Kapellen, T.M.; Kovacs, P.; Stumvoll, M.; Blüher, M.; Kiess, W. 2011: Vaspin is related to gender, puberty and deteriorating insulin sensitivity in children. International Journal of Obesity 35(4): 578-586
He, H.; Lu, M.; Shi, H.; Yue, G.; Luo, H. 2021: Vaspin regulated cartilage cholesterol metabolism through miR155/LXRα and participated in the occurrence of osteoarthritis in rats. Life Sciences 269: 119096
Liu, Y.; Xu, F.; Pei, H-Xia.; Zhu, X.; Lin, X.; Song, C-Yuan.; Liang, Q-Hua.; Liao, E-Yuan.; Yuan, L-Qing. 2016: Vaspin regulates the osteogenic differentiation of MC3T3-E1 through the PI3K-Akt/miR-34c loop. Scientific Reports 6: 25578
Wiens, J.J. 2021: Vast (but avoidable) underestimation of global biodiversity. Plos Biology 19(8): E3001192
Kolibius, L.D.; Born, J.; Feld, G.B. 2020: Vast Amounts of Encoded Items Nullify but do not Reverse the Effect of Sleep on Declarative Memory. Frontiers in Psychology 11: 607070
Ellegaard, K.M.; Suenami, S.; Miyazaki, R.; Engel, P. 2020: Vast Differences in Strain-Level Diversity in the Gut Microbiota of two Closely Related Honey Bee Species. Current Biology: Cb 30(13): 2520-2531.E7
Ivanovs, A.; Rybtsov, S.; Anderson, R.A.; Medvinsky, A. 2020: Vast Self-Renewal Potential of Human AGM Region HSCs Dramatically Declines in the Umbilical Cord Blood. Stem Cell Reports 15(4): 811-816
Wang, D.; Garcia, H.; Huang, W.; Tran, D.D.; Jain, A.D.; Yi, D.Hoon.; Gong, Z.; Jech, J.Michael.; Godø, O.Rune.; Makris, N.C.; Ratilal, P. 2016: Vast assembly of vocal marine mammals from diverse species on fish spawning ground. Nature 531(7594): 366-370
Vachon, R.; Montbarbon 1947: Vast cancer developed on a lightning burn scar. Lyon Medical 179(14): 240
Whiteman, G.; Hope, C.; Wadhams, P. 2013: Vast costs of Arctic change. Nature 499(7459): 401-403
Flandin 1947: Vast ulcerative dermatosis of the lumbar region following an injection for experience in a concentration camp in Germany (37 year old woman). Annales de Dermatologie et de Syphiligraphie 7(3): 141
De Grailly; Moncourier; Biraben 1948: Vast ulcerative epitheloma of the neck held back and slightly in regression under the influence of the vaccine virus. JournaldeMedecinedeBordeauxetduSud-Ouest 125(10): 458
Shen, Z.; Yao, C.; Wang, Z.; Yue, L.; Fang, Z.; Yao, H.; Lin, F.; Zhao, H.; Sun, Y-Jue.; Bian, X-Wu.; Jiang, W.; Wang, X.; Li, Y.; Lu, G.; Poon, W.Sang.; Kung, H-Fu.; Lin, M.Chia-Mi. 2016: Vastatin, an Endogenous Antiangiogenesis Polypeptide That Is Lost in Hepatocellular Carcinoma, Effectively Inhibits Tumor Metastasis. Molecular Therapy: the Journal of the American Society of Gene Therapy 24(8): 1358-1368
Kwon, S.H.; Kim, B.H.; Kim, D.W.; Yoon, H.; Yoon, Y.J. 2020: Vastly enhanced photoresponsivities of phase-controlled tin sulfide thin films. Nanotechnology 31(37): 375702
D'Amato, A.R.; Puhl, D.L.; Ellman, S.A.T.; Balouch, B.; Gilbert, R.J.; Palermo, E.F. 2019: Vastly extended drug release from poly(pro-17β-estradiol) materials facilitates in vitro neurotrophism and neuroprotection. Nature Communications 10(1): 4830
Girts, R.M.; Mota, J.A.; Harmon, K.K.; MacLennan, R.J.; Stock, M.S. 2020: Vastus Lateralis Motor Unit Recruitment Thresholds Are Compressed towards Lower Forces in Older Men. Journal of Frailty and Aging 9(4): 191-196
Coratella, G.; Longo, S.; Borrelli, M.; Doria, C.; Cè, E.; Esposito, F. 2020: Vastus intermedius muscle architecture predicts the late phase of the knee extension rate of force development in recreationally resistance-trained men. Journal of Science and Medicine in Sport 23(11): 1100-1104
Domroes, T.; Laube, G.; Bohm, S.; Arampatzis, A.; Mersmann, F. 2021: Vastus lateralis muscle volume prediction in early-adolescent boys. Journal of Biomechanics 128: 110735
Tsujii, M.; Matsumine, A.; Nakamura, T.; Satonaka, H.; Sudo, A. 2020: Vastus lateralis myocutaneous flap for ischial skin wound following the treatment of epithelioid sarcoma using pazopanib. Journal of Wound Care 29(6): 335-339
Xu, X.; Awad, A.; Robles-Martinez, P.; Gaisford, S.; Goyanes, A.; Basit, A.W. 2021: Vat photopolymerization 3D printing for advanced drug delivery and medical device applications. Journal of Controlled Release: Official Journal of the Controlled Release Society 329: 743-757
Marques, G.F.O.; Pires, A.F.; Osterne, V.J.S.; Pinto-Junior, V.R.; Silva, I.B.; Martins, M.G.Q.; Oliveira, M.V.; Gomes, A.M.; de Souza, L.A.G.; Pavão, M.S.ér.G.ça.; Cavada, B.S.; Assreuy, A.M.S.; Nascimento, K.S. 2021: Vatairea guianensis lectin stimulates changes in gene expression and release of TNF-α from rat peritoneal macrophages via glycoconjugate binding. Journal of Molecular Recognition: Jmr 34(10): E2922
Joensuu, H.; De Braud, F.; Grignagni, G.; De Pas, T.; Spitalieri, G.; Coco, P.; Spreafico, C.; Boselli, S.; Toffalorio, F.; Bono, P.; Jalava, T.; Kappeler, C.; Aglietta, M.; Laurent, D.; Casali, P.G. 2011: Vatalanib for metastatic gastrointestinal stromal tumour (GIST) resistant to imatinib: final results of a phase II study. British Journal of Cancer 104(11): 1686-1690
Pavlovsky, A.J. 1946: Vater's blister tumor. Boletines y Trabajos de la Academia Argentina de Cirugia. Academia Argentina de Cirugia 30(5): 190
Vignalou, J. 1948: Vater's bulb cancer. L' Hopital 36(559): 36-38
Caroli, J. 1949: Vater's bulb cancer diagnosis. La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 25(31): 1314-1322
Chalnot; Lochard; Guillaume 1950: Vaterian ampulloma; duodeno-pancreatectomy in one step; operative healing. Lyon Chirurgical 45(2): 252-256
Bosch, X. 2001: Vatican approves use of animal transplants 'to benefit humans'. Nature 413(6855): 445
Goodhart, C.B. 1994: Vatican error?. Nature 369(6483): 700
Meldolesi, A. 2011: Vatican panel backs GMOs. Nature Biotechnology 29(1): 11
Inoue, C.; Sobue, S.; Mizutani, N.; Kawamoto, Y.; Nishizawa, Y.; Ichihara, M.; Takeuchi, T.; Hayakawa, F.; Suzuki, M.; Ito, T.; Nozawa, Y.; Murate, T. 2020: Vaticanol C, a phytoalexin, induces apoptosis of leukemia and cancer cells by modulating expression of multiple sphingolipid metabolic enzymes. Nagoya Journal of Medical Science 82(2): 261-280
Kreft, C.; Menard, J.; Corvol, P. 1979: Vaule of renin measurement, saralasin test, and acebutolol treatment in hypertension. Kidney International 15(2): 176-183
Hahne, J.C.; Lampis, A.; Valeri, N. 2021: Vault RNAs: hidden gems in RNA and protein regulation. Cellular and Molecular Life Sciences: Cmls 78(4): 1487-1499
Xiong, Y.; Mao, Y.; Li, J.; Wan, X.; Li, M.; Zhang, J.; Wang, J.; Sun, X. 2021: Vault changes and pupillary responses to light in myopic and toric implantable collamer lens. Bmc Ophthalmology 21(1): 366
DeFranco, A.L. 2001: Vav and the B cell signalosome. Nature Immunology 2(6): 482-484
Löber, J.; Hitzing, C.; Münchhalfen, M.; Engels, N. 2020: Vav family proteins constitute disparate branching points for distinct BCR signaling pathways. European Journal of Immunology 50(12): 1912-1928
Lorenzo-Martín, L.Francisco.; Citterio, C.; Menacho-Márquez, M.; Conde, J.; Larive, R.M.; Rodríguez-Fdez, S.; García-Escudero, Rón.; Robles-Valero, J.; Cuadrado, M.; Fernández-Pisonero, I.; Dosil, M.; Sevilla, Mía.A.; Montero, Mía.J.; Fernández-Salguero, P.M.; Paramio, Jús.M.; Bustelo, Xé.R. 2019: Vav proteins maintain epithelial traits in breast cancer cells using miR-200c-dependent and independent mechanisms. Oncogene 38(2): 209-227
Bustelo, X.R. 2001: Vav proteins, adaptors and cell signaling. Oncogene 20(44): 6372-6381
Turner, S.D.; Tooze, R.; Maclennan, K.; Alexander, D.R. 2003: Vav-promoter regulated oncogenic fusion protein NPM-ALK in transgenic mice causes B-cell lymphomas with hyperactive Jun kinase. Oncogene 22(49): 7750-7761
Shalom, B.; Farago, M.; Pikarsky, E.; Katzav, S. 2018: Vav1 mutations identified in human cancers give rise to different oncogenic phenotypes. Oncogenesis 7(10): 80
Tsou, Y.-S.; Wang, C.-Y.; Chang, M.-Y.; Hsu, T.-I.; Wu, M.-T.; Wu, Y.-H.; Tsai, W.-L.; Chuang, J.-Y.; Kao, T.-J. 2022: Vav2 is required for Netrin-1 receptor-class-specific spinal motor axon guidance. Developmental Dynamics: An Official Publication of the American Association of Anatomists 251(3): 444-458
Lorenzo-Martín, L.Francisco.; Rodríguez-Fdez, S.; Fabbiano, S.; Abad, A.; García-Macías, Mía.C.; Dosil, M.; Cuadrado, M.; Robles-Valero, J.; Bustelo, Xé.R. 2020: Vav2 pharmaco-mimetic mice reveal the therapeutic value and caveats of the catalytic inactivation of a Rho exchange factor. Oncogene 39(28): 5098-5111
Badaoui, M.; Zoso, A.; Idris, T.; Bacchetta, M.; Simonin, J.; Lemeille, S.; Wehrle-Haller, B.; Chanson, M. 2020: Vav3 Mediates Pseudomonas aeruginosa Adhesion to the Cystic Fibrosis Airway Epithelium. Cell Reports 32(1): 107842
Sauzeau, V.; Sevilla, Mía.A.; Rivas-Elena, J.V.; de Alava, E.; Montero, Mía.J.; López-Novoa, Jé.M.; Bustelo, Xé.R. 2006: Vav3 proto-oncogene deficiency leads to sympathetic hyperactivity and cardiovascular dysfunction. Nature Medicine 12(7): 841-845
Faccio, R.; Teitelbaum, S.L.; Fujikawa, K.; Chappel, J.; Zallone, A.; Tybulewicz, V.L.; Ross, F.Patrick.; Swat, W. 2005: Vav3 regulates osteoclast function and bone mass. Nature Medicine 11(3): 284-290
Valcaneras 1945: Vavus to unique godet; primitive inoculation in lamellar skin. Actas Dermo-Sifiliograficas 37: 409-411
Byrne-Nash, R.T.; Miller, D.F.; Bueter, K.M.; Gillis, J.H.; Kuck, L.R.; Rowlen, K.L. 2018: VaxArray potency assay for rapid assessment of "pandemic" influenza vaccines. Npj Vaccines 3: 43
Berke, K.; Sun, P.; Ong, E.; Sanati, N.; Huffman, A.; Brunson, T.; Loney, F.; Ostrow, J.; Racz, R.; Zhao, B.; Xiang, Z.; Masci, A.M.; Zheng, J.; Wu, G.; He, Y. 2021: VaximmutorDB: a Web-Based Vaccine Immune Factor Database and its Application for Understanding Vaccine-Induced Immune Mechanisms. Frontiers in Immunology 12: 639491
Goodyear-Smith, F.; Darragh, M.; Warren, J. 2021: VeCHAT: a proof-of-concept study on screening and managing veterans. Journal of Primary Health Care 13(1): 75-83
Hepworth, L.; Rowe, F.; Waterman, H. 2019: VeRSE: Vertical Reading Strategy Efficacy for Homonymous Hemianopia after Stroke: a Feasibility Study. British and Irish Orthoptic Journal 15(1): 28-35
Verla, W.; Waterloos, M.; Waterschoot, M.; Van Parys, B.; Spinoit, A.-F.ço.; Lumen, N. 2020: VeSpAR trial: a randomized controlled trial comparing vessel-sparing anastomotic repair and transecting anastomotic repair in isolated short bulbar urethral strictures. Trials 21(1): 782
Fenard, D.; Ingrao, D.; Seye, A.; Buisset, J.; Genries, S.; Martin, S.; Kichler, A.; Galy, A. 2013: Vectofusin-1, a new viral entry enhancer, strongly promotes lentiviral transduction of human hematopoietic stem cells. Molecular Therapy. Nucleic Acids 2: E90
Deglaude, L.; Laurens, P. 1954: Vectographic diagnosis of myocardial infarction associated with a branch block. Archives des Maladies du Coeur et des Vaisseaux 47(7): 579-590
Meyer, P.; Herr, R. 1946: Vectographic studies during myocardial infarction. Archives des Maladies du Coeur et des Vaisseaux 39(5-6): 203-208
Kaufmann, H.; Nory, J. 1948: Vectographic study of a right block during a calcifying pericarditis; semiological value of the fixation of the vectogram in forced inspiration and expiration. Archives des Maladies du Coeur et des Vaisseaux 41(12): 735-738
Brand, J.; Moran, J.; Yoo, B. 2021: Vector Appropriate Distraction and Reduction of a Neglected Trimalleolar Fracture-Dislocation Performed with a Temporary Intraoperative External Fixator. Case Reports in Orthopedics 2021: 5577626
Moreno, I.; Davis, J.A.; Badham, K.; Sánchez-López, Mía.M.; Holland, J.E.; Cottrell, D.M. 2017: Vector Beam Polarization State Spectrum Analyzer. Scientific Reports 7(1): 2216
Azar, S.R.; Weaver, S.C. 2020: Vector Competence Analyses on Aedes aegypti Mosquitoes using Zika Virus. Journal of Visualized Experiments: Jove 2020(159)
Wei, Y.; Wang, J.; Wei, Y.-H.; Song, Z.; Hu, K.; Chen, Y.; Zhou, G.; Zhong, D.; Zheng, X. 2021: Vector Competence for DENV-2 Among Aedes albopictus (Diptera: Culicidae) Populations in China. Frontiers in Cellular and Infection Microbiology 11: 649975
Sullivan, W. 2020: Vector Control: Wolbachia Expands its Protective Reach from Humans to Plants. Current Biology: Cb 30(24): R1489-R1491
Santeramo, I.; Bagnati, M.; Harvey, E.J.; Hassan, E.; Surmacz-Cordle, B.; Marshall, D.; Di Cerbo, V. 2020: Vector Copy Distribution at a Single-Cell Level Enhances Analytical Characterization of Gene-Modified Cell Therapies. Molecular Therapy. Methods and Clinical Development 17: 944-956
Hansen, K.L.; Hansen, P.M.øl.; Ewertsen, C.; Lönn, L.; Jensen, J.ør.A.; Nielsen, M.B. 2019: Vector Flow Imaging Compared with Digital Subtraction Angiography for Stenosis Assessment in the Superficial Femoral Artery - a Study of Vector Concentration, Velocity Ratio and Stenosis Degree Percentage. Ultrasound International Open 5(2): E53-E59
Zuo, X.; Yuan, M.; Jia, H.; Zhang, M.; Zhang, C.; Zhi, G. 2021: Vector Flow Mapping Application in Local Cardiac Function in Hypertension Assessment. International Journal of General Medicine 14: 4793-4801
Dong, G.H.; Zhang, Z.W.; Sun, C.P.; Gong, Z.R. 2017: Vector Form of Symmetry Degree. Scientific Reports 7(1): 12947
Yu, J.; Ciaudo, C. 2017: Vector Integration Sites Identification for Gene-Trap Screening in Mammalian Haploid Cells. Scientific Reports 7: 44736
Khonina, S.N.; Ustinov, A.V.; Porfirev, A.P. 2020: Vector Lissajous laser beams. Optics Letters 45(15): 4112-4115
Arif, S.; Khan, M.J.; Naseer, N.; Hong, K.-S.; Sajid, H.; Ayaz, Y. 2021: Vector Phase Analysis Approach for Sleep Stage Classification: a Functional Near-Infrared Spectroscopy-Based Passive Brain-Computer Interface. Frontiers in Human Neuroscience 15: 658444
Browning, R. 2020: Vector Potential Photoelectron Microscopy Instrument Design. Ultramicroscopy 215: 113022
Jeske, A.M.; Boucher, P.; Curiel, D.T.; Voss, J.E. 2021: Vector Strategies to Actualize B Cell-Based Gene Therapies. Journal of Immunology 207(3): 755-764
Ni, J-Quan.; Markstein, M.; Binari, R.; Pfeiffer, B.; Liu, L-Ping.; Villalta, C.; Booker, M.; Perkins, L.; Perrimon, N. 2008: Vector and parameters for targeted transgenic RNA interference in Drosophila melanogaster. Nature Methods 5(1): 49-51
Jiang, L.; Yang, S.; Tsang, B.; Tu, M.; Granick, S. 2017: Vector assembly of colloids on monolayer substrates. Nature Communications 8: 15778
Shaw, W.Robert.; Catteruccia, F. 2019: Vector biology meets disease control: using basic research to fight vector-borne diseases. Nature Microbiology 4(1): 20-34
Rabinowitz, J.E.; Samulski, R.J. 2002: Vector biophysics: crystal-clear view. Gene Therapy 9(21): 1413-1414
Du, R.; Fang, X.; Gao, Y. 2021: Vector bundles on rational homogeneous spaces. Annali di Matematica Pura Ed Applicata 200(6): 2797-2827
Averlant, E.; Tlidi, M.; Thienpont, H.; Ackemann, T.; Panajotov, K. 2016: Vector cavity solitons in broad area Vertical-Cavity Surface-Emitting Lasers. Scientific Reports 6: 20428
Wu, Z.; Wang, X.; Sun, W.; Feng, S.; Han, P.; Ye, J.; Zhang, Y. 2017: Vector characterization of zero-order terahertz Bessel beams with linear and circular polarizations. Scientific Reports 7(1): 13929
Verly, T.; Costa, S.; Lima, N.; Mallet, J.; Odêncio, F.; Pereira, M.; Moreira, C.J.é d.C.; Britto, C.ça.; Pavan, M.ár.G. 2020: Vector competence and feeding-excretion behavior of Triatoma rubrovaria (Blanchard, 1843) (Hemiptera: Reduviidae) infected with Trypanosoma cruzi TcVi. Plos Neglected Tropical Diseases 14(9): E0008712